Updated on 2024/04/04

写真a

 
FUKUDA Daiju
 
Organization
Graduate School of Medicine Department of Clinical Medical Science Professor
School of Medicine Department of Medical Science
Title
Professor
Affiliation
Institute of Medicine

Position

  • Graduate School of Medicine Department of Clinical Medical Science 

    Professor  2022.04 - Now

  • School of Medicine Department of Medical Science 

    Professor  2022.04 - Now

Degree

  • 博士(医学) ( Osaka City University )

Research Areas

  • Life Science / Cardiology

Research Interests

  • 血管生物学

  • 血管内皮機能

  • 炎症

  • 動脈硬化

  • 免疫

  • メタボリック症候群

Professional Memberships

  • European Society of Cardiolog

  • American Heart Association

  • 日本腫瘍循環器学会

  • 日本心臓病学会

  • 日本心脈管作動物質学会

  • 日本血管不全学会

  • 日本血管生物医学会

  • 日本動脈硬化学会

  • 日本循環器学会

  • 日本内科学会

▼display all

Awards

  • 徳島大学医歯薬学研究部長表彰

    2019   徳島大学  

  • 徳島大学医歯薬学研究部長表彰

    2019   徳島大学  

  • 第10回井村臨床研究奨励賞

    2013   公益財団法人 成人血管病研究振興財団  

  • The 2nd Annual Obesity Research Incubator Session Award

    2012   The Cardiovascular, Diabetes and Metabolic Diseases Research Center at the BWH Biomedical Research Institute  

  • Young Investigator’s Award

    2010  

  • Young Investigator’s Award

    2007  

  • Intervention Research Award

    2006  

  • The CCT 2004 Award for Excellent presentation

    2004  

▼display all

Job Career (off-campus)

  • 大阪公立大学大学院医学研究科 循環器内科学・教授

    2022.04 - Now

  • 大阪市立大学大学院医学研究科 循環器内科学・教授

    2022.01 - 2022.03

  • 徳島大学大学院医歯薬学研究部循環器内科学分野・特任准教授

    2021.01 - 2021.12

  • 徳島大学大学院医歯薬学研究部心臓血管病態医学分野・特任准教授

    2019.07 - 2020.12

  • 徳島大学大学院医歯薬学研究部心臓血管病態医学分野・特任講師

    2016.11 - 2019.06

Papers

  • Leadless Pacemaker Implantation in Severe Kyphosis: Challenging Implantation for Tortuous IVC and Narrow RA

    Sakamoto S.

    JACC: Case Reports   29 ( 9 )   2024.05

     More details

  • Thoracic Aortic Plaque Burden and Prediction of Cardiovascular Events in Patients Undergoing 320-row Multidetector CT Coronary Angiography

    Otsuka Kenichiro, Ishikawa Hirotoshi, Yamaura Hiroki, Hojo Kana, Kono Yasushi, Shimada Kenei, Kasayuki Noriaki, Fukuda Daiju

    Journal of Atherosclerosis and Thrombosis   31 ( 3 )   273 - 287   2024.03( ISSN:13403478

     More details

    <p> <b>Aim:</b> Wide volume scan (WVS) coronary computed tomography angiography (CCTA) enables aortic arch visualization. This study assessed whether the thoracic aortic plaque burden (TAPB) score can predict major cardiovascular adverse events (MACE) in addition to and independently of other obstructive coronary artery disease (CAD) attributes.</p><p><b>Methods:</b> This study included patients with suspected CAD who underwent CCTA (<i>n</i>=455). CCTA-WVS was used to assess CAD and the prognostic capacity of TAPB scores. Data analysis included the coronary artery calcification score (CACS), CAD status and extent, and TAPB score, calculated as the sum of plaque thickness and plaque angle at five thoracic aortic segments. The primary endpoint was MACE defined as a composite event comprised of ischemic stroke, acute coronary syndrome, and cardiovascular death.</p><p> <b>Results:</b> During a mean follow-up period of 2.8±0.9 years, 40 of 455 (8.8%) patients experienced MACE. In the Cox proportional hazards model adjusted for clinical risks (Suita cardiovascular disease risk score), we identified TAPB score (T3) as a predictor of MACE independent of CACS >400 (hazards ratio [HR], 2.91; 95% confidence interval [CI], 1.26–6.72; <i>p</i>=0.012) or obstructive CAD (HR, 2.83; 95% CI, 1.30–6.18; <i>p</i>=0.009). The area under the curve for predicting MACE improved from 0.75 to 0.795 (<i>p</i> value=0.008) when TAPB score was added to CACS >400 and obstructive CAD.</p><p> <b>Conclusions:</b> We found that comprehensive non-invasive evaluation of TAPB and CAD has prognostic value in MACE risk stratification for suspected CAD patients undergoing CCTA.</p>

    DOI: 10.5551/jat.64251

    PubMed

  • Utility and optimal dose of nicorandil for physiological assessment of the femoropopliteal artery

    Yoshioka N.

    Catheterization and Cardiovascular Interventions   103 ( 4 )   670 - 677   2024.03( ISSN:15221946

     More details

  • Impact of diabetes mellitus and triglyceride glucose index on mortality and cardiovascular outcomes in patients with chronic coronary syndrome undergoing coronary computed tomography angiography

    Otsuka K.

    International Journal of Cardiology: Cardiovascular Risk and Prevention   20   2024.03

     More details

  • Exosomal miR206 Secreted From Growing Muscle Promotes Angiogenic Response in Endothelial Cells

    Hayashi Hiroya, Izumiya Yasuhiro, Ishida Toshifumi, Arima Yuichiro, Hayashi Ou, Yoshiyama Minoru, Tsujita Kenichi, Fukuda Daiju

    Circulation Journal   88 ( 3 )   425 - 433   2024.02( ISSN:13469843

     More details

    <p><b><i>Background:</i></b> Resistance exercise is beneficial in patients with lower extremity arterial disease. Muscle-derived exosomes contain many types of signaling molecules, including microRNAs (miRNAs). Here, we tested the hypothesis that exosomal miRNAs secreted by growing muscles promote an angiogenic response in endothelial cells (ECs).</p><p><b><i>Methods and Results:</i></b> Skeletal muscle-specific conditional Akt1 transgenic (Akt1-TG) mice, in which skeletal muscle growth can be induced were used as a model of resistance training. Remarkable skeletal muscle growth was observed in mice 2 weeks after gene activation. The protein amount in exosomes secreted by growing muscles did not differ between Akt1-TG and control mice. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway frequency analysis of 4,665 target genes, identified using an miRNA array miRNAs, revealed a significant increase in Akt and its downstream signaling pathway genes. Among the upregulated miRNAs, miR1, miR133, and miR206 were significantly upregulated in the serum of Akt1-TG mice. miR206 was also increased in insulin-like growth factor (IGF)-1-stimulated hypertrophied myotubes. Exogenous supplementation of exosomal miR206 to human umbilical vein ECs promoted angiogenesis, as assessed using the spheroid assay, and increased the expression of angiogenesis-related transcripts.</p><p><b><i>Conclusions:</i></b> Exosomal miR206 is upregulated in the blood of Akt1-TG mice and in IGF-stimulated cultured myotubes. Exogenous supplementation of miR206 promoted an angiogenic response in ECs. Our data suggest that miR206 secreted from growing muscles acts on ECs and promotes angiogenesis.</p>

    DOI: 10.1253/circj.cj-23-0353

    PubMed

  • Magnetic Resonance Imaging-Guided Intravenous Thrombolysis for Unknown Onset Cardiogenic Stroke

    Kure Yusuke, Otsuka Kenichiro, Fukuda Daiju

    Circulation Journal   88 ( 3 )   388 - 389   2024.02( ISSN:13469843

  • Narrow QRS Antidromic Tachycardia Utilizing a Slow-Conducting Bypass Tract

    Doi A.

    JACC: Clinical Electrophysiology   10 ( 2 )   439 - 446   2024.02( ISSN:2405500X

     More details

  • Unique Extraction of a Fractured Pacemaker Lead Adhered to the Spermatic Vein

    Sakamoto S.

    JACC: Case Reports   29 ( 2 )   2024.01

     More details

  • Sex differences in the association between epicardial adipose tissue volume and left atrial volume index.

    Satoshi Yamaguchi, Minetaka Maeda, Kageyuki Oba, Gulinu Maimaituxun, Osamu Arasaki, Shusuke Yagi, Kenya Kusunose, Takeshi Soeki, Hirotsugu Yamada, Daiju Fukuda, Hiroaki Masuzaki, Masataka Sata, Michio Shimabukuro

    BMC cardiovascular disorders   24 ( 1 )   46 - 46   2024.01

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: Sex disparities in the association between epicardial adipose tissue volume (EATV) and cardiovascular disease have been reported. The sex-dependent effects of EATV on left atrial (LA) size have not been elucidated. METHODS: Consecutive 247 subjects (median 65 [interquartile range 57, 75] years; 67% of men) who underwent multi-detector computed tomography without significant coronary artery disease or moderate to severe valvular disease were divided into two groups: patients with sinus rhythm (SR) or atrial fibrillation (AF). Sex differences in the association between the EATV index (EATVI) (mL/m2) and LA volume index (LAVI) in 63 SR (28 men and 35 women) and 184 AF (137 men and 47 women) patients were evaluated using univariate and multivariate regression analyses. RESULTS: In overall that includes both men and women, the relationship between EATVI and LAVI was not significantly correlated for patients with SR and AF. The relationship between EATVI and LAVI differed between men and women in both SR and AF groups. In SR patients, there was a positive relationship between EATVI and LAVI in men, but not in women. In contrast, in patients with AF, a negative relationship was found between EATVI and LAVI in women, whereas no association was found in men. CONCLUSIONS: We evaluated sex differences in the association between EATVI and LAVI in patients with either SR or AF, and found a positive relationship in men with SR and a negative relationship in women with AF. This is the first report to evaluate sex differences in the relationship between EATVI and LAVI, suggesting that EAT may play a role, at least in part, in sex differences in the etiology of AF.

    DOI: 10.1186/s12872-023-03569-1

    PubMed

  • Acute thrombus formation following stent implantation diagnosed by using intravascular polarimetry

    Shimada T.

    European Heart Journal   45 ( 2 )   2024.01( ISSN:0195668X

     More details

  • Effective ablation of atrial tachycardia with an epicardial circuit—insights from endocardial scars sites: a case study

    Tamura S.

    Journal of Interventional Cardiac Electrophysiology   67 ( 1 )   1 - 3   2024.01( ISSN:1383875X

     More details

  • Hemoglobin is an independent predictor of improvement exercise tolerance in male patients with non-ischemic cardiomyopathy

    Tanihata A.

    Heart and Vessels   2024( ISSN:09108327

     More details

  • Severe Left Main Coronary Artery Stenosis and Aortic Regurgitation in a Patient Presenting with Takayasu Arteritis

    Tanihata Akiko, Shibata Atsushi, Teragaki Kazutoshi, Yoshida Toshitake, Kitada Ryoko, Morisaki Akimasa, Ito Asahiro, Izumiya Yasuhiro, Fukuda Daiju

    Internal Medicine   advpub ( 0 )   2024( ISSN:09182918

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    <p>We herein report the case of a 46-year-old woman with Takayasu arteritis (TA), severe stenosis in the left main coronary artery (LMCA), and severe aortic regurgitation. Prednisolone and tacrolimus were initiated as TA treatments. Two months after initiating medical therapy, the aortic regurgitation severity improved to a moderate grade, although there was no obvious improvement in LMCA stenosis. Thus, after confirming the resolution of inflammation, we performed coronary artery bypass grafting alone without any aortic valve intervention. In TA patients with severe LMCA stenosis, surgical management of the coronary artery should therefore be considered only after successfully administering anti-inflammatory therapy. </p>

    DOI: 10.2169/internalmedicine.3032-23

    PubMed

  • Elevation of end-tidal CO2 during exercise is attenuated in patients with cardiac amyloidosis.

    Atsushi Shibata, Yasuhiro Izumiya, Toshitake Yoshida, Akiko Tanihata, Yumi Yamaguchi, Ryoko Kitada, Daiju Fukuda

    Heart and vessels   39 ( 4 )   340 - 348   2023.12( ISSN:09108327

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    Reduced exercise tolerance is one of the hallmarks of patients with cardiac amyloidosis (CA), but detailed biological responses during exercise were not investigated. The purpose of this study was to compare the cardiopulmonary exercise test (CPX) parameters between CA patients and propensity-matched heart failure patients. This was a single-center, retrospective, observational study of patients diagnosed with CA. The control group was extracted by propensity score matching from patients who underwent CPX for chronic heart failure during the same period. Clinical data including assessment of biological responses during CPX were compared between the patients with CA (CA group, n = 16) and the control group (non-CA group, n = 16). Echocardiography suggested more impaired diastolic function in the CA group than in the non-CA group. There was no significant difference between groups in the fraction of end-tidal carbon dioxide (FETCO2) at rest. However, the difference between the FETCO2 at rest and the FETCO2 at the respiratory compensation point (ΔFETCO2) was significantly smaller in the CA group than in the non-CA group (0.40% ± 0.37% vs. 0.82% ± 0.33%; p = 0.002). Only in the CA group, there was a significant negative correlation between the ΔFETCO2 and the E/e' ratio on echocardiography (r = - 0.521; p = 0.039) and the serum high-sensitivity troponin T concentration (r = - 0.501; p = 0.048). In conclusion, patients with CA may find it difficult to increase cardiac output during exercise due to severe diastolic dysfunction.

    DOI: 10.1007/s00380-023-02342-w

    PubMed

  • Correction: Tissue responses to everolimus-eluting stents implanted in severely calcified lesions following atherectomy.

    Tomohiro Yamaguchi, Takanori Yamazaki, Hisako Yoshida, Kotaro Matsumoto, Ryosuke Yahiro, Kazuhiro Nakao, Yusuke Kure, Tsukasa Okai, Takenobu Shimada, Kenichiro Otsuka, Yasuhiro Izumiya, Daiju Fukuda

    Cardiovascular intervention and therapeutics   39 ( 1 )   45 - 46   2023.12( ISSN:18684300

     More details

    International / domestic magazine:Domestic journal  

    DOI: 10.1007/s12928-023-00973-4

    PubMed

  • Association of Achilles Tendon Xanthoma Identified Based on New Guidelines from the Japan Atherosclerosis Society with Coronary Lesion Severity in Premature Coronary Artery Disease(タイトル和訳中)

    Fujiwara Ryosuke, Horio Takeshi, Yahiro Ryosuke, Yoshimura Ryutaro, Matsuoka Yujiro, Matsumoto Naoki, Fukuda Kohei, Izumiya Yasuhiro, Fukuda Daiju, Kawase Yoshio, Fujimoto Kohei, Kasayuki Noriaki

    Journal of Coronary Artery Disease   29 ( 4 )   97 - 103   2023.12

  • Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR)

    Tanaka A.

    Cardiovascular Diabetology   22 ( 1 )   2023.12

     More details

  • Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study

    Kishimoto S.

    Cardiovascular Diabetology   22 ( 1 )   2023.12

     More details

  • Factors associated with carotid intima-media thickness progression in patients with asymptomatic hyperuricemia: insights from the PRIZE study

    Saito Y.

    Scientific Reports   13 ( 1 )   2023.12

     More details

  • Diagnostic significance of paradoxical left ventricular hypertrophy in detecting cardiac amyloidosis

    Ota S.

    IJC Heart and Vasculature   49   2023.12( ISSN:23529067

     More details

  • Innate Immune System Regulated by Stimulator of Interferon Genes, a Cytosolic DNA Sensor, Regulates Endothelial Function.

    Phuong Tran Pham, Oyunbileg Bavuu, Joo-Ri Kim-Kaneyama, Xiao-Feng Lei, Takayuki Yamamoto, Kenichiro Otsuka, Kumiko Suto, Kenya Kusunose, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Michio Shimabukuro, Glen N Barber, Masataka Sata, Daiju Fukuda

    Journal of the American Heart Association   12 ( 22 )   e030084   2023.11

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Background Sterile inflammation caused by metabolic disorders impairs endothelial function; however, the underlying mechanism by which hyperglycemia induces inflammation remains obscure. Recent studies have suggested that stimulator of interferon genes (STING), a key cytosolic DNA sensor in the innate immune system, contributes to the pathogenesis of inflammatory diseases. This study examines the role of the STING in endothelial dysfunction in streptozotocin-induced diabetic mice. Methods and Results Injection of streptozotocin promoted the expression of STING and DNA damage markers in the aorta of wild-type mice. Streptozotocin elevated blood glucose and lipid levels in both wild-type and STING-deficient mice, which showed no statistical differences. Genetic deletion of STING ameliorated endothelial dysfunction as determined by the vascular relaxation in response to acetylcholine (P<0.001) and increased endothelial nitric oxide synthase phosphorylation in the aorta (P<0.05) in STZ-injected mice. Endothelium-independent vascular response to sodium nitroprusside did not differ. Treatment with a direct STING agonist, cyclic GMP-AMP, or mitochondrial DNA increased inflammatory molecule expression (eg, VCAM1 and IFNB) and decreased endothelial nitric oxide synthase phosphorylation in human umbilical vein endothelial cells, partially through the STING pathway. Cyclic GMP-AMP significantly impaired endothelial function of aortic segments obtained from wild-type mice, which was ameliorated in the presence of C-176, a STING inhibitor, or a neutralizing interferon-β antibody. Furthermore, the administration of C-176 ameliorated endothelial dysfunction in STZ-induced diabetic mice (P<0.01). Conclusions The DNA damage response regulated by STING impairs endothelial function. STING signaling may be a potential therapeutic target of endothelial dysfunction caused by hyperglycemia.

    DOI: 10.1161/JAHA.123.030084

    PubMed

  • Acute impact of atrial fibrillation on pacemaker lead-induced tricuspid regurgitation: Case report

    Tamura S.

    Journal of Cardiology Cases   28 ( 5 )   210 - 212   2023.11

     More details

  • Tricuspid annular area and leaflets stretch are associated with functional tricuspid regurgitation – insights from three-dimensional transesophageal echocardiography –

    Ogawa M.

    International Journal of Cardiovascular Imaging   39 ( 11 )   2119 - 2125   2023.11( ISSN:15695794

     More details

  • Olive mill wastewater and hydroxytyrosol inhibits atherogenesis in apolipoprotein E-deficient mice(タイトル和訳中)

    Hara Tomoya, Fukuda Daiju, Ganbaatar Byambasuren, Pham Phuong Tran, Aini Kunduziayi, Rahadian Arief, Suto Kumiko, Yagi Shusuke, Kusunose Kenya, Yamada Hirotsugu, Soeki Takeshi, Sata Masataka

    Heart and Vessels   38 ( 11 )   1386 - 1394   2023.11( ISSN:0910-8327

  • Acute impact of atrial fibrillation on pacemaker lead-induced tricuspid regurgitation: Case report(タイトル和訳中)

    Tamura Shota, Abe Yukio, Shimeno Kenji, Hayashi Yusuke, Naruko Takahiko, Fukuda Daiju

    Journal of Cardiology Cases   28 ( 5 )   210 - 212   2023.11

  • Tissue responses to everolimus-eluting stents implanted in severely calcified lesions following atherectomy.

    Tomohiro Yamaguchi, Takanori Yamazaki, Hisako Yoshida, Kotaro Matsumoto, Ryosuke Yahiro, Kazuhiro Nakao, Yusuke Kure, Tsukasa Okai, Takenobu Shimada, Kenichiro Otsuka, Yasuhiro Izumiya, Daiju Fukuda

    Cardiovascular intervention and therapeutics   39 ( 1 )   34 - 44   2023.10( ISSN:18684300

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    Histopathological examination has revealed that stents on severely calcified plaques were associated with delayed vascular healing. Although atherectomy devices can increase the number of malapposed struts, tissue responses to implanted drug eluting stents in atherectomy patients remain largely unknown. This retrospective observational study included 30 patients who underwent atherectomy and everolimus-eluting stent (EES) deployment for severely calcified coronary lesions (biodegradable polymer EES (BP-EES), n = 15; durable polymer EES (DP-EES), n  = 15). Optical coherence tomography was carried out at baseline and follow-up, and struts with acute stent malapposition (ASM) were categorized as struts on modified calcium (mod-Ca), non-modified calcium (non-mod-Ca), or non-calcium (non-Ca). Adequate vascular healing, defined as ASM resolution with neointimal coverage, was compared between the BP-EES and DP-EES groups. Multivariate linear regression analysis using a generalized estimated equation revealed that BP-EES use was associated with significantly better adequate vascular healing compared with DP-EES (odds ratio [OR]: 3.691, 95% confidence interval [CI] 1.175-11.592, P = 0.025). adequate vascular healing was associated with the underlying plaque morphology (mod-Ca vs non-mod-Ca: OR 2.833, 95% CI 1.491-5.384, P = 0.001; non-Ca vs non-mod-Ca: OR 1.248, 95% CI 0.440-3.543, P = 0.677). This study demonstrates that drug-eluting stent selection and calcium modification are possible factors affecting vascular healing of malapposed struts in severely calcified lesions.

    DOI: 10.1007/s12928-023-00965-4

    PubMed

  • Thrombus or tumor?

    Shiho Wakasa, Hiroya Hayashi, Takanori Yamazaki, Yasuhiro Izumiya, Daiju Fukuda

    Clinical case reports   11 ( 10 )   e7975   2023.10

     More details

    International / domestic magazine:International journal  

    KEY CLINICAL MESSAGE: Contrast defects in veins are often diagnosed as benign thrombi, but depending on the patient's background it is necessary to differentiate between tumor thrombi. It is difficult to differentiate between these using contrast-enhanced CT alone, but with angioscopy it is easy to visually distinguish between a benign and tumor thrombi. ABSTRACT: Contrast-enhanced computer tomography (CT) performed on a male patient being treated for de-differentiated chondrosarcoma revealed contrast defects in the pulmonary artery and right femoral vein, and a diagnosis of pulmonary artery thromboembolism and venous thromboembolism was made, and oral anticoagulant therapy was started. However, a follow-up CT showed that the contrast defect had extended to the inferior vena cava. Observation using an angioscope revealed that it was not a benign thrombi but a tumor.

    DOI: 10.1002/ccr3.7975

    PubMed

  • The E/e′ ratio on echocardiography as an independent predictor of the improvement of left ventricular contraction in patients with heart failure with reduced ejection fraction

    Yoshimura R.

    Journal of Clinical Ultrasound   51 ( 7 )   1131 - 1138   2023.09( ISSN:00912751

     More details

  • 3830 lead extraction from two patients with left bundle branch area pacing(タイトル和訳中)

    Hayashi Yusuke, Shimeno Kenji, Tamura Shota, Naruko Takahiko, Fukuda Daiju

    Journal of Arrhythmia   39 ( 4 )   623 - 626   2023.08( ISSN:1880-4276

  • Artificial intelligence-based model to classify cardiac functions from chest radiographs: a multi-institutional, retrospective model development and validation study

    Ueda D.

    The Lancet Digital Health   5 ( 8 )   e525 - e533   2023.08

     More details

  • Olive mill wastewater and hydroxytyrosol inhibits atherogenesis in apolipoprotein E-deficient mice.

    Tomoya Hara, Daiju Fukuda, Byambasuren Ganbaatar, Phuong Tran Pham, Kunduziayi Aini, Arief Rahadian, Kumiko Suto, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takeshi Soeki, Masataka Sata

    Heart and vessels   38 ( 11 )   1386 - 1394   2023.07( ISSN:09108327

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    The Mediterranean diet, which is characterized by high consumption of olive oil, prevents cardiovascular disease. Meanwhile, olive mill wastewater (OMWW), which is obtained as a byproduct during olive oil production, contains various promising bioactive components such as water-soluble polyphenols. Hydroxytyrosol (HT), the major polyphenol in OMWW, has anti-oxidative and anti-inflammatory properties; however, the atheroprotective effects of OMWW and HT remain to be fully understood. Here, we investigated the effect of OMWW and HT on atherogenesis. Male 8-week-old apolipoprotein E-deficient mice were fed a western-type diet supplemented with OMWW (0.30%w/w) or HT (0.02%w/w) for 20 weeks. The control group was fed a non-supplemented diet. OMWW and HT attenuated the development of atherosclerosis in the aortic arch as determined by Sudan IV staining (P < 0.01, respectively) without alteration of body weight, plasma lipid levels, and blood pressure. OMWW and HT also decreased the production of oxidative stress (P < 0.01, respectively) and the expression of NADPH oxidase subunits (e.g., NOX2 and p22phox) and inflammatory molecules (e.g. IL-1β and MCP-1) in the aorta. The results of in vitro experiments demonstrated that HT inhibited the expression of these molecules that were stimulated with LPS in RAW264.7 cells, murine macrophage-like cells. OMWW and HT similarly attenuated atherogenesis. HT is a major component of water-soluble polyphenols in OMWW, and it inhibited inflammatory activation of macrophages. Therefore, our results suggest that the atheroprotective effects of OMWW are at least partially attributable to the anti-inflammatory effects of HT.

    DOI: 10.1007/s00380-023-02290-5

    PubMed

  • 'Conventional' haemodynamics even in the quadricuspid aortic valve: clinical recognition using multimodality imaging

    Wakasa S.

    European Heart Journal Cardiovascular Imaging   24 ( 7 )   2023.07( ISSN:20472404

     More details

  • Rapidly progressed coronary aneurysm in immunoglobulin G4-related disease.

    Hiroki Yamaura, Kenichiro Otsuka, Daiju Fukuda

    European heart journal. Case reports   7 ( 7 )   ytad278   2023.07

     More details

    International / domestic magazine:International journal  

    DOI: 10.1093/ehjcr/ytad278

    PubMed

  • 心内膜双極電位は左房後壁内部への追加通電の必要性を予測する(Endocardial Bipolar Voltage Predicts the Need for Additional Ablation Inside the Left Atrial Posterior Wall)

    Yanagishita Tomoya, Yoshiyama Tomotaka, Kawai Ryota, Toyoda Natsumi, Nakatsuji Kenichi, Izumiya Yasuhiro, Shintani Ayumi, Fukuda Daiju

    Osaka City Medical Journal   69 ( 1 )   1 - 9   2023.06( ISSN:0030-6096

     More details

    肺静脈隔離(PVI)への左房後壁隔離(LA PWI)の追加はPVI単独よりも非発作性心房細動(AF)患者の予後を改善することが報告されている。本研究では、左房後壁内部への追加通電の必要性の予測因子を明らかするため、後ろ向きコホート研究を行った。2018年6月~2020年7月に当院で非発作性AFに対して初回のPVIとLA PWIを行った患者77例を対象とした。3Dマッピングシステムを用いて左房内の双極電位を記録した後にPVIとLA PWIを行った。天井ラインと底部ラインの作成でLA PWIが完成、もしくはライン上のgapへの追加通電で隔離が完成したA群35例(男性68.6%、平均68.2±8.3歳)と、それでは隔離できず左房後壁内部への通電が必要であったB群42例(男性78.6%、平均62.9±11.8歳)に分けた。最終的に全例でPVIが達成され、追加通電によって全例でLA PWIが達成された。A群はB群と比較して年齢が有意に高く、天井ライン上の最大電位と平均電位が有意に高かった。年齢を調整後の多変量解析では、天井ライン上の最大電位と平均電位が、後壁内部の追加通電の独立した予測因子であった。

  • 血管内視鏡により静脈内血栓と鑑別した静脈内腫瘍浸潤の一例

    林 浩也, 若狭 志保, 山崎 貴紀, 泉家 康宏, 福田 大受

    静脈学   34 ( 2 )   266 - 266   2023.06( ISSN:0915-7395

  • Emerging roles of protease-activated receptors in cardiometabolic disorders.

    Tomoya Hara, Masataka Sata, Daiju Fukuda

    Journal of cardiology   81 ( 4 )   337 - 346   2023.04( ISSN:0914-5087

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Cardiometabolic disorders, including obesity-related insulin resistance and atherosclerosis, share sterile chronic inflammation as a major cause; however, the precise underlying mechanisms of chronic inflammation in cardiometabolic disorders are not fully understood. Accumulating evidence suggests that several coagulation proteases, including thrombin and activated factor X (FXa), play an important role not only in the coagulation cascade but also in the proinflammatory responses through protease-activated receptors (PARs) in many cell types. Four members of the PAR family have been cloned (PAR 1-4). For instance, thrombin activates PAR-1, PAR-3, and PAR-4. FXa activates both PAR-1 and PAR-2, while it has no effect on PAR-3 or PAR-4. Previous studies demonstrated that PAR-1 and PAR-2 activated by thrombin or FXa promote gene expression of inflammatory molecules mainly via the NF-κB and ERK1/2 pathways. In obese adipose tissue and atherosclerotic vascular tissue, various stresses increase the expression of tissue factor and procoagulant activity. Recent studies indicated that the activation of PARs in adipocytes and vascular cells by coagulation proteases promotes inflammation in these tissues, which leads to the development of cardiometabolic diseases. This review briefly summarizes the role of PARs and coagulation proteases in the pathogenesis of inflammatory diseases and describes recent findings (including ours) on the potential participation of this system in the development of cardiometabolic disorders. New insights into PARs may ensure a better understanding of cardiometabolic disorders and suggest new therapeutic options for these major health threats.

    DOI: 10.1016/j.jjcc.2022.09.013

    PubMed

  • Endoscopic assessment of WATCHMAN 17 months after implantation.

    Takanori Yamazaki, Tomotaka Yoshiyama, Asahiro Ito, Yasuhiro Izumiya, Daiju Fukuda

    Cardiovascular intervention and therapeutics   38 ( 2 )   258 - 259   2023.04( ISSN:18684300

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    DOI: 10.1007/s12928-022-00902-x

    PubMed

  • 選択的ミネラルコルチコイド受容体ブロッカーエサキセレノンによるC57BL/6糖尿病マウスの血管機能障害緩和作用(A Selective Mineralocorticoid Receptor Blocker, Esaxerenone, Attenuates Vascular Dysfunction in Diabetic C57BL/6 Mice)

    Munkhjargal Uugantsetseg, Fukuda Daiju, Ganbaatar Byambasuren, Suto Kumiko, Matsuura Tomomi, Ise Takayuki, Kusunose Kenya, Yamaguchi Koji, Yagi Shusuke, Yamada Hirotsugu, Soeki Takeshi, Wakatsuki Tetsuzo, Sata Masataka

    Journal of Atherosclerosis and Thrombosis   30 ( 4 )   326 - 334   2023.04( ISSN:1340-3478

     More details

    新規非ステロイド性選択的ミネラルコルチコイド受容体(MR)ブロッカーエサキセレノンが糖尿病誘発性血管機能障害に及ぼす影響について検討した。8週齢の雄性C57BL/6マウスにストレプトゾトシン(STZ)を単回投与して糖尿病モデルを作成し、エサキセレノン3mg/kg/日または賦形剤を3週間投与した。投与後、代謝パラメータ、血漿中アルドステロン、腎機能パラメータを測定し、大動脈セグメントにおける血管内皮依存性・非依存性血管反応を評価した。さらに、ヒト臍帯静脈内皮細胞(HUVECs)をin vitro評価に用いた。糖尿病モデルマウスにおいて血糖値の有意な上昇のほか、血漿中糖アルブミン、血漿脂質、血漿中アルドステロンの増加が生じており、エサキセレノン投与では血圧減少はみられず、代謝パラメータへの影響もみられなかった。STZ投与に伴い血管拡張能に障害が誘発されたが、エサキセレノン投与後、血管内皮依存性血管障害に改善が認められ、内皮非依存性血管拡張には有意な変化はみられなかった。HUVECsを用いた検討では、アルドステロンによって用量依存性にeNOS Ser1177のリン酸化が有意に減少しており、eNOS Thr495リン酸化の増大、eNOS Ser1177/eNOS Thr495リン酸化比の有意な減少が観察された。エサキセレノン投与ではeNOS Ser1177のリン酸化とeNOS Ser1177/eNOS Thr495リン酸化比の有意な増加、eNOS Thr495リン酸化の有意な減少が認められた。エサキセレノンは糖尿病誘発性血管機能障害に対して緩和作用を有することが示された。

  • Cystatin C-based Estimated Glomerular Filtration Rate Associated with Three-year Mortality after Transcatheter Aortic Valve Implantation(タイトル和訳中)

    呉 裕介, 岡井 主, 泉家 康宏, 山口 智大, 小川 真奈, 柴田 敦, 伊藤 朝広, 高橋 洋介, 柴田 利彦, 福田 大受

    日本循環器学会学術集会抄録集   87回   PJ094 - 3   2023.03

  • Tricuspid Annular Plane Systolic Excursion could Predict the Exercise Tolerance in Patients with Chronic Thromboembolic Pulmonary Disease(タイトル和訳中)

    林 央, 山口 智大, 伊藤 文花, Kim Andrew T., 林 浩也, 石川 世良, 柴田 敦, 伊藤 朝広, 泉家 康宏, 福田 大受

    日本循環器学会学術集会抄録集   87回   PJ043 - 6   2023.03

  • Hemoglobin is an Independent Predictor of Improved Exercise Tolerance in Male Patients with Non-ischemic Cardiomyopathy(タイトル和訳中)

    谷畑 慧子, 柴田 敦, 林 央, 吉田 俊丈, 林 浩也, 北田 諒子, 泉家 康宏, 福田 大受

    日本循環器学会学術集会抄録集   87回   PJ039 - 4   2023.03

  • Extent of coronary atherosclerosis is associated with deterioration of left ventricular global longitudinal strain in patients with preserved ejection fraction undergoing coronary computed tomography angiography.

    Hirotoshi Ishikawa, Kenichiro Otsuka, Yasushi Kono, Kana Hojo, Hiroki Yamaura, Kumiko Hirata, Noriaki Kasayuki, Yasuhiro Izumiya, Daiju Fukuda

    International journal of cardiology. Heart & vasculature   44   101176 - 101176   2023.02( ISSN:23529067

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: This study aimed to investigate the association between the extent and severity of coronary atherosclerosis, epicardial adipose tissue (EAT) accumulation, and left ventricular (LV) global longitudinal strain (GLS) in patients with preserved LV ejection fraction (LVEF) and without LV regional wall motion abnormalities. METHODS: This study included 169 preserved LVEF patients without LV wall motion abnormalities who underwent coronary computed tomography (CT) angiography for the assessment of suspected coronary artery disease (CAD). The segment stenosis score (SSS) and segment involvement score (SIS) were calculated to evaluate CAD extent. The EAT volume was defined as CT attenuation values ranging from -250 to -30 HU within the pericardial sac. LVGLS was measured using echocardiography to assess subclinical LV dysfunction. RESULTS: All patients had preserved LVEF of ≥50%, and the mean LVGLS was -18.7% (-20.5% to -16.9%). Mean SSS and SIS were 2.0 (0-5) and 4.0 (0-36), respectively, while mean EAT volume was 116.1 mL (22.9-282.5 mL). Multivariate analysis using linear regression model demonstrated that LVEF (β, -17.0; 95% CI, -20.9 - -13.1), LV mass index (β, 0.03; 95% CI, 0.01-0.06), and EAT volume (β, 0.010; 95% CI, 0.0020-0.0195) were independently associated with LVGLS; however, obstructive CAD was not. The multivariate models demonstrated that SSS (Î, 0.12; 95% CI, 0.05-0.18) and SIS (Î, 0.27; 95% CI, 0.10-0.44) were correlated with deterioration of LVGLS, independent of other parameters. CONCLUSION: This study demonstrates that EAT volume and CAD extent are associated with the deterioration of LVGLS in this population.

    DOI: 10.1016/j.ijcha.2023.101176

    PubMed

  • Association of Microluminal Structures Assessed by Optical Coherence Tomography With Local Inflammation in Adjacent Epicardial Adipose Tissue and Coronary Plaque Characteristics in Fresh Cadavers

    Kawabata Yutaka, Wakatsuki Tetsuzo, Yamaguchi Koji, Fukuda Daiju, Ito Hiroyuki, Matsuura Tomomi, Kusunose Kenya, Ise Takayuki, Yagi Shusuke, Yamada Hirotsugu, Soeki Takeshi, Tsuruo Yoshihiro, Sata Masataka

    Circulation Journal   87 ( 2 )   329 - 335   2023.01( ISSN:1346-9843

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    <p><b><i>Background:</i></b> Coronary intraplaque microluminal structures (MS) are associated with plaque vulnerability, and the inward progression of vascular inflammation from the adventitia towards the media and intima has also been demonstrated. Therefore, in the present study we investigated the relationships among MS, local inflammation in adjacent epicardial adipose tissue (EAT), and coronary plaque characteristics.</p><p><b><i>Methods and Results:</i></b> Optical coherence tomography (OCT) revealed MS in the left anterior descending coronary artery in 10 fresh cadaveric hearts. We sampled 30 lesions and subdivided them based on the presence of MS: MS (+) group (n=19) and MS (−) group (n=11). We measured inflammatory molecule levels in the adjacent EAT and percentage lipid volume assessed by integrated backscatter intravascular ultrasound in each lesion. The expression levels of vascular endothelial growth factor B and C-C motif chemokine ligand 2 were significantly higher in the MS (+) group than in the MS (−) group (0.9±0.7 vs. 0.2±0.2 arbitrary units (AU), P=0.04 and 1.5±0.5 vs. 0.6±0.7 AU, P=0.02, respectively). Percentage lipid volume was significantly higher in the MS (+) group than in the MS (−) group (38.7±16.5 vs. 23.7±10.9%, P=0.03).</p><p><b><i>Conclusions:</i></b> Intraplaque MS observed on OCT were associated with lipid-rich plaques and local inflammation in the adjacent EAT. Collectively, these results suggest that local inflammation in the EAT is associated with coronary plaque vulnerability via MS.</p>

    DOI: 10.1253/circj.CJ-22-0299

    PubMed

  • NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload.

    Yasutomi Higashikuni, Wenhao Liu, Genri Numata, Kimie Tanaka, Daiju Fukuda, Yu Tanaka, Yoichiro Hirata, Teruhiko Imamura, Eiki Takimoto, Issei Komuro, Masataka Sata

    Circulation   147 ( 4 )   338 - 355   2023.01( ISSN:0009-7322

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: Mechanical stress on the heart, such as high blood pressure, initiates inflammation and causes hypertrophic heart disease. However, the regulatory mechanism of inflammation and its role in the stressed heart remain unclear. IL-1β (interleukin-1β) is a proinflammatory cytokine that causes cardiac hypertrophy and heart failure. Here, we show that NLRP3 (neural signals activate the nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing 3) inflammasome for IL-1β production to induce adaptive hypertrophy in the stressed heart. METHODS: C57BL/6 mice, knockout mouse strains for NLRP3 and P2RX7 (P2X purinoceptor 7), and adrenergic neuron-specific knockout mice for SLC17A9, a secretory vesicle protein responsible for the storage and release of ATP, were used for analysis. Pressure overload was induced by transverse aortic constriction. Various animal models were used, including pharmacological treatment with apyrase, lipopolysaccharide, 2'(3')-O-(4-benzoylbenzoyl)-ATP, MCC950, anti-IL-1β antibodies, clonidine, pseudoephedrine, isoproterenol, and bisoprolol, left stellate ganglionectomy, and ablation of cardiac afferent nerves with capsaicin. Cardiac function and morphology, gene expression, myocardial IL-1β and caspase-1 activity, and extracellular ATP level were assessed. In vitro experiments were performed using primary cardiomyocytes and fibroblasts from rat neonates and human microvascular endothelial cell line. Cell surface area and proliferation were assessed. RESULTS: Genetic disruption of NLRP3 resulted in significant loss of IL-1β production, cardiac hypertrophy, and contractile function during pressure overload. A bone marrow transplantation experiment revealed an essential role of NLRP3 in cardiac nonimmune cells in myocardial IL-1β production and cardiac phenotype. Pharmacological depletion of extracellular ATP or genetic disruption of the P2X7 receptor suppressed myocardial NLRP3 inflammasome activity during pressure overload, indicating an important role of ATP/P2X7 axis in cardiac inflammation and hypertrophy. Extracellular ATP induced hypertrophic changes of cardiac cells in an NLRP3- and IL-1β-dependent manner in vitro. Manipulation of the sympathetic nervous system suggested sympathetic efferent nerves as the main source of extracellular ATP. Depletion of ATP release from sympathetic efferent nerves, ablation of cardiac afferent nerves, or a lipophilic β-blocker reduced cardiac extracellular ATP level, and inhibited NLRP3 inflammasome activation, IL-1β production, and adaptive cardiac hypertrophy during pressure overload. CONCLUSIONS: Cardiac inflammation and hypertrophy are regulated by heart-brain interaction. Controlling neural signals might be important for the treatment of hypertensive heart disease.

    DOI: 10.1161/CIRCULATIONAHA.122.060860

    PubMed

  • Successful Extraction of Guidewire Entrapped in the Tricuspid Valve Leaflet Using a Laser Sheath.

    Sakamoto S, Irishio M, Nakatani Y, Kataoka T, Fukuda D

    JACC. Case reports   6   101676   2023.01

  • Association of Microluminal Structures Assessed by Optical Coherence Tomography With Local Inflammation in Adjacent Epicardial Adipose Tissue and Coronary Plaque Characteristics in Fresh Cadavers(和訳中)

    Kawabata Yutaka, Wakatsuki Tetsuzo, Yamaguchi Koji, Fukuda Daiju, Ito Hiroyuki, Matsuura Tomomi, Kusunose Kenya, Ise Takayuki, Yagi Shusuke, Yamada Hirotsugu, Soeki Takeshi, Tsuruo Yoshihiro, Sata Masataka

    Circulation Journal   87 ( 2 )   329 - 335   2023.01( ISSN:1346-9843

     More details

    冠動脈プラーク内に観察される微小管腔構造(MS)、隣接する心外膜脂肪組織(EAT)の局所炎症、冠動脈プラークの性状の関連性を新鮮献体で調べた。新鮮献体10体(女性7名、年齢69~96歳)の左冠動脈前下行枝を対象とした。光干渉断層法(OCT)を施行してMSの評価を行った。標本として選出した30病変を、MS陽性の19病変とMS陰性の11病変に分類した。病変毎に、隣接EAT内の炎症性分子レベルの測定、および後方散乱血管内超音波法による脂質体積百分率の評価を行った。血管内皮細胞増殖因子(VEGF)BとC-Cモチーフケモカインリガンド2の発現レベルは、いずれもMS陰性の病変群に対しMS陽性の群で有意に上昇していた(0.9±0.7 vs.0.2±0.2任意単位[AU]、P=0.04、1.5±0.5 vs.0.6±0.7AU、P=0.02)。脂質体積百分率はMS陽性群で平均38.7±16.5%、MS陰性群で平均23.7±10.9%となり、MS陽性群の方が有意に高かった(P=0.03)。OCTで観察されるプラーク内MS所見は、隣接EATの局所炎症、および脂質が豊富なプラークと関連していた。総合すると、EAT内の局所炎症は、MSによって生じる冠動脈プラークの脆弱性に関連していることが示唆された。

  • Role of plaque imaging for identification of vulnerable patients beyond the stage of myocardial ischemia

    Kitada R.

    Frontiers in Cardiovascular Medicine   10   2023

     More details

  • Association of Achilles Tendon Xanthoma Identified Based on New Guidelines from the Japan Atherosclerosis Society with Coronary Lesion Severity in Premature Coronary Artery Disease

    Fujiwara Ryosuke, Horio Takeshi, Yahiro Ryosuke, Yoshimura Ryutaro, Matsuoka Yujiro, Matsumoto Naoki, Fukuda Kohei, Izumiya Yasuhiro, Fukuda Daiju, Kawase Yoshio, Fujimoto Kohei, Kasayuki Noriaki

    Journal of Coronary Artery Disease   29 ( 4 )   97 - 103   2023

     More details

    Objective: The cutoff value on radiography for judging Achilles tendon xanthoma (ATX), one of the diagnostic criteria for familial hypercholesterolemia, was altered from 9 mm to 8/7.5 mm (men/women) in the new guidelines from the Japan Atherosclerosis Society. The present study investigated whether or not ATX newly identified by the revised criteria, i.e. Achilles tendon thickness (ATT) of ≥ 8 mm and < 9 mm in men, is associated with coronary lesion severity in premature coronary artery disease (CAD) patients.<br>Methods: Eighty-seven male subjects with a history of acute coronary syndrome (ACS) under 60 years old and with a maximum ATT for the right and left sides of < 9 mm were enrolled. The severity of the coronary lesions was assessed using the SYNTAX score derived from coronary angiography at the onset of ACS.<br/>Results: Nine patients (10%) had a maximum ATT ≥ 8 mm (ATX group) among the present subjects. The SYNTAX score was significantly larger in the ATX group than in the non-ATX group (18.3 ± 9.8 vs. 12.3 ± 7.3, <i>P</i> = 0.028). The ATX group also had an increased body mass index (BMI) and C-reactive protein (CRP) level. In all subjects, the maximum ATT was positively correlated with the SYNTAX score (R = 0.337, <i>P</i> = 0.001). A multiple regression analysis revealed that the presence of ATX was significantly associated with the SYNTAX score, independent of confounding factors, including the BMI and CRP.<br>Conclusions: This study demonstrated that ATX, even when mild, was associated with coronary lesion severity in premature CAD. ATX, based on new criteria, may be an independent predictor of CAD progression.<br/>

    DOI: 10.7793/jcad.29.23-00010

  • Quantification of pulmonary perfusion using LSIM-CT correlates with pulmonary hemodynamics in patients with CTEPD.

    Tomohiro Yamaguchi, Shoichi Ehara, Hisako Yoshida, Daisuke Himoto, Shinichiro Izuta, Ou Hayashi, Hiroya Hayashi, Mana Ogawa, Atsushi Shibata, Takanori Yamazaki, Yasuhiro Izumiya, Daiju Fukuda

    Frontiers in cardiovascular medicine   10   1237296 - 1237296   2023

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: Lung subtraction iodine mapping (LSIM)-CT is a clinically useful technique that can visualize pulmonary mal-perfusion in patients with chronic thromboembolic pulmonary disease (CTEPD). However, little is known about the associations of LSIM images with hemodynamic parameters of patients with CTEPD. This study investigates a parameter of LSIM images associated with mean pulmonary arterial pressure (mPAP) and validates the association between pulmonary vascular resistance, right atrial pressure, cardiac index, and exercise capacity in patients with CTEPD. METHODS: This single-center, prospective, observational study involved 30 patients diagnosed with CTEPD using lung perfusion scintigraphy. To examine the correlation of decreased pulmonary perfusion area (DPA) with mPAP, areas with 0-10, 0-15, 0-20, and 0-30 HU in lung subtraction images were adopted in statistical analysis. The DPA to total lung volume ratio (DPA ratio, %) was calculated as the ratio of each DPA volume to the total lung volume. To assess the correlation between DPA ratios of 0-10, 0-15, 0-20, and 0-30 HU and mPAP, Spearman's rank correlation coefficient was used. RESULTS: The DPA ratio of 0-10 HU had the most preferable correlation with mPAP than DPA ratios of 0-15, 0-20, and 0-30 HU (ρ = 0.440, P = 0.015). The DPA ratio of 0-10 HU significantly correlates with pulmonary vascular resistance (ρ = 0.445, P = 0.015). The receiver operating characteristic curve analysis indicated that the best cutoff value of the DPA ratio of 0-10 HU for the prediction of an mPAP of ≥30 mmHg was 8.5% (AUC, 0.773; 95% CI, 0.572-0.974; sensitivity, 83.3%; specificity, 75.0%). Multivariate linear regression analysis, which was adjusted for the main pulmonary arterial to ascending aortic diameter ratio and right ventricular to left ventricular diameter ratio, indicated that the DPA ratio of 0-10 HU was independently and significantly associated with mPAP (B = 89.7; 95% CI, 46.3-133.1, P < 0.001). CONCLUSION: The DPA ratio calculated using LSIM-CT is possibly useful for estimating the hemodynamic status in patients with CTEPD.

    DOI: 10.3389/fcvm.2023.1237296

    PubMed

  • Impact of cystatin C-derived glomerular filtration rate in patients undergoing transcatheter aortic valve implantation.

    Yusuke Kure, Tsukasa Okai, Yasuhiro Izumiya, Hisako Yoshida, Kazuki Mizutani, Tomohiro Yamaguchi, Mana Ogawa, Atsushi Shibata, Asahiro Ito, Yosuke Takahashi, Toshihiko Shibata, Daiju Fukuda

    Frontiers in cardiovascular medicine   10   1035736 - 1035736   2023

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: Chronic kidney disease (CKD) impacts prognosis in patients undergoing transcatheter aortic valve implantation (TAVI). While estimated glomerular filtration rate (eGFR) calculated from serum creatinine [eGFR (creatinine)] is affected by body muscle mass which reflects frailty, eGFR calculated from serum cystatin C [eGFR (cystatin C)] is independent of body composition, resulting in better renal function assessment. METHODS: This study included 390 consecutive patients with symptomatic severe aortic stenosis (AS) who underwent TAVI, and measured cystatin C-based eGFR at discharge. Patients were divided into two groups, with or without CKD estimated with eGFR (cystatin C). The primary endpoint of this study was the 3-year all-cause mortality after TAVI. RESULTS: The median patient age was 84 years, and 32.8% patients were men. Multivariate Cox regression analysis indicated that eGFR (cystatin C), diabetes mellitus, and liver disease were independently associated with 3-year all-cause mortality. In the receiver-operating characteristic (ROC) curve, the predictive value of eGFR (cystatin C) was significantly higher than that of eGFR (creatinine). Furthermore, Kaplan-Meier estimates revealed that 3-year all-cause mortality was higher in the CKD (cystatin C) group than that in the non-CKD (cystatin C) group with log-rank p = 0.009. In contrast, there was no significant difference between the CKD (creatinine) and non-CKD (creatinine) groups with log-rank p = 0.94. CONCLUSIONS: eGFR (cystatin C) was associated with 3-year all-cause mortality in patients who underwent TAVI, and it was superior to eGFR (creatinine) as a prognostic biomarker.

    DOI: 10.3389/fcvm.2023.1035736

    PubMed

  • 320列CT冠動脈血管造影を用いた冠動脈病変と胸部大動脈プラークの包括的診断法の開発とその臨床的意義の探索

    大塚 憲一郎, 笠行 典章, 福田 大受

    福田記念医療技術振興財団情報   ( 35 )   115 - 121   2022.12

     More details

    冠動脈CT血管造影(CCTA)-Wide Volume Scan(WVS)により冠動脈疾患と胸部大動脈プラークを同時に評価し、心血管予後との関連について検討した。2017年4月〜2019年11月の期間にCCTA-WVS検査により冠動脈疾患の評価と大動脈弓を含む胸部大動脈の評価を行った胸痛患者455名(男性234名、女性221名、平均65±13歳)を対象とした。CCTA-WVS所見は冠動脈石灰化スコア0、0〜100、101〜400、>400がそれぞれ42.9%、26.8%、20.6%、11.2%であった。平均2.8±0.9年の追跡期間中、445例中34例(7.6%)に主要有害事象(MACE)を認めた。吹田CVDリスクスコアで調整したCox比例ハザードモデルでは、冠動脈石灰化スコア>400と胸部大動脈プラークスコア(T3)が心血管イベント発症の独立した予測因子であった。CCTA-WVSを用いた胸部大動脈プラークスコアと冠動脈疾患の包括的評価が心血管イベントリスクの層別化に貢献できると考えられた。

  • Role of Cardiac Magnetic Resonance (CMR) in Determining Implantable Cardioverter-Defibrillator (ICD) Indication in Acromegalic Cardiomyopathy: A Case Report.

    Inoue N, Hayashi H, Ehara S, Izumiya Y, Fukuda D

    Cureus   14 ( 12 )   e32234   2022.12( ISSN:2168-8184

     More details

  • Real-World Management of Pharmacological Thromboprophylactic Strategies for COVID-19 Patients in Japan: From the CLOT-COVID Study.

    Hayashi H, Izumiya Y, Fukuda D, Wakita F, Mizobata Y, Fujii H, Yachi S, Takeyama M, Nishimoto Y, Tsujino I, Nakamura J, Yamamoto N, Nakata H, Ikeda S, Umetsu M, Aikawa S, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Ikeda N, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo M, Yamashita Y, CLOT-COVID Study Investigators

    JACC. Asia   2 ( 7 )   897 - 907   2022.12

  • Correlation between Low Amount of Epicardial Adipose Tissue and the Severity of Right Ventricular Dysfunction in Patients with Nonischemic Heart Failure with Reduced Ejection Fraction(和訳中)

    Tanihata Akiko, Ehara Shoichi, Kitada Ryoko, Ishikawa Hirotoshi, Yoshida Toshitake, Hayashi Hiroya, Yamaguchi Yumi, Shibata Atsushi, Izumiya Yasuhiro, Fukuda Daiju

    Osaka City Medical Journal   68 ( 2 )   61 - 72   2022.12( ISSN:0030-6096

     More details

    心外膜脂肪組織(EAT)量は冠動脈疾患や心房細動と関連するので、心不全(HF)で駆動率(EF)の低下(HFrEF)した患者におけるEAT量と右心室(RV)の収縮機能の関係を調べた。心臓MRIとCTを行った非虚血性HFの100名の患者を被験者とした。始めに患者を左心室(LV)EF50%以上と50%未満に分け、EFの保たれている(HFpEF)群14名と、HFrEF群86名とした。HFrEF群はさらにRV機能障害のある群(RVEF=45%未満)54名と、ない群(RVEF=45%以上)32名に分けた。HFrEFでRV機能障害群における体表面積(BSA)に対するEAT量は、他の群よりも有意に低かった。HFrEF群では、BSAに対するEAT量はRVEFと正相関を示したが、LVEFとは相関しなかった。RV機能障害のあるHFrEF患者は、HFpEF患者よりもEATが少なく、EATの低値がHFrEFのRV機能障害の重篤性と関連することが示された。

  • Cardiovascular and bleeding risks of inactive cancer in patients with acute myocardial infarction who received primary percutaneous coronary intervention using drug-eluting stent and dual/triple antithrombotic therapy.

    Hayashi H, Kataoka Y, Murai K, Sawada K, Iwai T, Matama H, Honda S, Fujino M, Yoneda S, Takagi K, Otsuka F, Asaumi Y, Izumiya Y, Fukuda D, Noguchi T

    Cardiovascular diagnosis and therapy   12 ( 6 )   803 - 814   2022.12( ISSN:2223-3652

     More details

  • Aortic arch plaque morphology in patients with coronary artery disease undergoing coronary computed tomography angiography with wide-volume scan.

    Kenichiro Otsuka, Hirotoshi Ishikawa, Yasushi Kono, Shinya Oku, Hiroki Yamaura, Kuniyuki Shirasawa, Kumiko Hirata, Kenei Shimada, Noriaki Kasayuki, Daiju Fukuda

    Coronary artery disease   33 ( 7 )   531 - 539   2022.11( ISSN:0954-6928

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: Wide-volume scanning with 320-row multidetector computed tomography coronary angiography (CTCA-WVS) enables the assessment of the aortic arch plaque (AAP) morphology and coronary arteries without requiring additional contrast volume. This study aimed to investigate the prevalence of AAPs and their association with coronary artery disease (CAD) and major adverse cardiovascular events (MACEs) in patients who underwent CTCA-WVS. METHODS: This study included 204 patients without known CAD (mean age, 65 years; 53% men) who underwent CTCA-WVS. We evaluated the presence of aortic plaques in the ascending aorta, aortic arch, and thoracic descending aorta using CTCA-WVS. Large aortic plaques were defined as plaques of at least 4 mm in thickness. A complex aortic plaque was defined as a plaque with ulceration or protrusion. MACEs were defined as composite events of cardiovascular (CV) death, nonfatal myocardial infarction, and ischemic stroke. RESULTS: AAPs and large/complex AAPs were identified in 51% ( n = 105) and 18% ( n = 36) of the study patients, respectively. The prevalence of AAPs with large/complex morphology increased with CAD severity (2.1% in no CAD, 12% in nonobstructive CAD, and 39% in obstructive CAD). The univariate Cox hazard model demonstrated that the predictors associated with MACEs were diabetes, obstructive CAD, and large/complex AAPs. Independent factors associated with large/complex AAPs were male sex [odds ratio (OR), 2.90; P = 0.025], stroke history (OR, 3.48; P = 0.026), obstructive CAD (OR, 3.35; P = 0.011), and thoracic aortic calcification (OR, 1.77; P = 0.005). CONCLUSION: CTCA-WVS provides a comprehensive assessment of coronary atherosclerosis and thoracic aortic plaques in patients with CAD, which may improve the stratification of patients at risk for CV events.

    DOI: 10.1097/MCA.0000000000001171

    PubMed

  • Achievement rate and learning curve of left bundle branch capture in left bundle branch area pacing procedure performed to demonstrate output-dependent QRS transition.

    Shimeno K, Tamura S, Hayashi Y, Abe Y, Naruko T, Fukuda D

    Journal of cardiovascular electrophysiology   33 ( 10 )   2183 - 2191   2022.10( ISSN:1045-3873

     More details

  • Reply to "Is left ventricular septal pacing enough clinically, or must left bundle branch be captured absolutely?".

    Shimeno K, Tamura S, Hayashi Y, Abe Y, Naruko T, Fukuda D

    Journal of cardiovascular electrophysiology   33 ( 10 )   2234   2022.10( ISSN:1045-3873

     More details

  • 両心不全で搬送された超高齢慢性血栓塞栓性肺高血圧症の一例

    山口 智大, 泉家 康宏, 林 央, 林 浩也, 柴田 敦, 山崎 貴紀, 福田 大受

    脈管学   62 ( Suppl. )   S174 - S174   2022.10( ISSN:0387-1126

  • Esaxerenone, a selective mineralocorticoid receptor blocker, improves insulin sensitivity in mice consuming high-fat diet.

    Oyunbileg Bavuu, Daiju Fukuda, Byambasuren Ganbaatar, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    European journal of pharmacology   931   175190 - 175190   2022.09( ISSN:0014-2999

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: Esaxerenone is a novel, non-steroidal selective mineralocorticoid receptor (MR) blocker. MR activation plays a crucial role in the development of cardiovascular and metabolic diseases. In this study, we investigated the effects of esaxerenone on various metabolic parameters in mice. MATERIALS AND METHODS: Esaxerenone (3 mg/kg/day) was orally administered to high-fat diet (HFD)-fed male C57BL/6 mice. Mice fed a normal diet (ND) served as controls. Glucose and insulin tolerance, plasma lipid levels, and transaminase levels were assessed as metabolic parameters. Macrophage accumulation in the adipose tissue was evaluated using histological analysis. 3T3-L1 adipocytes, HepG2 cells, and C2C12 myotubes were used for in vitro experiments. Gene expression and insulin signaling were examined using quantitative RT-PCR and western blotting, respectively. RESULTS: HFD successfully induced insulin resistance compared with that in ND. Esaxerenone ameliorated insulin resistance (P < 0.05) without altering other metabolic parameters, such as the lipid profile. Esaxerenone administration tended to decrease plasma transaminase levels compared with those in the non-treated group. In the adipose tissue, esaxerenone decreased macrophage accumulation (P < 0.05) and increased the expression levels of adiponectin and PPARγ. Aldosterone significantly decreased the expression levels of PPARγ and adiponectin in 3T3-L1 adipocytes. Furthermore, aldosterone attenuated insulin-induced Akt phosphorylation in 3T3-L1 adipocytes, HepG2 cells, and C2C12 myotubes in a dose-dependent manner (P < 0.01). These effects were ameliorated by pretreatment with esaxerenone. CONCLUSION: Esaxerenone ameliorated insulin resistance in HFD-fed mice. Reduction of inflammation and improvement in insulin signaling may underlie the beneficial effects of esaxerenone.

    DOI: 10.1016/j.ejphar.2022.175190

    PubMed

  • Clinical course and decision-making in heart failure by preload stress echocardiography: a preliminary study.

    Kenya Kusunose, Hirotsugu Yamada, Yoshihito Saijo, Susumu Nishio, Yukina Hirata, Takayuki Ise, Koji Yamaguchi, Daiju Fukuda, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    ESC heart failure   9 ( 6 )   4020 - 4029   2022.08

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    AIMS: Abnormal left ventricular diastolic response to preload stress can be an early marker of heart failure (HF). The aim of this study was to assess clinical course in patients with HF with preserved ejection fraction (HFpEF) who underwent preload stress echocardiography. In the subgroup analysis, we assessed the prognosis of patients with unstable signs during preload stress classified by treatment strategies. METHODS AND RESULTS: We prospectively conducted preload stress echocardiographic studies between January 2006 and December 2013 in 211 patients with HFpEF. Fifty-eight patients had abnormal diastolic reserve during preload stress (unstable impaired relaxation: unstable IR). Of 58 patients with unstable IR, 19 patients were assigned to additional therapy by increased or additional therapy and 39 patients were assigned to standard therapy. Composite outcomes were prespecified as the primary endpoint of death and hospitalization for deteriorating HF. During a median period of 6.9 years, 19 patients (33%) reached the composite outcome. Unstable group with standard therapy had significantly shorter event-free survival than stable group. Patients with uptitration of therapy had longer event-free survival than those with standard therapy group after adjustment of laboratory data (hazard ratio, 0.20, 95% confidence interval, 0.05-0.90; P = 0.036); the 10 year event-free survival in patients with and without uptitration of therapy was 93% and 51%, respectively (P = 0.023). CONCLUSIONS: Patients with unstable sign had significantly shorter event-free survival than patients with stable sign. After additional therapy, the prognosis of patients with unstable signs improved. This technique may impact decision-making for improving their prognosis.

    DOI: 10.1002/ehf2.14127

    PubMed

  • トランスサイレチンアミロイドーシスの変異型であった患者でタファミジス治療後に示された左室肥大の退縮(Regression of left ventricular hypertrophy after tafamidis therapy in a patient with transthyretin amyloidosis variant)

    Yagi Shusuke, Yamazaki Hiromu, Kusunose Kenya, Osaki Yusuke, Ise Takayuki, Kadota Muneyuki, Tserensonom Munkhtsetseg, Kawabata Yutaka, Hara Tomoya, Ueno Rie, Saijo Yoshihito, Matsuura Tomomi, Yamaguchi Koji, Yamada Hirotsugu, Fukuda Daiju, Soeki Takeshi, Wakatsuki Tetsuzo, Sata Masataka

    The Journal of Medical Investigation   69 ( 3-4 )   320 - 322   2022.08( ISSN:1343-1420

     More details

    症例は71歳男性で、末梢性ポリニューロパチーに起因した四肢の痺れと歩行困難を訴えていた。心疾患の病歴は無かったが、心電図検査では低電位と第1度房室ブロックが、心エコー法では前壁中隔の高度の肥大が、心臓MRIでは左室心外膜にガドリニウム遅延造影所見が示された。遺伝子検査でトランスサイレチン遺伝子にVal30Met変異が示され、遺伝性トランスサイレチンアミロイドーシス(ATTR variant)の孤発例と診断した。ポリニューロパチーに対しタファミジス20mgでの加療を9ヵ月間続けたが、神経筋症状は消退しなかった。しかし、心エコー評価では中隔の厚が減り左室心筋重量係数は低下するなど、左室肥大の退縮を意味する所見が示された。タファミジス治療から2年後に通院が困難との理由で他院へ転院し、その後、タファミジス治療を受けつつも歩行困難のため入院となっていた。

  • Drug-coated balloon angioplasty for severe pulmonary vein stenosis resulting from cryoballoon ablation for atrial fibrillation.

    Koji Yamaguchi, Tetsuzo Wakatsuki, Tomomi Matsuura, Kazuhisa Matsumoto, Yutaka Kawabata, Muneyuki Kadota, Kenya Kusunose, Takayuki Ise, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Masataka Sata

    Journal of cardiology cases   26 ( 1 )   35 - 38   2022.07

     More details

    International / domestic magazine:Domestic journal  

    We performed a drug-coated balloon (DCB) angioplasty for severe pulmonary vein (PV) stenosis resulting from cryoballoon ablation for atrial fibrillation. Three and fourteen months after the angioplasty, follow-up multidetector computed tomography did not show restenosis. Lesion regression was observed at 14-month follow-up. Two years after PV angioplasty with DCB, the patient was well without any symptoms. DCB angioplasty may become an alternative effective procedure for PV stenosis. Learning objective: The usefulness and safety of drug-coated balloon angioplasty for severe pulmonary vein stenosis resulting from cryoballoon ablation for atrial fibrillation was observed at 14-month follow-up.

    DOI: 10.1016/j.jccase.2022.02.009

    PubMed

  • 心房細動のクライオバルーンアブレーション後の重篤な肺静脈狭窄に対する薬剤被覆バルーン血管形成術(Drug-coated balloon angioplasty for severe pulmonary vein stenosis resulting from cryoballoon ablation for atrial fibrillation)

    Yamaguchi Koji, Wakatsuki Tetsuzo, Matsuura Tomomi, Matsumoto Kazuhisa, Kawabata Yutaka, Kadota Muneyuki, Kusunose Kenya, Ise Takayuki, Yagi Shusuke, Fukuda Daiju, Yamada Hirotsugu, Soeki Takeshi, Sata Masataka

    Journal of Cardiology Cases   26 ( 1 )   35 - 38   2022.07

     More details

    症例は68歳男性で、発作性心房細動の既往があり、第2世代クライオバルーンを用いた冷凍アブレーションを受けた。使用したバルーン径は28mmで、各肺静脈におけるバルーン留置時間は180秒であった。クライオバルーンの冷却温度は左上肺静脈で-55℃、左下肺静脈で-41℃、右下肺静脈で-53℃、右上肺静脈で-60℃であった。術後に肺静脈再伝導はなく、追加の冷却凝固は必要なかった。術後9ヵ月の再診で多列検出器型CT装置(MDCT)を用いた検査を施行した。左上肺静脈に中等度狭窄病変を認めた。3ヵ月後(術後12ヵ月)に再度MDCTを実施したところ、肺静脈狭窄の重症化を認めたため、血管形成術を計画した。肺静脈狭窄による症状は見られなかった。術前にクロピドグレル(75mg)を投与した。0.014インチのガイディングワイヤを挿入し、4Frマルチパーパスカテーテルを左上肺静脈へ挿入した。血管内超音波法で観察したところ、線維性およびfibro-fattyの新生内膜形成を認めた。薬剤被覆バルーンを拡張したところ、肺静脈圧較差は2mmHgに低下した。術後経過は良好で、14ヵ月後の再診で肺静脈狭窄の再発はなかった。

  • A Selective Mineralocorticoid Receptor Blocker, Esaxerenone, Attenuates Vascular Dysfunction in Diabetic C57BL/6 Mice

    Munkhjargal Uugantsetseg, Fukuda Daiju, Ganbaatar Byambasuren, Suto Kumiko, Matsuura Tomomi, Ise Takayuki, Kusunose Kenya, Yamaguchi Koji, Yagi Shusuke, Yamada Hirotsugu, Soeki Takeshi, Wakatsuki Tetsuzo, Sata Masataka

    Journal of Atherosclerosis and Thrombosis   30 ( 4 )   326 - 334   2022.06( ISSN:1340-3478

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    <p> <b>Aims:</b> Pharmacological blockade of mineralocorticoid receptors (MRs) is a potential therapeutic approach to reduce cardiovascular complications since MRs play a crucial role in cardiovascular regulation. Recent studies suggest that MR antagonists affect several extrarenal tissues, including vessel function. We investigated the effect of a novel nonsteroidal selective MR blocker, esaxerenone, on diabetes-induced vascular dysfunction.</p><p><b>Methods:</b> Diabetes was induced by a single dose of streptozotocin in 8-week-old male C57BL/6 mice. Esaxerenone (3 mg/kg/day) or a vehicle was administered by gavage to diabetic mice for 3 weeks. Metabolic parameters, plasma aldosterone levels, and parameters related to renal function were measured. Endothelium-dependent or -independent vascular responses of the aortic segments were analyzed with acetylcholine or sodium nitroprusside, respectively. Human umbilical vein endothelial cells (HUVECs) were used for the in vitro study.</p><p><b>Results:</b> Induction of diabetes elevated plasma aldosterone level (<i>P</i><0.05) and impaired endothelium-dependent vascular relaxation (<i>P</i><0.05). The administration of esaxerenone ameliorated the endothelial dysfunction (<i>P</i><0.01) without the alteration of metabolic parameters, blood pressure, and renal function. Esaxerenone improved the eNOS<sup>Ser1177</sup> phosphorylation in the aorta obtained from diabetic mice (<i>P</i><0.05) compared with that in the vehicle-treated group. Furthermore, a major MR agonist, aldosterone, decreased eNOS<sup>Ser1177</sup> phosphorylation and increased eNOS<sup>Thr495</sup> phosphorylation in HUVECs, which recovered with esaxerenone. Esaxerenone ameliorated the endothelium-dependent vascular relaxation caused by aldosterone in the aortic segments obtained from C57BL/6 mice (<i>P</i><0.001).</p><p><b>Conclusion:</b> Esaxerenone attenuates the development of diabetes-induced endothelial dysfunction in mice. These results suggest that esaxerenone has potential vascular protective effects in individuals with diabetes.</p>

    DOI: 10.5551/jat.63382

    PubMed

  • Epicardial adipose tissue volume is an independent predictor of left ventricular reverse remodeling in patients with non-ischemic cardiomyopathy.

    Yumi Yamaguchi, Atsushi Shibata, Toshitake Yoshida, Akiko Tanihata, Hiroya Hayashi, Ryoko Kitada, Shoichi Ehara, Yasuhiro Izumiya, Daiju Fukuda

    International journal of cardiology   356   60 - 65   2022.06( ISSN:0167-5273

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: In some patients with non-ischemic cardiomyopathy, left ventricular (LV) contraction is improved by optimal medical therapy, leading to LV reverse remodeling (RR). Patients with heart failure with improved ejection fraction and LVRR have a good prognosis, but the factors that predict RR are not fully understood. The relationship between body composition and cardiovascular disease has been reported. The present study aimed to assess the clinical predictors of LVRR in association with body composition. METHODS: We recruited patients who were diagnosed with non-ischemic cardiomyopathy between September 2017 and January 2020. Finally, 89 patients with a reduced LV ejection fraction were enrolled in this prospective study. Body composition, including ectopic fat, was measured in all patients using computed tomography. Echocardiography was performed 6 months after enrollment to evaluate LVRR. RESULTS: LVRR was observed in 39 patients (43.8%) after 6 months. In terms of the demographic findings, epicardial adipose tissue volume was greater in the LVRR group than in the non-LVRR group (135.2 cm3 [SD 128.4 cm3] vs. 88.9 cm3 [SD 54.6 cm3]; p = 0.040). The Kaplan-Meier analysis demonstrated that adverse cardiac events were significantly less frequent in the LVRR group than in the non-LVRR group (log-rank test, p = 0.013). The multivariate logistic regression analysis identified epicardial adipose tissue volume as an independent predictor of LVRR (odds ratio [OR]: 1.010, 95% confidence interval [CI]: 1.001-1.01; p = 0.036). CONCLUSION: Epicardial adipose tissue volume is an independent predictor of LVRR in patients with non-ischemic cardiomyopathy.

    DOI: 10.1016/j.ijcard.2022.03.051

    PubMed

  • Effects of Radiofrequency Catheter Ablation on Cardiac Reserve Using Preload Stress Echocardiography in Paroxysmal and Persistent Atrial Fibrillation.

    Nao Ishii, Kenya Kusunose, Ayu Shono, Kensuke Matsumoto, Susumu Nishio, Natsumi Yamaguchi, Yukina Hirata, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    The American journal of cardiology   168   71 - 77   2022.04( ISSN:0002-9149

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    The effects of catheter ablation on exercise tolerance and quality of life in patients with atrial fibrillation (AF) have been reported. We assessed cardiac function in more detail using the leg positive pressure (LPP) technique and found that contractile reserve is particularly important in relation to exercise tolerance and prognosis. In this study, we used the LPP technique to examine changes in contractile reserve immediately after ablation and 6 months later. We prospectively enrolled patients who underwent catheter ablation for AF at 2 institutes. We performed LPP stress echocardiography 2 to 3 days after (FU-1) and 6 months after (FU-2) ablation to examine changes in cardiac function indexes. The primary end point was improvement in contractile reserve. Ultimately, 109 patients (mean age 67.4 ± 9.6 years; 70% men) underwent 2 sessions of LPP stress echocardiography. The median CHA2DS2-VASC score was 2 (interquartile range 13). From FU-1 to FU-2, the change in the stroke volume index after the LPP maneuver increased in patients with paroxysmal and persistent AF with low CHA2DS2-VASC scores (both p <0.05). Regardless of AF subtype, contractile reserve at FU-2 improved in patients with low CHA2DS2-VASC scores compared with that at FU-1. In contrast, patients with high CHA2DS2-VASC scores had no change. In conclusion, patients with AF with a low CHA2DS2-VASC score had improved contractile reserve after ablation, whereas patients with high scores did not show any improvement. Aggressive interventions in patients with high scores may lead to better management after catheter ablation.

    DOI: 10.1016/j.amjcard.2021.12.026

    PubMed

  • Emerging Roles of the Innate Immune System Regulated by DNA Sensors in the Development of Vascular and Metabolic Diseases.

    Daiju Fukuda, Phuong Tran Pham, Masataka Sata

    Journal of atherosclerosis and thrombosis   29 ( 3 )   297 - 307   2022.03( ISSN:1340-3478

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    Sterile chronic inflammation causes cardiometabolic disorders; however, the mechanisms are not fully understood. Previous studies have demonstrated the degradation of cells/tissues in the vasculature and metabolic organs in lifestyle-associated diseases, such as diabetes and hyperlipidemia, suggesting the release and/or accumulation of nucleic acids from damaged cells. DNA is indispensable for life; however, DNA fragments, especially those from pathogens, strongly induce inflammation by the activation of DNA sensors. Growing evidence suggests that DNA-sensing mechanisms, which are normally involved in self-defense against pathogens as the innate immune system, are associated with the progression of inflammatory diseases in response to endogenous DNA fragments. There are several types of DNA sensors in our bodies. Toll-like receptor 9 (TLR9)-one of the most studied DNA sensors-recognizes DNA fragments in endosome. In addition, stimulator of interferon genes (STING), which has recently been extensively investigated, recognizes cyclic GMP-AMP (cGAMP) generated from DNA fragments in the cytosol. Both TLR9 and STING are known to play pivotal roles in host defense as the innate immune system. However, recent studies have indicated that the activation of these DNA sensors in immune cells, such as macrophages, promotes inflammation leading to the development of vascular and metabolic diseases associated with lifestyle. In this review, we discuss recent advances in determining the roles of DNA sensors in these disease contexts. Revealing a novel mechanism of sterile chronic inflammation regulated by DNA sensors might facilitate clinical interventions for these health conditions.

    DOI: 10.5551/jat.RV17059

    PubMed

    CiNii Article

  • Evaluation of the input site and characteristics of the antegrade fast pathway based on three-dimensional bi-atrial stimulus-ventricle mapping

    Matsumoto K.

    Journal of Interventional Cardiac Electrophysiology   63 ( 2 )   417 - 424   2022.03( ISSN:1383875X

     More details

  • 近赤外分光法-血管内超音波法による冠動脈プラークの脆弱性と脂質コア負荷の初評価(First Assessment of Coronary Plaque Vulnerability and Lipid Core Burden Assessed by Near-Infrared Spectroscopy-Intravascular Ultrasound in a Fresh Cadaver)

    川端 豊, 若槻 哲三, 山口 浩司, 福田 大受, 西條 良仁, 門田 宗之, 松浦 朋美, 伊勢 孝之, 楠瀬 賢也, 八木 秀介, 山田 博胤, 添木 武, 佐田 政隆

    日本循環器学会学術集会抄録集   86回   CRDP4 - 1   2022.03

  • 選択的ミネラルコルチコイド受容体拮抗薬エサキセレノンは血管機能障害とアテローム性動脈硬化を抑制する(A Selective Mineralocorticoid Receptor Blocker, Esaxerenone, Attenuates Vascular Dysfunction and Atherosclerosis)

    Munkhjargal Uugantsetseg, 福田 大受, 佐田 政隆

    日本循環器学会学術集会抄録集   86回   PJ50 - 3   2022.03

  • Preload Stress Echocardiography for the Assessment of Heart Failure With Preserved Ejection Fraction.

    Kenya Kusunose, Hirotsugu Yamada, Yoshihito Saijo, Susumu Nishio, Yukina Hirata, Takayuki Ise, Koji Yamaguchi, Daiju Fukuda, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    JACC. Cardiovascular imaging   15 ( 2 )   375 - 378   2022.02( ISSN:1936-878X

     More details

    International / domestic magazine:International journal  

    DOI: 10.1016/j.jcmg.2021.09.005

    PubMed

  • Clinical clerkship students' preferences and satisfaction regarding online lectures during the COVID-19 pandemic.

    Shusuke Yagi, Daiju Fukuda, Takayuki Ise, Koji Yamaguchi, Kenya Kusunose, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Tomohiro Soga, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Shinji Kawahito, Masataka Sata

    BMC medical education   22 ( 1 )   43 - 43   2022.01

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: The COVID-19 pandemic has caused an unprecedented disruption in medical education. Students and lecturers had to adapt to online education. The current study aimed to investigate the level of satisfaction and future preference for online lectures among clinical clerkship students and elucidated the factors that affect these outcomes. METHODS: We selected a sample of 114 medical students undergoing clinical clerkship during the COVID-19 pandemic. We conducted onsite lectures before the pandemic and online lectures after the outbreak. A survey was conducted, and the sample included students and 17 lecturers. The average scores of total satisfaction and future preference related to online lectures were computed. RESULTS: Students' scores on total satisfaction with online lectures and their future preference were higher than those for onsite lectures. Scores on the ease of debating dimension were low and those on accessibility of lectures in online lectures were higher than those in onsite lectures. There was no difference between the two groups in the scores on the comprehensibility and ease of asking questions dimensions. Results of the multiple regression analysis revealed that accessibility determined total satisfaction, and future preference was determined by comprehensibility as well as accessibility. Contrary to students' future preferences, lecturers favored onsite lectures to online ones. CONCLUSION: Online lectures are an acceptable mode of teaching during the COVID-19 pandemic for students undergoing clinical clerkship. Online lectures are expected to become more pervasive to avoid the spread of COVID-19.

    DOI: 10.1186/s12909-021-03096-7

    PubMed

  • Determinants of Non-calcified Low-Attenuation Coronary Plaque Burden in Patients Without Known Coronary Artery Disease: A Coronary CT Angiography Study.

    Hiroki Yamaura, Kenichiro Otsuka, Hirotoshi Ishikawa, Kuniyuki Shirasawa, Daiju Fukuda, Noriaki Kasayuki

    Frontiers in cardiovascular medicine   9   824470 - 824470   2022( ISSN:2297-055X

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: Although epicardial adipose tissue (EAT) is associated with coronary artery disease (CAD), it is unclear whether EAT volume (EAV) can be used to diagnose high-risk coronary plaque burden associated with coronary events. This study aimed to investigate (1) the prognostic impact of low-attenuation non-calcified coronary plaque (LAP) burden on patient level analysis, and (2) the association of EAV with LAP volume in patients without known CAD undergoing coronary computed tomography angiography (CCTA). MATERIALS AND METHODS: This retrospective study consisted of 376 patients (male, 57%; mean age, 65.2 ± 13 years) without known CAD undergoing CCTA. Percent LAP volume (%LAP, <30 HU) was calculated as the LAP volume divided by the vessel volume. EAT was defined as adipose tissue with a CT attenuation value ranging from -250 to -30 HU within the pericardial sac. The primary endpoint was a composite event of death, non-fatal myocardial infarction, and unstable angina and worsening symptoms requiring unplanned coronary revascularization >3 months after CCTA. The determinants of %LAP (Q4) were analyzed using a multivariable logistic regression model. RESULTS: During the follow-up period (mean, 2.2 ± 0.9 years), the primary endpoint was observed in 17 patients (4.5%). The independent predictors of the primary endpoint were %LAP (Q4) (hazard ratio [HR], 3.05; 95% confidence interval [CI], 1.09-8.54; p = 0.033] in the Cox proportional hazard model adjusted by CAD-RADS category. Cox proportional hazard ratio analysis demonstrated that %LAP (Q4) was a predictor of the primary endpoint, independnet of CAD severity, Suita score, EAV, or CACS. The independent determinants of %LAP (Q4) were CACS ≥218.3 (p < 0.0001) and EAV ≥125.3 ml (p < 0.0001). The addition of EAV to CACS significantly improved the area under the curve (AUC) to identify %LAP (Q4) than CACS alone (AUC, EAV + CACS vs. CACS alone: 0.728 vs. 0.637; p = 0.013). CONCLUSIONS: CCTA-based assessment of EAV, CACS, and LAP could help improve personalized cardiac risk management by administering patient-suited therapy.

    DOI: 10.3389/fcvm.2022.824470

    PubMed

  • Expanding role of deoxyribonucleic acid-sensing mechanism in the development of lifestyle-related diseases.

    Sachiko Nishimoto, Masataka Sata, Daiju Fukuda

    Frontiers in cardiovascular medicine   9   881181 - 881181   2022( ISSN:2297-055X

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    In lifestyle-related diseases, such as cardiovascular, metabolic, respiratory, and kidney diseases, chronic inflammation plays a causal role in their pathogenesis; however, underlying mechanisms of sterile chronic inflammation are not well-understood. Previous studies have confirmed the damage of cells in these organs in the presence of various risk factors such as diabetes, dyslipidemia, and cigarette smoking, releasing various endogenous ligands for pattern recognition receptors. These studies suggested that nucleic acids released from damaged tissues accumulate in these tissues, acting as an endogenous ligand. Undamaged DNA is an integral factor for the sustenance of life, whereas, DNA fragments, especially those from pathogens, are potent activators of the inflammatory response. Recent studies have indicated that inflammatory responses such as the production of type I interferon (IFN) induced by DNA-sensing mechanisms which contributes to self-defense system in innate immunity participates in the progression of inflammatory diseases by the recognition of nucleic acids derived from the host, including mitochondrial DNA (mtDNA). The body possesses several types of DNA sensors. Toll-like receptor 9 (TLR9) recognizes DNA fragments in the endosomes. In addition, the binding of DNA fragments in the cytosol activates cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase (cGAS), resulting in the synthesis of the second messenger cyclic GMP-AMP (cGAMP). The binding of cGAMP to stimulator of interferon genes (STING) activates NF-κB and TBK-1 signaling and consequently the production of many inflammatory cytokines including IFNs. Numerous previous studies have demonstrated the role of DNA sensors in self-defense through the recognition of DNA fragments derived from pathogens. Beyond the canonical role of TLR9 and cGAS-STING, this review describes the role of these DNA-sensing mechanism in the inflammatory responses caused by endogenous DNA fragments, and in the pathogenesis of lifestyle-related diseases.

    DOI: 10.3389/fcvm.2022.881181

    PubMed

  • Regression of left ventricular hypertrophy after tafamidis therapy in a patient with transthyretin amyloidosis variant

    Yagi Shusuke, Yamazaki Hiromu, Kusunose Kenya, Osaki Yusuke, Ise Takayuki, Kadota Muneyuki, Tserensonom Munkhtsetseg, Kawabata Yutaka, Hara Tomoya, Ueno Rie, Saijo Yoshihito, Matsuura Tomomi, Yamaguchi Koji, Yamada Hirotsugu, Fukuda Daiju, Soeki Takeshi, Wakatsuki Tetsuzo, Sata Masataka

    The Journal of Medical Investigation   69 ( 3.4 )   320 - 322   2022( ISSN:13496867

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    <p>Transthyretin amyloidosis (ATTR) variant is a life-threatening hereditary disease predominantly affecting the peripheral nervous system and heart. Tafamidis, which prevents the deposition of amyloid by stabilizing transthyretin, is available for the treatment of neuropathy and cardiomyopathy of ATTR. However, whether tafamidis could eliminate established amyloid deposits and improve cardiac function remains unknown. We reported a case of regression of left ventricular hypertrophy after tafamidis therapy in a patient with an ATTR variant. J. Med. Invest. 69 : 320-322, August, 2022</p>

    DOI: 10.2152/jmi.69.320

    PubMed

  • Comparison of Direct Oral Anticoagulants for Acute Hospital Mortality in Venous Thromboembolism.

    Yuichiro Okushi, Kenya Kusunose, Michikazu Nakai, Yoko Sumita, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    American journal of cardiovascular drugs : drugs, devices, and other interventions   22 ( 4 )   407 - 416   2021.12( ISSN:1175-3277

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: The choice of direct oral anticoagulants (DOACs) for venous thromboembolism (VTE) is at the physician's discretion; however, it is useful to know the differences in the clinical data of DOACs to help physicians choose. OBJECTIVE: We aimed to compare the mortality associated with the use of rivaroxaban, edoxaban, and apixaban in clinical practice. METHODS: We identified 38,245 patients with first hospitalization for VTE from the Diagnosis Procedure Combination database in the Japanese Registry of All Cardiac and Vascular Datasets (JROAD-DPC). We classified patients into three groups by DOAC (rivaroxaban and edoxaban group, rivaroxaban and apixaban group, and edoxaban and apixaban group) and compared the in-hospital mortality and bleeding risk by propensity score (PS) matching in each group. RESULTS: After PS matching, patients with rivaroxaban use had significantly lower total in-hospital mortality (1.2% vs. 2.1%; odds ratio [OR] 0.55, p = 0.012) and in-hospital mortality within 21 days (0.4% vs. 1.0%; OR 0.41, p = 0.020) and 28 days (0.7% vs. 1.3%; OR 0.53, p = 0.042) than patients with apixaban use. In the subanalysis, significant differences were only observed in patients younger than 80 years of age, patients with pulmonary embolism, and patients without heart failure. There was no significant difference in in-hospital mortality in the other groups and in the rate of bleeding events among the three groups. CONCLUSION: On PS-matched analysis, there was a difference in in-hospital mortality, especially in the rivaroxaban and apixaban group. Identifying the clinical characteristics of patients associated with each DOAC, as well as prognosis, will be useful in determining treatment strategies for VTE.

    DOI: 10.1007/s40256-021-00514-5

    PubMed

  • Pemafibrate, A Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator, Reduces Plasma Eicosanoid Levels and Ameliorates Endothelial Dysfunction in Diabetic Mice.

    Kumiko Suto, Daiju Fukuda, Masakazu Shinohara, Byambasuren Ganbaatar, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takeshi Soeki, Ken-Ichi Hirata, Masataka Sata

    Journal of atherosclerosis and thrombosis   28 ( 12 )   1349 - 1360   2021.12( ISSN:1340-3478

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    AIMS: Various pathological processes related to diabetes cause endothelial dysfunction. Eicosanoids derived from arachidonic acid (AA) have roles in vascular regulation. Fibrates have recently been shown to attenuate vascular complications in diabetics. Here we examined the effects of pemafibrate, a selective peroxisome proliferator-activated receptor α modulator, on plasma eicosanoid levels and endothelial function in diabetic mice. METHODS: Diabetes was induced in 7-week-old male wild-type mice by a single injection of streptozotocin (150 mg/kg). Pemafibrate (0.3 mg/kg/day) was administered orally for 3 weeks. Untreated mice received vehicle. Circulating levels of eicosanoids and free fatty acids were measured using both gas and liquid chromatography-mass spectrometry. Endothelium-dependent and endothelium-independent vascular responses to acetylcholine and sodium nitroprusside, respectively, were analyzed. RESULTS: Pemafibrate reduced both triglyceride and non-high-density lipoprotein -cholesterol levels (P<0.01), without affecting body weight. It also decreased circulating levels of AA (P<0.001), thromboxane B2 (P<0.001), prostaglandin E2, leukotriene B4 (P<0.05), and 5-hydroxyeicosatetraenoic acid (P<0.001), all of which were elevated by the induction of diabetes. In contrast, the plasma levels of 15-deoxy-Δ12,14-prostaglandin J2, which declined following diabetes induction, remained unaffected by pemafibrate treatment. In diabetic mice, pemafibrate decreased palmitic acid (PA) and stearic acid concentrations (P<0.05). Diabetes induction impaired endothelial function, whereas pemafibrate ameliorated it (P<0.001). The results of ex vivo experiments indicated that eicosanoids or PA impaired endothelial function. CONCLUSION: Pemafibrate diminished the levels of vasoconstrictive eicosanoids and free fatty acids accompanied by a reduction of triglyceride. These effects may be associated with the improvement of endothelial function by pemafibrate in diabetic mice.

    DOI: 10.5551/jat.61101

    PubMed

    CiNii Article

  • Pemafibrate, A Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator, Reduces Plasma Eicosanoid Levels and Ameliorates Endothelial Dysfunction in Diabetic Mice(和訳中)

    Suto Kumiko, Fukuda Daiju, Shinohara Masakazu, Ganbaatar Byambasuren, Yagi Shusuke, Kusunose Kenya, Yamada Hirotsugu, Soeki Takeshi, Hirata Ken-ichi, Sata Masataka

    Journal of Atherosclerosis and Thrombosis   28 ( 12 )   1349 - 1360   2021.12( ISSN:1340-3478

     More details

    糖尿病マウスにおいて、血漿脂質濃度、アラキドン酸(AA)由来エイコサノイド値、内皮機能に対するペマフィブラート(PF)の影響を調べた。マウスを非糖尿病対照、未処理糖尿病、PF処理糖尿病の3群に無作為に分けた。糖尿病マウスはストレプトゾトシン注入によって糖尿病を誘発させ、PFまたは溶媒のみを投与して、PF群と未処理群とした。エイコサノイドと遊離脂肪酸の血中濃度はガスクロマトグラフィー質量分析と液体クロマトグラフィー質量分析計で測定した。内皮依存性血管反応はアセチルコリン、内皮非依存性血管反応はニトロプルシドナトリウムへの反応で解析した。PFは体重への影響なしでトリグリセリド値と非HDLコレステロール値を低下させ、糖尿病誘発によって上昇したAA、トロンボキサンB2、プロスタグランジンE2、ロイコトリエンB4、5-ヒドロキシエイコサテトラエン酸の血中濃度を減少させた。15-デオキシ-Δ12,14-プロスタグランジンJ2の血漿中濃度は糖尿病誘発後に低下したが、PF処理の影響はなかった。糖尿病マウスではPFはパルミチン酸(PA)値とステアリン酸値を低下させた。糖尿病誘発によって血管内皮機能が低下したが、PFによって改善した。ex vivo実験の結果、エイコサノイドまたはPAは血管内皮機能を低下させることが示された。

  • Predictive value of left atrial function for latent paroxysmal atrial fibrillation as the cause of embolic stroke of undetermined source(和訳中)

    Kusunose Kenya, Takahashi Hironori, Nishio Susumu, Hirata Yukina, Zheng Robert, Ise Takayuki, Yamaguchi Koji, Yagi Shusuke, Fukuda Daiju, Yamada Hirotsugu, Soeki Takeshi, Wakatsuki Tetsuzo, Shimada Kenji, Kanematsu Yasuhisa, Takagi Yasushi, Sata Masataka

    Journal of Cardiology   78 ( 5-6 )   355 - 361   2021.12( ISSN:0914-5087

     More details

    塞栓源不明脳塞栓症(ESUS)の入院患者121例(男性71例)を対象に心エコー検査を実施し、左房機能の評価がESUSの原因として発作性心房細動(AF)を予測するかどうかを検討した。AFの既往、左室駆出率が30%未満、感染性心内膜炎の患者は除外した。平均追跡期間は18日で、AFは46例(38%)で新規発生した。患者をAF発症群46例(男性50%、平均80±8歳)と非AF群75例(男性64%、平均73±14歳)に分類した。患者背景はAF発症群で高血圧症が多かったが、併存症および使用薬剤に関して有意な群間差はなかった。左房機能評価で左房容積係数(LAVI)はAF発症群の方が有意に高く、左房リザーバー機能およびポンプ機能はAF発症群の方が有意に低かった。AFの発症に関するROC曲線で、標準的な臨床データに加えて左房リザーバー機能または左房ポンプ機能のパラメータを組み込んだモデルの曲線下面積(AUC)は、それぞれ0.76±0.05と0.86±0.04で、通常モデルにLAVIを組み込んだモデルのAUC(0.68±0.04)より有意に高かった(P<0.05)。

  • 左冠動脈主幹部の急性冠症候群の2症例

    手束 一貴, 高橋 智紀, 西條 良仁, 川端 豊, 門田 宗之, 松浦 朋美, 伊勢 孝之, 山口 浩司, 八木 秀介, 福田 大受, 山田 博胤, 添木 武, 若槻 哲三, 佐田 政隆, 佐村 高明, 秦 広樹

    四国医学雑誌   77 ( 5-6 )   297 - 297   2021.12( ISSN:0037-3699

  • 生活習慣病を克服して、健康寿命を延伸するために カテーテル大動脈弁置換術(TAVI)によって激変した大動脈弁狭窄症治療

    伊勢 孝之, 門田 宗之, 川端 豊, 楠瀬 賢也, 山口 浩司, 八木 秀介, 福田 大受, 山田 博胤, 添木 武, 若槻 哲三, 佐田 政隆, 佐村 高明, 藤本 鋭貴, 秦 広樹

    四国医学雑誌   77 ( 5-6 )   288 - 288   2021.12( ISSN:0037-3699

  • 動脈硬化性疾患の高リスク患者において大動脈弁の石灰化と血清リポ蛋白との関連

    Munkhtsetseg Tserrensonom, 八木 秀介, 伊勢 孝之, 門田 宗之, 川端 豊, 西條 良仁, 松浦 朋美, 楠瀬 賢也, 山口 浩司, 福田 大受, 山田 博胤, 添木 武, 若槻 哲三, 佐田 政隆

    四国医学雑誌   77 ( 5-6 )   296 - 297   2021.12( ISSN:0037-3699

  • 極長鎖一価不飽和脂肪酸は腸内細菌叢の変化を介して血管内皮機能を改善する

    米田 祥広, 堤 理恵, 三島 優奈, 黒田 雅士, 板東 正浩, 阪上 浩, 福田 大受, 佐田 正隆, 粟飯原 賢一

    四国医学雑誌   77 ( 5-6 )   293 - 293   2021.12( ISSN:0037-3699

  • STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseases.

    Phuong Tran Pham, Daiju Fukuda, Sachiko Nishimoto, Joo-Ri Kim-Kaneyama, Xiao-Feng Lei, Yutaka Takahashi, Tomohito Sato, Kimie Tanaka, Kumiko Suto, Yutaka Kawabata, Koji Yamaguchi, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Kenji Shimada, Yasuhisa Kanematsu, Yasushi Takagi, Michio Shimabukuro, Mitsutoshi Setou, Glen N Barber, Masataka Sata

    European heart journal   42 ( 42 )   4336 - 4348   2021.11( ISSN:0195-668X

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    AIMS : Lifestyle-related diseases promote atherosclerosis, a chronic inflammatory disease; however, the molecular mechanism remains largely unknown. Endogenous DNA fragments released under over-nutrient condition provoke sterile inflammation through the recognition by DNA sensors. Here, we investigated the role of stimulator of interferon genes (STING), a cytosolic DNA sensor, in atherogenesis. METHODS AND RESULTS : Apolipoprotein E-deficient (Apoe-/-) mice fed a western-type diet (WTD), a hypercholesterolaemic mouse model, showed higher STING expression and markers for DNA damage such as γH2AX, p53, and single-stranded DNA (ssDNA) accumulation in macrophages in the aorta compared with wild-type (WT) mice. The level of cGAMP, a STING agonist, in the aorta was higher in Apoe-/- mice. Genetic deletion of Sting in Apoe-/- mice reduced atherosclerotic lesions in the aortic arch, lipid, and macrophage accumulation in plaques, and inflammatory molecule expression in the aorta compared with the control. Pharmacological blockade of STING using a specific inhibitor, C-176, ameliorated atherogenesis in Apoe-/- mice. In contrast, bone marrow-specific STING expression in Apoe-/- mice stimulated atherogenesis. Expression or deletion of STING did not affect metabolic parameters and blood pressure. In vitro studies revealed that STING activation by cGAMP or mitochondrial DNA accelerated inflammatory molecule expression (e.g. TNF-α or IFN-β) in mouse and human macrophages. Activation of nuclear factor-κB and TANK binding kinase 1 was involved in STING-associated vascular inflammation and macrophage activation. Furthermore, human atherosclerotic lesions in the carotid arteries expressed STING and cGAMP. CONCLUSION : Stimulator of interferon genes stimulates pro-inflammatory activation of macrophages, leading to the development of atherosclerosis. Stimulator of interferon genes signalling may serve as a potential therapeutic target for atherosclerosis.

    DOI: 10.1093/eurheartj/ehab249

    PubMed

  • Clinical Utility of Overlap Time for Incomplete Relaxation to Predict Cardiac Events in Heart Failure.

    Kenya Kusunose, Miharu Arase, Robert Zheng, Yukina Hirata, Susumu Nishio, Takayuki Ise, Koji Yamaguchi, Daiju Fukuda, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    Journal of cardiac failure   27 ( 11 )   1222 - 1230   2021.11( ISSN:1071-9164

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: The overlap time of transmitral flow can be a novel marker of subclinical left ventricular dysfunction for predicting adverse events in heart failure (HF). We aimed to (1) investigate the role of overlap time of the E-A wave in association with clinical parameters and (2) evaluate whether the overlap time could add prognostic information with respect to other conventional clinical prognosticators in HF. METHODS: We prospectively evaluated 153 patients hospitalized with HF (mean age 68 ± 15 years; 63% male). The primary endpoint was readmission following HF or cardiac death. RESULTS: During a median period of 25 months, 43 patients were readmitted or died. Overlap time appeared to be associated with worse outcomes. After adjustment for readmission scores and ratios of diastolic filling period and cardiac cycle length in a Cox proportional-hazards model, overlap time was associated with event-free survival, independent of elevated left atrial pressure based on guidelines. When overlap time was added to the model based on clinical variables and elevated left atrial pressure, the C-statistic significantly improved from 0.70 (95% CI: 0.63-0.77) to 0.77 (95% CI: 0.69-0.83, compared) (P = 0.035). CONCLUSION: This preliminary study suggested that prolonged overlap time may have potential for predicting readmission and cardiac mortality risk assessment in patients with HF.

    DOI: 10.1016/j.cardfail.2021.05.018

    PubMed

  • Predictive value of left atrial function for latent paroxysmal atrial fibrillation as the cause of embolic stroke of undetermined source.

    Kenya Kusunose, Hironori Takahashi, Susumu Nishio, Yukina Hirata, Robert Zheng, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Kenji Shimada, Yasuhisa Kanematsu, Yasushi Takagi, Masataka Sata

    Journal of cardiology   78 ( 5 )   355 - 361   2021.11( ISSN:0914-5087

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: In patients with embolic stroke of undetermined source (ESUS), paroxysmal atrial fibrillation (AF) is often diagnosed, however, the risk of paroxysmal AF in ESUS has not been well described. Several studies have suggested a linkage between left atrial (LA) functional parameters and risk of AF in stroke patients. The aim of this study was to assess the role of LA functional parameters as predictors of latent paroxysmal AF in ESUS on admission. METHODS: Between January 2015 and December 2019, consecutive stroke patients with suspected ESUS at admission were prospectively included in this study. They were under hospital electrocardiographic monitoring for detection of new-onset AF. Various echocardiographic parameters including left atrial strain were assessed for association with new-onset AF. RESULTS: We gathered 1082 consecutive patients with ischemic stroke. After exclusions, 121 patients with suspected ESUS at admission formed the study cohort. New-onset AF was detected in 46 (38%) patients during hospital electrocardiographic monitoring (median follow-up: 18 days). LA pump and reservoir strains were significantly and independently associated with new-onset AF. Receiver operating characteristic analysis for the association with new-onset AF showed that the areas under the curve (AUCs) of clinical parameters plus one of each strain (LA pump strain: AUC: 0.86±0.04 and LA reservoir strain: AUC: 0.76±0.05) models were significantly better than plus LA volume index (AUC: 0.68±0.04, compared p-values <0.05). CONCLUSIONS: LA strain was significantly associated with new development of AF. Patients with impaired LA function at admission should be carefully monitored to find AF.

    DOI: 10.1016/j.jjcc.2021.05.005

    PubMed

  • Long-chain monounsaturated fatty acids improve endothelial function with altering microbial flora.

    Rie Tsutsumi, Yuki Yamasaki, Jiro Takeo, Hiroko Miyahara, Mayu Sebe, Masahiro Bando, Yousuke Tanba, Yuna Mishima, Kana Takeji, Nanako Ueshima, Masashi Kuroda, Saeko Masumoto, Nagakatsu Harada, Daiju Fukuda, Ryoko Yoshimoto, Yasuo M Tsutsumi, Ken-Ichi Aihara, Masataka Sata, Hiroshi Sakaue

    Translational research : the journal of laboratory and clinical medicine   237   16 - 30   2021.11( ISSN:1931-5244

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Fish oil-derived long-chain monounsaturated fatty acids (LCMUFAs) with a carbon chain length longer than 18 units ameliorate cardiovascular risk in mice. In this study, we investigated whether LCMUFAs could improve endothelial functions in mice and humans. In a double-blind, randomized, placebo-controlled, parallel-group, multi-center study, healthy subjects were randomly assigned to either an LCMUFA oil (saury oil) or a control oil (olive and tuna oils) group. Sixty subjects were enrolled and administrated each oil for 4 weeks. For the animal study, ApoE-/- mice were fed a Western diet supplemented with 3% of either gadoleic acid (C20:1) or cetoleic acid (C22:1) for 12 weeks. Participants from the LCMUFA group showed improvements in endothelial function and a lower trimethylamine-N-oxide level, which is a predictor of coronary artery disease. C20:1 and C22:1 oils significantly improved atherosclerotic lesions and plasma levels of several inflammatory cytokines, including IL-6 and TNF-α. These beneficial effects were consistent with an improvement in the gut microbiota environment, as evident from the decreased ratio of Firmicutes and/ or Bacteroidetes, increase in the abundance of Akkermansia, and upregulation of short-chain fatty acid (SCFA)-induced glucagon-like peptide-1 (GLP-1) expression and serum GLP-1 level. These data suggest that LCMUFAs alter the microbiota environment that stimulate the production of SCFAs, resulting in the induction of GLP-1 secretion. Fish oil-derived long-chain monounsaturated fatty acids might thus help to protect against cardiovascular disease.

    DOI: 10.1016/j.trsl.2021.03.016

    PubMed

  • Impact of cancer on short-term in-hospital mortality after primary acute myocardial infarction.

    Zheng R, Kusunose K, Okushi Y, Okayama Y, Nakai M, Sumita Y, Ise T, Yamaguchi K, Yagi S, Fukuda D, Yamada H, Soeki T, Wakatsuki T, Sata M

    Open heart   8 ( 2 )   2021.11

  • Impact of cancer on short-term in-hospital mortality after primary acute myocardial infarction.

    Robert Zheng, Kenya Kusunose, Yuichiro Okushi, Yoshihiro Okayama, Michikazu Nakai, Yoko Sumita, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    Open heart   8 ( 2 )   2021.11

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: Cardiovascular diseases are the second most common cause of mortality among cancer survivors, after death from cancer. We sought to assess the impact of cancer on the short-term outcomes of acute myocardial infarction (AMI), by analysing data obtained from a large-scale database. METHODS: This study was based on the Diagnosis Procedure Combination database in the Japanese Registry of All Cardiac and Vascular Diseases and the Diagnosis Procedure Combination. We identified patients who were hospitalised for primary AMI between April 2012 and March 2017. Propensity Score (PS) was estimated with logistic regression model, with cancer as the dependent variable and 21 clinically relevant covariates. The main outcome was in-hospital mortality. RESULTS: We split 1 52 208 patients into two groups with or without cancer. Patients with cancer tended to be older (cancer group 73±11 years vs non-cancer group 68±13 years) and had smaller body mass index (cancer group 22.8±3.6 vs non-cancer 23.9±4.3). More patients in the non-cancer group had hypertension or dyslipidaemia than their cancer group counterparts. The non-cancer group also had a higher rate of percutaneous coronary intervention (cancer 92.6% vs non-cancer 95.2%). Patients with cancer had a higher 30-day mortality (cancer 6.0% vs non-cancer 5.3%) and total mortality (cancer 8.1% vs non-cancer 6.1%) rate, but this was statistically insignificant after PS matching. CONCLUSION: Cancer did not significantly impact short-term in-hospital mortality rates after hospitalisation for primary AMI.

    DOI: 10.1136/openhrt-2021-001860

    PubMed

  • Impact of cancer on short-term in-hospital mortality after primary acute myocardial infarction

    Robert Zheng, Kenya Kusunose, Yuichiro Okushi, Yoshihiro Okayama, Michikazu Nakai, Yoko Sumita, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    OPEN HEART   8 ( 2 )   2021.11( ISSN:2053-3624

     More details

    Publishing type:Research paper (scientific journal)  

    Background Cardiovascular diseases are the second most common cause of mortality among cancer survivors, after death from cancer. We sought to assess the impact of cancer on the short-term outcomes of acute myocardial infarction (AMI), by analysing data obtained from a large-scale database.Methods This study was based on the Diagnosis Procedure Combination database in the Japanese Registry of All Cardiac and Vascular Diseases and the Diagnosis Procedure Combination. We identified patients who were hospitalised for primary AMI between April 2012 and March 2017. Propensity Score (PS) was estimated with logistic regression model, with cancer as the dependent variable and 21 clinically relevant covariates. The main outcome was in-hospital mortality.Results We split 1 52 208 patients into two groups with or without cancer. Patients with cancer tended to be older (cancer group 73 +/- 11 years vs non-cancer group 68 +/- 13 years) and had smaller body mass index (cancer group 22.8 +/- 3.6vs non-cancer 23.9 +/- 4.3). More patients in the non-cancer group had hypertension or dyslipidaemia than their cancer group counterparts. The non-cancer group also had a higher rate of percutaneous coronary intervention (cancer 92.6% vs non-cancer 95.2%). Patients with cancer had a higher 30-day mortality (cancer 6.0% vs non-cancer 5.3%) and total mortality (cancer 8.1% vs non-cancer 6.1%) rate, but this was statistically insignificant after PS matching.Conclusion Cancer did not significantly impact short-term in hospital mortality rates after hospitalisation for primary AMI.

    DOI: 10.1136/openhrt-2021-001860

  • Infective Endocarditis from Furuncle with Meningitis Complication Caused by Methicillin-resistant Staphylococcus aureus.

    Shusuke Yagi, Tomoko Takahashi, Keiji Murakami, Momoyo Azuma, Mikio Sugano, Ryosuke Miyamoto, Mariko Niki, Hirotsugu Yamada, Yutaka Kawabata, Akihiro Tani, Daiju Fukuda, Muneyuki Kadota, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Tomomi Matsuura, Koji Yamaguchi, Takeshi Soeki, Tetsuzo Wakatsuki, Hiroki Hata, Masataka Sata

    Internal medicine (Tokyo, Japan)   60 ( 20 )   3251 - 3255   2021.10( ISSN:0918-2918

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    Infective endocarditis (IE) may be acquired in the community as community-acquired (CA) IE or in the healthcare setting. In Japan, cases of CA-methicillin-resistant Staphylococcus aureus (MRSA) infection as skin infection have been increasing. CA-MRSA strains, including the USA300 clone, have higher pathogenicity and are more destructive to tissue than healthcare-associated MRSA strains because of the toxins they produce, including arginine-catabolic mobile element (ACME) and Panton-Valentine leukocidin (PVL). However, only a few IE cases induced by USA300 have been reported. We herein report a 64-year-old man who developed CA-IE from a furuncle caused by USA300 MRSA producing PVL and ACME, which resulted in complications of meningitis.

    DOI: 10.2169/internalmedicine.6902-20

    PubMed

    CiNii Article

  • メチシリン耐性黄色ブドウ球菌により引き起こされた髄膜炎合併を伴うせつによる感染性心内膜炎(Infective Endocarditis from Furuncle with Meningitis Complication Caused by Methicillin-resistant Staphylococcus aureus)

    Yagi Shusuke, Takahashi Tomoko, Murakami Keiji, Azuma Momoyo, Sugano Mikio, Miyamoto Ryosuke, Niki Mariko, Yamada Hirotsugu, Kawabata Yutaka, Tani Akihiro, Fukuda Daiju, Kadota Muneyuki, Ise Takayuki, Kusunose Kenya, Tobiume Takeshi, Matsuura Tomomi, Yamaguchi Koji, Soeki Takeshi, Wakatsuki Tetsuzo, Hata Hiroki, Sata Masataka

    Internal Medicine   60 ( 20 )   3251 - 3255   2021.10( ISSN:0918-2918

     More details

    症例は64歳男性で、1年前に僧帽弁逸脱のため僧帽弁形成術を施行されていた。今回、左大腿に発疹を認めて皮膚科を受診した。せつと診断され、膿培養はメチシリン耐性黄色ブドウ球菌(MRSA)陽性であった。7日間にわたりレボフロキサシン500mg/日が処方され、せつは徐々に改善した。25日後、全身性疲労と摂氏39度超の発熱が出現し、右胸に別の発疹を認めた。組織学的所見から、皮膚膿瘍が示唆された。3日後、意識消失後に転倒して救急来院した。入院後、意識レベルは改善したが、頸部痛を訴えた。腰椎穿刺の所見から、髄膜炎が示唆された。経食道心エコー検査の所見では、大動脈弁左冠尖の疣贅が強く疑われた。血液培養でMRSAが検出されたことから、髄膜炎を合併したせつによる感染性心内膜炎(IE)と診断した。IEの原因として、皮膚感染症とUSA300株MRSAによる組織破壊性市中IEが疑われた。マルチプレックスPCR検査を行い、MRSAはUSA300株であり、Panton-Valentineロイコシジンとアルギニン異化可動性元素に陽性であることを確認した。

  • Use of Echocardiography and Heart Failure In-Hospital Mortality from Registry Data in Japan.

    Kenya Kusunose, Yuichiro Okushi, Yoshihiro Okayama, Robert Zheng, Michikazu Nakai, Yoko Sumita, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    Journal of cardiovascular development and disease   8 ( 10 )   2021.09

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: Echocardiography requires a high degree of skill on the part of the examiner, and the skill may be more improved in larger volume centers. This study investigated trends and outcomes associated with the use and volume of echocardiographic exams from a real-world registry database of heart failure (HF) hospitalizations. METHODS: This study was based on the Diagnosis Procedure Combination database in the Japanese Registry of All Cardiac and Vascular Datasets (JROAD-DPC). A first analysis was performed to assess the trend of echocardiographic examinations between 2012 and 2016. A secondary analysis was performed to assess whether echocardiographic use was associated with in-hospital mortality in 2015. RESULTS: During this period, the use of echocardiography grew at an average annual rate of 6%. Patients with echocardiography had declining rates of hospital mortality, and these trends were associated with high hospitalization costs. In the 2015 sample, a total of 52,832 echocardiograms were examined, corresponding to 65.6% of all HF hospital admissions for that year. We found that the use and volume of echocardiography exams were associated with significantly lower odds of all-cause hospital mortality in heart failure (adjusted odds ratio (OR): 0.48 for use of echocardiography and 0.78 for the third tertile; both p < 0.001). CONCLUSIONS: The use of echocardiography was associated with decreased odds of hospital mortality in HF. The volumes of echocardiographic examinations were also associated with hospital mortality.

    DOI: 10.3390/jcdd8100124

    PubMed

  • Left Atrial Strain Associated with Functional Recovery in Patients Receiving Optimal Treatment for Heart Failure.

    Yuta Torii, Kenya Kusunose, Yukina Hirata, Susumu Nishio, Takayuki Ise, Koji Yamaguchi, Daiju Fukuda, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography   34 ( 9 )   966 - 975.e2   2021.09( ISSN:0894-7317

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: Heart failure with recovered ejection fraction (HFrecEF) has been reported in several previous studies to have a better prognosis than heart failure with reduced ejection fraction (HFrEF). However, the factors associated with HFrecEF have not been identified. The aim of this study was to test the hypothesis that left atrial (LA) strain could help identify patients with recovered ejection fraction (EF) among those with heart failure (HF) with low EF on admission. METHODS: One hundred consecutive patients hospitalized for the first time for new-onset HF were enrolled. Patients were clinically diagnosed with HFrEF on admission (left ventricular EF < 40%) and received optimal treatment for HF. Twenty-eight patients improved to HFrecEF during 6 months of follow-up. RESULTS: Regarding clinical background, there were significantly more women and a lower rate of atrial fibrillation in the HFrecEF group than in the HFrEF group. In a multivariate logistic regression analysis, LA strain was an independent predictor of HFrecEF, even after adjustment for gender and left ventricular EF (odds ratio: 4.06; 95% CI: 2.04-8.07; P < .001). A cutoff value of 10.8% for LA strain showed high sensitivity (96%) and specificity (82%) in identifying HFrecEF in patients with HF presenting with low EF on admission. During a follow-up period of 24 ± 13 months, 31 patients (31%) had cardiovascular death or readmission for HF. Patients with reduced LA strain (<10.8%) had significantly shorter event-free survival than those with preserved LA strain (P = .02). CONCLUSIONS: LA strain is a useful indicator for predicting HFrecEF and should be considered as a routine measurement in patients with HFrEF on admission.

    DOI: 10.1016/j.echo.2021.03.016

    PubMed

  • 冠動脈塞栓症を発症した2症例の臨床的検討

    川端 豊, 若槻 哲三, 山口 浩司, 門田 宗之, 伊勢 孝之, 楠瀬 賢也, 松浦 朋美, 八木 秀介, 福田 大受, 山田 博胤, 添木 武, 佐田 政隆

    日本心臓病学会学術集会抄録   69回   O - 114   2021.09

  • Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial Fibrillation.

    Tomomi Matsuura, Takeshi Soeki, Daiju Fukuda, Etsuko Uematsu, Takeshi Tobiume, Tomoya Hara, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki, Masataka Sata

    Circulation journal : official journal of the Japanese Circulation Society   85 ( 8 )   1383 - 1391   2021.07( ISSN:1346-9843

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    BACKGROUND: Activated factor X (FXa), which contributes to chronic inflammation via protease-activated receptor 2 (PAR2), might play an important role in atrial fibrillation (AF) arrhythmogenesis. This study aimed to assess whether PAR2 signaling contributes to AF arrhythmogenesis and whether rivaroxaban ameliorates atrial inflammation and prevents AF.Methods and Results:In Study 1, PAR2 deficient (PAR2-/-) and wild-type mice were infused with angiotensin II (Ang II) or a vehicle via an osmotic minipump for 2 weeks. In Study 2, spontaneously hypertensive rats (SHRs) were treated with rivaroxaban, warfarin, or vehicle for 2 weeks after 8 h of right atrial rapid pacing. The AF inducibility and atrial remodeling in both studies were examined. Ang II-treated PAR2-/- mice had a lower incidence of AF and less mRNA expression of collagen1 and collagen3 in the atrium compared to wild-type mice treated with Ang II. Rivaroxaban significantly reduced AF inducibility compared with warfarin or vehicle. In SHRs treated with a vehicle, rapid atrial pacing promoted gene expression of inflammatory and fibrosis-related biomarkers in the atrium. Rivaroxaban, but not warfarin, significantly reduced expression levels of these genes. CONCLUSIONS: The FXa-PAR2 signaling pathway might contribute to AF arrhythmogenesis associated with atrial inflammation. A direct FXa inhibitor, rivaroxaban, could prevent atrial inflammation and reduce AF inducibility, probably by inhibiting the pro-inflammatory activation.

    DOI: 10.1253/circj.CJ-20-1006

    PubMed

    CiNii Article

  • プロテアーゼ活性化受容体2を介した活性化血液凝固第X因子のシグナル伝達経路は心房細動予防のための新たな治療標的である(Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial Fibrillation)

    Matsuura Tomomi, Soeki Takeshi, Fukuda Daiju, Uematsu Etsuko, Tobiume Takeshi, Hara Tomoya, Kusunose Kenya, Ise Takayuki, Yamaguchi Koji, Yagi Shusuke, Yamada Hirotsugu, Wakatsuki Tetsuzo, Sata Masataka

    Circulation Journal   85 ( 8 )   1383 - 1391   2021.07( ISSN:1346-9843

     More details

    プロテアーゼ活性化受容体2(PAR2)シグナル伝達と心房細動(AF)との関連、および活性化血液凝固第X因子(FXa)阻害薬rivaroxabanの心房炎症やAF予防への効果について検討した。PAR2欠損マウスでは、野生型マウスに比べてangiotensin II投与後のAF発生率が低く、心房でのcollagen1とcollagen3のmRNA発現が少なかった。高血圧自然発症ラットにおいて、高頻度右心房ペーシング施行8時間後のrivaroxaban投与群では、warfarin投与群や賦形剤投与群に比べてAF発生率が有意に低かった。賦形剤投与群の心房では高頻度ペーシングにより炎症および線維化関連バイオマーカーの遺伝子発現が増加したが、rivaroxaban投与群では有意に減少した。FXa-PAR2シグナル伝達経路は心房炎症と関連するAFの発生に関与している可能性があり、rivaroxabanは心房炎症を予防し、AF発生率を抑制する可能性が示された。

  • Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice.

    Byambasuren Ganbaatar, Daiju Fukuda, Masakazu Shinohara, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takeshi Soeki, Ken-Ichi Hirata, Masataka Sata

    Journal of atherosclerosis and thrombosis   28 ( 6 )   630 - 642   2021.06( ISSN:1340-3478

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    AIM: The bioactive lipid, sphingosine-1-phosphate (S1P), has various roles in the physiology and pathophysiology of many diseases. There are five S1P receptors; however, the role of each S1P receptor in atherogenesis is still obscure. Here we investigated the contribution of S1P receptor 2 (S1P2) to atherogenesis by using a specific S1P2 antagonist, ONO-5430514, in apolipoprotein E-deficient (Apoe-/-) mice. METHODS: Apoe-/- mice fed with a western-type diet (WTD) received ONO-5430514 (30 mg/kg/day) or vehicle. To examine the effect on atherogenesis, Sudan IV staining, histological analysis, qPCR, and vascular reactivity assay was performed. Human umbilical vein endothelial cells (HUVEC) were used for in vitro experiments. RESULTS: WTD-fed Apoe-/- mice had significantly higher S1P2 expression in the aorta compared with wild-type mice. S1P2 antagonist treatment for 20 weeks reduced atherosclerotic lesion development (p<0.05). S1P2 antagonist treatment for 8 weeks ameliorated endothelial dysfunction (p<0.05) accompanied with significant reduction of lipid deposition, macrophage accumulation, and inflammatory molecule expression in the aorta compared with vehicle. S1P2 antagonist attenuated the phosphorylation of JNK in the abdominal aorta compared with vehicle (p<0.05). In HUVEC, S1P promoted inflammatory molecule expression such as MCP-1 and VCAM-1 p<0.001), which was attenuated by S1P2 antagonist or a JNK inhibitor (p<0.01). S1P2 antagonist also inhibited S1P-induced JNK phosphorylation in HUVEC (p<0.05). CONCLUSIONS: Our results suggested that an S1P2 antagonist attenuates endothelial dysfunction and prevents atherogenesis. S1P2, which promotes inflammatory activation of endothelial cells, might be a therapeutic target for atherosclerosis.

    DOI: 10.5551/jat.54916

    PubMed

    CiNii Article

  • S1P2型受容体を阻害することで、アポリポ蛋白E欠損マウスの内皮機能不全が軽減され、アテローム形成が抑制される(Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice)

    Ganbaatar Byambasuren, Fukuda Daiju, Shinohara Masakazu, Yagi Shusuke, Kusunose Kenya, Yamada Hirotsugu, Soeki Takeshi, Hirata Ken-ichi, Sata Masataka

    Journal of Atherosclerosis and Thrombosis   28 ( 6 )   630 - 642   2021.06( ISSN:1340-3478

     More details

    高コレステロール血症マウスモデルにおける内皮機能不全およびアテローム性動脈硬化症の発症におけるスフィンゴシン1-リン酸2型受容体(S1P2)の役割について検討した。Western-Type Diet(WTD)を与えたApoE-/-マウスにS1P2アンタゴニスト(30mg/kg/day)またはビヒクルを投与した。Sudan IV染色、組織学的解析、qPCR、血管反応性アッセイにより動脈硬化への影響について検討した。その結果、WTD食餌ApoE-/-マウスでは、野生型マウスと比較して、大動脈におけるS1P2発現が有意に高かった。また、S1P2アンタゴニストの20週間の投与により、動脈硬化病変の進展が抑制された(p<0.05)。8週間の投与では、ビヒクル群と比較して内皮機能不全の改善(p<0.05)、大動脈における脂質沈着、マクロファージの蓄積、炎症性分子の発現の減少が認められた。また、S1P2アンタゴニストはビヒクルと比較して、腹部大動脈におけるJNKリン酸化を抑制した(p<0.05)。さらに、ヒト臍帯静脈内皮細胞(HUVEC)を使用したin vitro実験を行った。その結果、HUVECにおいて、S1PはMCP-1やVCAM-1などの炎症分子の発現を促進したが(p<0.001)、S1P2アンタゴニストやJNK阻害剤により、その効果は減弱した(p<0.01)。また、S1P2アンタゴニストはHUVECにおけるS1P誘導性のJNKリン酸化を抑制した(p<0.05)。

  • Acute Hospital Mortality of Venous Thromboembolism in Patients With Cancer From Registry Data.

    Yuichiro Okushi, Kenya Kusunose, Yoshihiro Okayama, Robert Zheng, Michikazu Nakai, Yoko Sumita, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    Journal of the American Heart Association   10 ( 11 )   e019373   2021.06

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Background The prognosis of patients with cancer-venous thromboembolism (VTE) is not well known because of a lack of registry data. Moreover, there is also no knowledge on how specific types are related to prognosis. We sought to evaluate the clinical characteristics and outcomes of patients with cancer-associated VTE, compared with a matched cohort without cancer using real-world registry data of VTE. Methods and Results This study was based on the Diagnosis Procedure Combination database in the JROAD-DPC (Japanese Registry of All Cardiac and Vascular Diseases and the Diagnosis Procedure Combination). Of 5 106 151 total patients included in JROAD-DPC, we identified 49 580 patients who were first hospitalized with VTE from April 2012 to March 2017. Propensity score was estimated with a logistic regression model, with cancer as the dependent variable and 18 clinically relevant covariates. After propensity matching, there were 25 148 patients with VTE with or without cancer. On propensity score-matched analysis with 25 148 patients with VTE, patients with cancer had higher total in-hospital mortality within 7 days (1.3% versus 1.1%, odds ratio [OR], 1.66; 95% CI, 1.31-2.11; P<0.0001), 14 days (2.5% versus 1.5%, OR, 2.07; 95% CI, 1.72-2.49; P<0.0001), and 30 days (4.8% versus 2.0%, OR, 2.85; 95% CI, 2.45-3.31; P<0.0001). On analysis for each type of cancer, in-hospital mortality in 11 types of cancer was significantly high, especially pancreas (OR, 12.96; 95% CI, 6.41-26.20), biliary tract (OR, 8.67; 95% CI, 3.00-25.03), and liver (OR, 7.31; 95% CI, 3.05-17.50). Conclusions Patients with cancer had a higher in-hospital acute mortality for VTE than those without cancer, especially in pancreatic, biliary tract, and liver cancers.

    DOI: 10.1161/JAHA.120.019373

    PubMed

  • 大動脈四尖弁に対してTAVIを施行した一症例

    山田 拓也, 谷 彰浩, 門田 宗之, 伊勢 孝之, 川端 豊, 松浦 朋美, 楠瀬 賢也, 飛梅 威, 山口 浩司, 八木 秀介, 福田 大受, 山田 博胤, 添木 武, 若槻 哲三, 佐田 政隆

    四国医学雑誌   77 ( 1-2 )   120 - 121   2021.04( ISSN:0037-3699

  • 当院におけるイバブラジンの使用経験

    ムーギー, 八木 秀介, 門田 宗之, 川端 豊, 松本 和久, 楠瀬 賢也, 山口 浩司, 飛梅 威, 松浦 朋美, 福田 大受, 山田 博胤, 添木 武, 若槻 哲三, 佐田 政隆

    四国医学雑誌   77 ( 1-2 )   114 - 114   2021.04( ISSN:0037-3699

  • Frontiers of inflammatory disease research: inflammation in cardiovascular-cerebral diseases.

    Daiju Fukuda, Masataka Sata

    Inflammation and regeneration   41 ( 1 )   10 - 10   2021.03( ISSN:1880-9693

     More details

    International / domestic magazine:International journal  

    DOI: 10.1186/s41232-021-00160-z

    PubMed

  • 【糖尿病専門医に必要な心不全の知識update】SGLT2阻害薬と心不全

    八木 秀介, 福田 大受, 平田 有紀奈, Byambasuren Ganbaatar, Arief Rahadian, 伊勢 孝之, 楠瀬 賢也, 山田 博胤, 山口 浩司, 松浦 朋美, 飛梅 威, 曽我 朋宏, 添木 武, 若槻 哲三, 川人 伸次, 佐田 政隆

    糖尿病・内分泌代謝科   52 ( 3 )   257 - 264   2021.03( ISSN:2435-1946

  • Relationship between Coronary Intraplaque Microluminal Structure and Epicardial Adipose Tissue and Plaque Formation: A Fresh Cadaveric Study(和訳中)

    川端 豊, 若槻 哲三, 山口 浩司, 福田 大受, 松浦 朋美, 伊勢 孝之, 楠瀬 賢也, 飛梅 威, 八木 秀介, 山田 博胤, 添木 武, 佐田 政隆

    日本循環器学会学術集会抄録集   85回   OJ17 - 3   2021.03

  • Effects of Vitamin D Supplementation on Heart Failure Mortality from Japanese Registry of All Cardiac and Vascular Datasets(和訳中)

    阿部 美保, 楠瀬 賢也, 大櫛 祐一郎, Zheng Robert, 伊勢 孝之, 飛梅 威, 山口 浩司, 八木 秀介, 福田 大受, 山田 博胤, 添木 武, 若槻 哲三, 佐田 政隆

    日本循環器学会学術集会抄録集   85回   OJ63 - 3   2021.03

  • Deep Learning for Detection of Elevated Pulmonary Artery Wedge Pressure Using Standard Chest X-Ray(和訳中)

    平田 有紀奈, 楠瀬 賢也, 辻 拓将, 藤森 康平, 山口 夏美, 森田 沙瑛, 西尾 進, 大櫛 祐一郎, 瀬野 弘光, 高橋 智紀, 伊勢 孝之, 飛梅 威, 山口 浩司, 福田 大受, 八木 秀介, 山田 博胤, 添木 武, 若槻 哲三, 古徳 純一, 佐田 政隆

    日本循環器学会学術集会抄録集   85回   SS23 - 3   2021.03

  • 冠動脈内微小管腔構造と心外膜脂肪組織およびプラーク形成との関連 新鮮遺体を用いた研究(Relationship between Coronary Intraplaque Microluminal Structure and Epicardial Adipose Tissue and Plaque Formation: A Fresh Cadaveric Study)

    川端 豊, 若槻 哲三, 山口 浩司, 福田 大受, 松浦 朋美, 伊勢 孝之, 楠瀬 賢也, 飛梅 威, 八木 秀介, 山田 博胤, 添木 武, 佐田 政隆

    日本循環器学会学術集会抄録集   85回   OJ17 - 3   2021.03

  • 心不全死亡率に対するビタミンD補充の効果 循環器疾患診療実態調査より(Effects of Vitamin D Supplementation on Heart Failure Mortality from Japanese Registry of All Cardiac and Vascular Datasets)

    阿部 美保, 楠瀬 賢也, 大櫛 祐一郎, Zheng Robert, 伊勢 孝之, 飛梅 威, 山口 浩司, 八木 秀介, 福田 大受, 山田 博胤, 添木 武, 若槻 哲三, 佐田 政隆

    日本循環器学会学術集会抄録集   85回   OJ63 - 3   2021.03

  • Deep Learning for Detection of Elevated Pulmonary Artery Wedge Pressure using Standard Chest X-Ray. Reviewed

    Yukina Hirata, Kenya Kusunose, Takumasa Tsuji, Kohei Fujimori, Jun'ichi Kotoku, Masataka Sata

    The Canadian journal of cardiology   37 ( 8 )   1198 - 1206   2021.02

     More details

    International / domestic magazine:International journal  

    BACKGROUND: To accurately diagnose and control heart failure (HF), it is important to carry out a simple assessment of elevated pulmonary arterial wedge pressure (PAWP). The aim of this study was to develop and validate an objective method for detecting elevated PAWP by applying deep learning (DL) to a chest X-ray (CXR). METHODS: We enrolled 1,013 consecutive patients with a right heart catheter between October 2009 and February 2020. We developed a convolutional neural network to identify patients with an elevated PAWP (> 18 mmHg) as the actual value of PAWP to be used in the dataset for training. In the prospective validation dataset used to detect elevated PAWP, the area under the receiver operating characteristic curve (AUC) was calculated using the DL model that evaluated the CXR. RESULTS: In the prospective validation dataset, the AUC of the DL model with CXR was not significantly different than the AUC produced by brain natriuretic peptide and the echocardiographic left ventricular diastolic dysfunction algorithm (DL model: 0.77 vs. BNP: 0.77 vs. DD algorithm: 0.70; respectively; p=NS for all comparisons), however was significantly higher than the AUC of the cardiothoracic ratio (DL model vs. CTR: 0.66, p=0.044). The model based on three parameters (BNP, DD algorithm, and CTR) was improved by adding the DL model (AUC: from 0.80 to 0.86; p=0.041). CONCLUSIONS: Applying the DL model based on a CXR (a classical, universal, and low-cost test) is useful for screening for elevated PAWP.

    DOI: 10.1016/j.cjca.2021.02.007

    PubMed

    J-GLOBAL

  • Cardiac reserve by 6-minute walk stress echocardiography in systemic sclerosis.

    Miharu Arase, Kenya Kusunose, Sae Morita, Natsumi Yamaguchi, Yukina Hirata, Susumu Nishio, Yuichiro Okushi, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Daiju Fukuda, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    Open heart   8 ( 1 )   2021.02( ISSN:2398595X

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    OBJECTIVES: There is a high prevalence of left ventricular diastolic dysfunction (LVDD) in systemic sclerosis (SSc) which is associated with high mortality. Thus, early detection of LVDD could be important in management of SSc. We hypothesised that exercise echocardiography in SSc patients with normal resting haemodynamics may expose early phase LVDD, which could affect its prognosis, defined as cardiovascular death and unplanned hospitalisation for heart failure. METHODS: Between January 2014 and December 2018, we prospectively enrolled 140 patients with SSc who underwent 6-minute walk (6MW) stress echocardiographic studies with normal range of estimated mean pulmonary arterial pressure (mPAP) (<25 mm Hg) and mean pulmonary artery wedge pressure (mPAWP) (<15 mm Hg) at rest. We used ΔmPAP/Δcardiac output (CO) to assess pulmonary vascular reserve and ΔmPAWP/ΔCO to assess LV cardiac reserve between resting and post-6MW. RESULTS: During a median period of 3.6 years (IQR 2.0-5.1 years), 25 patients (18%) reached the composite outcome. Both ΔmPAP/ΔCO and ΔmPAWP/ΔCO in patients with events were significantly greater than in those without events (8.9±3.8 mm Hg/L/min vs 3.0±1.7 mm Hg/L/min; p=0.002, and 2.2±0.9 mm Hg/L/min vs 0.9±0.5 mm Hg/L/min; p<0.001, respectively). Patients with both impaired LV cardiac reserve (ΔmPAWP/ΔCO>1.4 mm Hg/L/min) and impaired pulmonary vascular reserve (ΔmPAP/ΔCO>3.0 mm Hg/L/min) had worse outcomes compared with those without these abnormalities (p<0.001). CONCLUSION: The 6MW stress echocardiography revealed impaired LV cardiac reserve in SSc patients with normal resting haemodynamics. Furthermore, LV cardiac reserve independently associates with clinical worsening in SSc, providing incremental prognostic utility, in addition to pulmonary vascular parameters.

    DOI: 10.1136/openhrt-2020-001559

    PubMed

  • Antegrade slow pathway mapping of typical atrioventricular nodal reentrant tachycardia based on direct slow pathway capture

    Tobiume T.

    Journal of Arrhythmia   37 ( 1 )   128 - 139   2021.02( ISSN:18804276

     More details

  • Association between Vitamin D and Heart Failure Mortality in 10,974 Hospitalized Individuals.

    Kenya Kusunose, Yuichiro Okushi, Yoshihiro Okayama, Robert Zheng, Miho Abe, Michikazu Nakai, Yoko Sumita, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    Nutrients   13 ( 2 )   1 - 12   2021.01

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    A broad range of chronic conditions, including heart failure (HF), have been associated with vitamin D deficiency. Existing clinical trials involving vitamin D supplementation in chronic HF patients have been inconclusive. We sought to evaluate the outcomes of patients with vitamin D supplementation, compared with a matched cohort using real-world big data of HF hospitalization. This study was based on the Diagnosis Procedure Combination database in the Japanese Registry of All Cardiac and Vascular Datasets (JROAD-DPC). After exclusion criteria, we identified 93,692 patients who were first hospitalized with HF between April 2012 and March 2017 (mean age was 79 ± 12 years, and 52.2% were male). Propensity score (PS) was estimated with logistic regression model, with vitamin D supplementation as the dependent variable and clinically relevant covariates. On PS-matched analysis with 10,974 patients, patients with vitamin D supplementation had lower total in-hospital mortality (6.5 vs. 9.4%, odds ratio: 0.67, p < 0.001) and in-hospital mortality within 7 days and 30 days (0.9 vs. 2.5%, OR, 0.34, and 3.8 vs. 6.5%, OR: 0.56, both p < 0.001). In the sub-group analysis, mortalities in patients with age < 75, diabetes, dyslipidemia, atrial arrhythmia, cancer, renin-angiotensin system blocker, and β-blocker were not affected by vitamin D supplementation. Patients with vitamin D supplementation had a lower in-hospital mortality for HF than patients without vitamin D supplementation in the propensity matched cohort. The identification of specific clinical characteristics in patients benefitting from vitamin D may be useful for determining targets of future randomized control trials.

    DOI: 10.3390/nu13020335

    PubMed

  • Effect of febuxostat on left ventricular diastolic function in patients with asymptomatic hyperuricemia: a sub analysis of the PRIZE Study

    Kusunose K.

    Hypertension Research   45 ( 1 )   106 - 115   2021( ISSN:09169636

     More details

  • Roles of Epicardial Adipose Tissue in the Pathogenesis of Coronary Atherosclerosis - An Update on Recent Findings.

    Kimie Tanaka, Daiju Fukuda, Masataka Sata

    Circulation journal : official journal of the Japanese Circulation Society   85 ( 1 )   2 - 8   2020.12( ISSN:1346-9843

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    Adipose tissue serves not only as an energy store or a mechanical cushion, but also as an endocrine organ. Recent evidence revealed that perivascular adipose tissue is involved in vascular homeostasis and pathophysiology of adjacent arteries by producing various adipokines. Epicardial adipose tissue (EAT) is located between the surface of the heart and the visceral layer of the pericardium and surrounds the coronary arteries. Many clinical studies suggest that an increase in EAT volume is associated with coronary artery disease. It has been reported that exercise and some antidiabetic drugs can reduce EAT volume. In this review, we outline recent findings on the roles of EAT in the pathogenesis of coronary atherosclerosis.

    DOI: 10.1253/circj.CJ-20-0935

    PubMed

    CiNii Article

  • Biodegradable Extremely-Small-Diameter Vascular Graft Made of Silk Fibroin can be Implanted in Mice.

    Kimie Tanaka, Daiju Fukuda, Yasutomi Higashikuni, Yoichiro Hirata, Issei Komuro, Toshiki Saotome, Yoshihiro Yamashita, Tetsuo Asakura, Masataka Sata

    Journal of atherosclerosis and thrombosis   27 ( 12 )   1299 - 1309   2020.12( ISSN:1340-3478

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    AIM: Synthetic vascular grafts are widely used in surgical revascularization, mainly for medium- to large-sized vessels. However, synthetic grafts smaller than 6 mm in diameter are associated with a high incidence of thrombosis. In this study, we evaluated silk fibroin, a major protein of silk, with high biocompatibility and biodegradability, as a useful material for extremely-small-diameter vascular grafts. METHODS: A small-sized (0.9 mm inner diameter) graft was braided from a silk fibroin thread. The right carotid arteries of 8- to 14-week-old male C57BL/6 mice were cut at the midpoint, and fibroin grafts (5- to 7-mm in length) were transplanted using a cuff technique with polyimide cuffs. The grafts were harvested at different time points and analyzed histologically. RESULTS: CD31+ endothelial cells had already started to proliferate at 2 weeks after implantation. At 4 weeks, neointima had formed with α-smooth muscle actin+ cells, and the luminal surface was covered with CD31+endothelial cells. Mac3+ macrophages were accumulated in the grafts. Graft patency was confirmed at up to 6 months after implantation. CONCLUSION: This mouse model of arterial graft implantation enables us to analyze the remodeling process and biocompatibility of extremely-small-diameter vascular grafts. Biodegradable silk fibroin might be applicable for further researches using genetically modified mice.

    DOI: 10.5551/jat.52720

    PubMed

    CiNii Article

  • 絹フィブロインから成る生分解性極小径人工血管はマウスに移植し得る(Biodegradable Extremely-Small-Diameter Vascular Graft Made of Silk Fibroin can be Implanted in Mice)

    Tanaka Kimie, Fukuda Daiju, Higashikuni Yasutomi, Hirata Yoichiro, Komuro Issei, Saotome Toshiki, Yamashita Yoshihiro, Asakura Tetsuo, Sata Masataka

    Journal of Atherosclerosis and Thrombosis   27 ( 12 )   1299 - 1309   2020.12( ISSN:1340-3478

     More details

    絹フィブロインの極小径人工血管としての素材の有用性を評価した。絹フィブロイン糸から内径0.9mmのグラフトを編んだ。生後8〜14週の雄C57BL/6マウスの右頸動脈の中間点を切断して、ポリイミドカフによるカフ法を用いてフィブロイングラフトを移植した。グラフトを移植後1、2週、3、6ヵ月に採取して、免疫組織化学染色法を行って組織学的解析を実施した。移植後2週でCD31+内皮細胞が増殖し始めた。4週には平滑筋αアクチン+細胞で新生内膜が形成され、管腔側はCD31+内皮細胞で被覆された。Mac3+マクロファージがグラフト内に蓄積した。グラフト開存性は移植後6ヵ月まで確認できた。本動脈グラフト移植マウスモデルによって、極小径人工血管のリモデリング過程と生体適合性の解析が可能となった。

  • Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice.

    Arief Rahadian, Daiju Fukuda, Hotimah Masdan Salim, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takeshi Soeki, Masataka Sata

    Journal of atherosclerosis and thrombosis   27 ( 11 )   1141 - 1151   2020.11( ISSN:1340-3478

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    AIM: Recent studies have demonstrated that selective sodium-glucose cotransporter 2 inhibitors (SGLT2is) reduce cardiovascular events, although their mechanism remains obscure. We examined the effect of canagliflozin, an SGLT2i, on atherogenesis and investigated its underlying mechanism. METHOD: Canagliflozin (30 mg/kg/day) was administered by gavage to streptozotocin-induced diabetic apolipoprotein E-deficient (ApoE-/-) mice. Sudan IV staining was performed at the aortic arch. Immunostaining, quantitative RT-PCR, and vascular reactivity assay were performed using the aorta. In vitro experiments using human umbilical vein endothelial cells (HUVECs) were also performed. RESULT: Canagliflozin decreased blood glucose (P<0.001) and total cholesterol (P<0.05) levels. Sudan IV staining showed that 12-week canagliflozin treatment decreased atherosclerotic lesions (P<0.05). Further, 8-week canagliflozin treatment ameliorated endothelial dysfunction, as determined by acetylcholine-induced vasodilation (P<0.05), and significantly reduced the expressions of inflammatory molecules such as ICAM-1 and VCAM-1 in the aorta at the RNA and protein levels. Canagliflozin also reduced the expressions of NADPH oxidase subunits such as NOX2 and p22phox in the aorta and reduced urinary excretion of 8-OHdG, suggesting a reduction in oxidative stress. Methylglyoxal, a precursor of advanced glycation end products, increased the expressions of ICAM-1 and p22phox in HUVECs (P<0.05, both). Methylglyoxal also decreased the phosphorylation of eNOSSer1177 and Akt but increased the phosphorylation of eNOSThr495 and p38 MAPK in HUVECs. CONCLUSION: Canagliflozin prevents endothelial dysfunction and atherogenesis in diabetic ApoE-/- mice. Anti-inflammatory and antioxidative potential due to reduced glucose toxicity to endothelial cells might be its underlying mechanisms.

    DOI: 10.5551/jat.52100

    PubMed

    CiNii Article

  • カナグリフロジンはApoE欠損マウスにおいて糖尿病性血管障害を予防する(Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice)

    Rahadian Arief, Fukuda Daiju, Salim Hotimah Masdan, Yagi Shusuke, Kusunose Kenya, Yamada Hirotsugu, Soeki Takeshi, Sata Masataka

    Journal of Atherosclerosis and Thrombosis   27 ( 11 )   1141 - 1151   2020.11( ISSN:1340-3478

     More details

    カナグリフロジンが糖尿病性アポリポ蛋白質e-欠損(ApoE-/-)マウスにおいて血管内皮機能障害を改善し、アテローム形成を予防できるか検討した。ApoE-/-マウスにストレプトゾトシンを投与して糖尿病を誘発させ、カナグリフロジンを12週間または8週間にわたり強制経口投与した。ヒト臍帯静脈内皮細胞(HUVEC)を用いてin vitro検査を実施した。カナグリフロジンは血糖値と総コレステロール値を低下させた。12週間のカナグリフロジン投与では動脈硬化病変が減少し、8週間投与では血管内皮機能障害が改善し、大動脈における細胞間接着分子(ICAM)-1や血管細胞接着分子-1などの炎症性分子がRNAおよび蛋白質レベルで発現低下した。カナグリフロジンによって大動脈におけるニコチンアミドアデニンジヌクレオチドリン酸オキシダーゼ2やp22phoxが発現低下し、8-ヒドロキシデオキシグアノシンの尿中排泄量が減少し、酸化ストレスの減少が示唆された。メチルグリオキサールによってHUVECにおいてICAM-1およびp22phoxが発現亢進した。メチルグリオキサールはHUVECにおいて内皮型一酸化窒素合成酵素(eNOS)Ser1177とAktのリン酸化を減少させたが、eNOSThr495とp38マイトジェン活性化プロテインキナーゼのリン酸化を増加させた。

  • Possible Anti-atherosclerotic Action of a Direct Oral Anticoagulant

    Tanaka Kimie, Fukuda Daiju, Sata Masataka

    The Journal of Japanese College of Angiology   60 ( 10 )   171 - 179   2020.10( ISSN:03871126

     More details

    <p>Rupture of vulnerable atherosclerotic plaques or erosion of fibrous plaques cause thrombotic occlusion of coronary artery, leads to acute myocardial infarction or unstable angina. Both aggregation of platelets and activation of blood coagulation system play central role in thrombus formation. Blood coagulation factors, especially activated factor X and thrombin, are also involved in inflammation via activation of protease-activated receptors (PARs) expressed on vascular cells and inflammatory cells. Administration of rivaroxaban, one of direct oral anticoagulants, to apolipoprotein-E deficient (ApoE-/-) mouse attenuates progression of atherosclerotic plaque with decrease in accumulation of macrophages and expression of inflammatory cytokines. Similarly, deficiency of PAR-2 gene in bone marrow cells of ApoE-/- mouse reduces expression of inflammatory cytokines in macrophages and atherosclerotic lesion progression. A recent clinical study indicated that rivaroxaban is effective in secondary prevention of arteriosclerotic diseases when used in combination with aspirin. This effect is conceivable mainly by inhibition of thrombus formation. However, it would be possible that the anti-atherosclerotic action of rivaroxaban contributes to these favorable effects.</p>

    DOI: 10.7133/jca.20-00031

    CiNii Article

  • 動脈硬化抑制に向けた直接経口抗凝固薬の可能性

    田中 君枝, 福田 大受, 佐田 政隆

    脈管学   60 ( 10 )   171 - 179   2020.10( ISSN:0387-1126

     More details

    冠動脈の動脈硬化プラークが破綻すると血栓が形成され,急激な管腔閉塞により心筋梗塞や不安定狭心症の原因となる。血栓形成には,血小板と血液凝固系の両方が関与する。血液凝固因子は,血管構成細胞のプロテアーゼ活性型受容体の活性化を介して血管の炎症にも関与する。最近の臨床試験で直接経口抗凝固薬は,抗血小板薬との併用により動脈硬化疾患の二次予防に有効であった。この効果には抗炎症作用も寄与している可能性がある。(著者抄録)

  • 動脈硬化抑制に向けた直接経口抗凝固薬の可能性

    田中 君枝, 福田 大受, 佐田 政隆

    脈管学   60 ( 10 )   171 - 179   2020.10( ISSN:0387-1126

  • Association between Sarcopenia/Lower Muscle Mass and Short-Term Regression of Deep Vein Thrombosis Using Direct Oral Anticoagulants.

    Yuta Torii, Kenya Kusunose, Robert Zheng, Hirotsugu Yamada, Rie Amano, Rikizo Matsumoto, Yukina Hirata, Susumu Nishio, Nao Yamada, Takayuki Ise, Koji Yamaguchi, Takeshi Tobiume, Daiju Fukuda, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki, Yoshihiro Okayama, Masataka Sata

    International heart journal   61 ( 4 )   787 - 794   2020.07( ISSN:1349-2365

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    Advanced age, obesity, and muscle weakness are independent factors in the onset of deep vein thrombosis (DVT). Recently, an association between sarcopenia and DVT has been reported. We hypothesized that sarcopenia related factors, observed by ultrasonography, are associated with the regression effect on the thrombus following anticoagulation therapy. The present study focused on gastrocnemius muscle (GCM) thickness and the GCM's internal echogenic brightness. We examined the association with DVT regression following direct oral anticoagulants (DOACs) treatment.The prospective cohort study period was between October 2017 and August 2018. We enrolled 46 patients diagnosed with DVT by ultrasonography, who were aged >60 years old and treated with DOACs. Sarcopenia was evaluated using the Asian Working Group for Sarcopenia flowchart. The average DOACs treatment period was 94 days, and 29 patients exhibited thrombus regression. On univariate logistic regression analysis, sarcopenia, average GCM diameter index, and gastrocnemius integrated backscatter index were significantly associated with thrombus regression. In a multivariate model, only the average GCM diameter index correlated with thrombus regression.The average GCM diameter index is associated with DVT regression treated with DOACs. Considering the GCM diameter during DVT treatment can be a marker to make a decision for the treatment of DVT.

    DOI: 10.1536/ihj.20-032

    PubMed

    CiNii Article

  • Deterioration of biventricular strain is an early marker of cardiac involvement in confirmed sarcoidosis.

    Kenya Kusunose, Mika Fujiwara, Hirotsugu Yamada, Susumu Nishio, Yoshihito Saijo, Nao Yamada, Yukina Hirata, Yuta Torii, Takayuki Ise, Koji Yamaguchi, Daiju Fukuda, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    European heart journal. Cardiovascular Imaging   21 ( 7 )   796 - 804   2020.07( ISSN:2047-2404

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    AIMS: Risk assessment of developing cardiac involvement in systemic sarcoidosis can be challenging because of limited data. Recently, attention has been given to left ventricular and right ventricular (LV and RV) involvement in cardiac sarcoidosis (CS) and its prevalence, relevance, and prognostic value. The aim of this study was to assess the role of biventricular strain to predict prognosis in confirmed sarcoidosis patients. METHODS AND RESULTS: LV and RV longitudinal strains (LSs) were evaluated by 2D speckle tracking in 139 consecutive confirmed sarcoidosis patients without other pre-existing structural heart diseases, and 52 age- and gender-matched control subjects. The primary endpoint was CS-related events (cardiac death or development of cardiac involvement). Sarcoidosis without cardiac involvement had significantly lower LV and RV free wall LS compared with control subjects. Basal LS had a higher area under the curve for differentiation of sarcoidosis in patients without cardiac involvement compared to control (cut-off value: -18% with 89% sensitivity and 69% specificity). During a median period of 50 months, the occurrence of CS-related events was observed in 20 patients. In a multivariate analysis, basal LV LS and RV free wall LS were associated with the events [hazard ratio (HR) 0.72, P < 0.001 and HR: 0.83, P = 0.006, respectively]. Patients with impaired biventricular function had significantly shorter event-free survival than those with preserved biventricular function (P < 0.001). CONCLUSION: Deterioration of biventricular strain was associated with CS-related events. This information might be useful for clinical evaluation and follow-up in sarcoidosis.

    DOI: 10.1093/ehjci/jez235

    PubMed

  • 深部静脈血栓症に対する直接経口抗凝固薬の短期的な血栓退縮効果とサルコペニア/筋肉量の減少との関連性(Association between Sarcopenia/Lower Muscle Mass and short-Term Regression of Deep Vein Thrombosis Using Direct Oral Anticoagulants)

    Torii Yuta, Kusunose Kenya, Zheng Robert, Yamada Hirotsugu, Amano Rie, Matsumoto Rikizo, Hirata Yukina, Nishio Susumu, Yamada Nao, Ise Takayuki, Yamaguchi Koji, Tobiume Takeshi, Fukuda Daiju, Yagi Shusuke, Soeki Takeshi, Wakatsuki Tetsuzo, Okayama Yoshihiro, Sata Masataka

    International Heart Journal   61 ( 4 )   787 - 794   2020.07( ISSN:1349-2365

     More details

    サルコペニア/筋肉量の減少が直接経口抗凝固薬による血栓退縮効果に及ぼす影響について検討した。直接経口抗凝固薬を服薬中の深部静脈血栓症患者46例(男性17例、女性29例、平均72±11歳)を対象とした。サルコペニアの診断にはアジアのワーキンググループによるAWGSを用いた。全患者で超音波検査を実施し、腓腹筋の筋厚値と超音波高周波信号の反射波から算出したIB値を測定した。直接経口抗凝固薬の平均治療期間は94日で、29例で血栓退縮効果を認めた。患者を血栓退縮群29例(男性41%、平均72±13歳)と非血栓退縮群17例(男性29%、平均72±9歳)の2群に分類した。性別、年齢、BMI、深部静脈血栓症の症状に有意な群間差はなかった。サルコペニアは血栓退縮群(10%)の方が非血栓退縮群(35%)より有意に少なかった(P=0.02)。腓腹筋の筋厚値は血栓退縮群の方が有意に高く、IB値は有意に低かった(いずれもP<0.001)。多変量ロジスティック回帰モデルでは腓腹筋の筋厚値が直接経口抗凝固薬による血栓退縮の唯一の予測因子であった(OR:4.104,95%CI:1.738〜9.690,P=0.001)。

  • Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice.

    Byambasuren Ganbaatar, Daiju Fukuda, Masakazu Shinohara, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takeshi Soeki, Ken-Ichi Hirata, Masataka Sata

    European journal of pharmacology   875   173040 - 173040   2020.05( ISSN:0014-2999

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Recent studies reported cardioprotective effects of sodium glucose co-transporter 2 (SGLT2) inhibitors; however, the underlying mechanisms are still obscure. Here, we investigated whether empagliflozin attenuates atherogenesis and endothelial dysfunction in diabetic apolipoprotein E-deficient (ApoE-/-) mice. Male streptozotocin (STZ) - induced diabetic ApoE-/- mice were treated with empagliflozin for 12 or 8 weeks. Empagliflozin lowered blood glucose (P < 0.001) and lipid levels in diabetic ApoE-/- mice. Empagliflozin treatment for 12 weeks significantly decreased atherosclerotic lesion size in the aortic arch (P < 0.01) along with reduction of lipid deposition (P < 0.05), macrophage accumulation (P < 0.001), and inflammatory molecule expression in plaques compared with the untreated group. Empagliflozin treatment for 8 weeks significantly ameliorated diabetes-induced endothelial dysfunction as determined by the vascular response to acetylcholine (P < 0.001). Empagliflozin reduced RNA expression of a macrophage marker, CD68, and inflammatory molecules such as MCP-1 (P < 0.05) and NADPH oxidase subunits in the aorta compared with the untreated group. Empagliflozin also reduced plasma levels of vasoconstrictive eicosanoids, prostaglandin E2 and thromboxane B2 (P < 0.001), which were elevated in diabetic condition. Furthermore, empagliflozin attenuated RNA expression of inflammatory molecules in perivascular adipose tissue (PVAT), suggesting the reduction of inflammation in PVAT. In in vitro studies, methylglyoxal (MGO), a precursor of AGEs, significantly increased the expression of inflammatory molecules such as MCP-1 and TNF-α in a murine macrophage cell line, RAW264.7. Our results indicated that empagliflozin attenuated endothelial dysfunction and atherogenesis in diabetic ApoE-/- mice. Reduction of vasoconstrictive eicosanoids and inflammation in the vasculature and PVAT may have a role as underlying mechanisms at least partially.

    DOI: 10.1016/j.ejphar.2020.173040

    PubMed

  • Deep Learning for Assessment of Left Ventricular Ejection Fraction from Echocardiographic Images.

    Kenya Kusunose, Akihiro Haga, Natsumi Yamaguchi, Takashi Abe, Daiju Fukuda, Hirotsugu Yamada, Masafumi Harada, Masataka Sata

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography   33 ( 5 )   632 - 635.e1   2020.05( ISSN:0894-7317

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    DOI: 10.1016/j.echo.2020.01.009

    PubMed

  • Clinically Feasible and Accurate View Classification of Echocardiographic Images Using Deep Learning.

    Kenya Kusunose, Akihiro Haga, Mizuki Inoue, Daiju Fukuda, Hirotsugu Yamada, Masataka Sata

    Biomolecules   10 ( 5 )   2020.04

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    A proper echocardiographic study requires several video clips recorded from different acquisition angles for observation of the complex cardiac anatomy. However, these video clips are not necessarily labeled in a database. Identification of the acquired view becomes the first step of analyzing an echocardiogram. Currently, there is no consensus whether the mislabeled samples can be used to create a feasible clinical prediction model of ejection fraction (EF). The aim of this study was to test two types of input methods for the classification of images, and to test the accuracy of the prediction model for EF in a learning database containing mislabeled images that were not checked by observers. We enrolled 340 patients with five standard views (long axis, short axis, 3-chamber view, 4-chamber view and 2-chamber view) and 10 images in a cycle, used for training a convolutional neural network to classify views (total 17,000 labeled images). All DICOM images were rigidly registered and rescaled into a reference image to fit the size of echocardiographic images. We employed 5-fold cross validation to examine model performance. We tested models trained by two types of data, averaged images and 10 selected images. Our best model (from 10 selected images) classified video views with 98.1% overall test accuracy in the independent cohort. In our view classification model, 1.9% of the images were mislabeled. To determine if this 98.1% accuracy was acceptable for creating the clinical prediction model using echocardiographic data, we tested the prediction model for EF using learning data with a 1.9% error rate. The accuracy of the prediction model for EF was warranted, even with training data containing 1.9% mislabeled images. The CNN algorithm can classify images into five standard views in a clinical setting. Our results suggest that this approach may provide a clinically feasible accuracy level of view classification for the analysis of echocardiographic data.

    DOI: 10.3390/biom10050665

    PubMed

  • Atherosclerotic Coronary Plaque Is Associated With Adventitial Vasa Vasorum and Local Inflammation in Adjacent Epicardial Adipose Tissue in Fresh Cadavers.

    Hiroyuki Ito, Tetsuzo Wakatsuki, Koji Yamaguchi, Daiju Fukuda, Yutaka Kawabata, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Yoshihiro Tsuruo, Masataka Sata

    Circulation journal : official journal of the Japanese Circulation Society   84 ( 5 )   769 - 775   2020.04( ISSN:1346-9843

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    BACKGROUND: The coronary adventitia has recently attracted attention as a source of inflammation because it harbors nutrient blood vessels, termed the vasa vasorum (VV). This study assessed the link between local inflammation in adjacent epicardial adipose tissue (EAT) and coronary arterial atherosclerosis in fresh cadavers.Methods and Results:Lesion characteristics in the left anterior descending coronary artery of 10 fresh cadaveric hearts were evaluated using integrated backscatter intravascular ultrasound (IB-IVUS), and the density of the VV and levels of inflammatory molecules from the adjacent EAT were measured for each of the assessed lesions. The lesions were divided into lipid-rich, lipid-moderate, and lipid-poor groups according to percentage lipid volume assessed by IB-IVUS. Higher expression of inflammatory molecules (i.e., vascular endothelial growth factor A [VEGFA] andVEGFB) was observed in adjacent EAT of lipid-rich (n=11) than in lipid-poor (n=11) lesions (7.99±3.37 vs. 0.45±0.85 arbitrary units [AU], respectively, forVEGFA; 0.27±0.15 vs. 0.11±0.07 AU, respectively, forVEGFB; P<0.05). The density of adventitial VV was greater in lipid-rich than lipid-poor lesions (1.50±0.58% vs. 0.88±0.23%; P<0.05). CONCLUSIONS: Lipid-rich coronary plaques are associated with adventitial VV and local inflammation in adjacent EAT in fresh cadavers. This study suggests that local inflammation of EAT is associated with coronary plaque progression via the VV.

    DOI: 10.1253/circj.CJ-19-0914

    PubMed

    CiNii Article

  • ジルチアゼム大量服薬による循環不全に対し経皮的心肺補助装置を導入し救命し得た1例

    田中 真波, 高橋 智紀, 高橋 智子, 谷 彰浩, 藤本 裕太, 大櫛 祐一郎, 數藤 久美子, 松本 和久, 上野 理絵, 門田 宗之, 川端 豊, 山田 なお, 松浦 朋美, 伊勢 孝之, 楠瀬 賢也, 飛梅 威, 山口 浩司, 八木 秀介, 福田 大受, 山田 博胤, 添木 武, 若槻 哲三, 佐田 政隆

    四国医学雑誌   76 ( 1-2 )   128 - 129   2020.04( ISSN:0037-3699

  • 血管内皮機能改善作用を有する新たな機能性脂質の同定

    阪上 浩, 堤 理恵, 宮原 裕子, 板東 正浩, 黒田 雅士, 竹尾 仁良, 福田 大受, 佐田 政隆

    日本臨床分子医学会学術総会プログラム・抄録集   57回   70 - 70   2020.04

  • 冠動脈のアテローム性プラークは新鮮死体の心外膜脂肪組織における炎症および外膜内の脈管の脈管に関連する(Atherosclerotic Coronary Plaque Is Associated With Adventitial Vasa Vasorum and Local Inflammation in Adjacent Epicardial Adipose Tissue in Fresh Cadavers)

    Ito Hiroyuki, Wakatsuki Tetsuzo, Yamaguchi Koji, Fukuda Daiju, Kawabata Yutaka, Matsuura Tomomi, Kusunose Kenya, Ise Takayuki, Tobiume Takeshi, Yagi Shusuke, Yamada Hirotsugu, Soeki Takeshi, Tsuruo Yoshihiro, Sata Masataka

    Circulation Journal   84 ( 5 )   769 - 775   2020.04( ISSN:1346-9843

     More details

    死後硬直していない解剖用遺体10例(男性5例、女性5例、死亡時年齢69〜96歳)の心臓を用いて、冠動脈のアテローム性動脈硬化と心外膜脂肪組織における炎症の関連について検討した。後方散乱を利用した血管内超音波エコー(IB-IVUS)により新鮮死体の左前下行枝(37病変)を評価し、心外膜脂肪組織における血管内皮増殖因子(VEGF)および栄養血管である外膜内の脈管の脈管の密度を測定した。左前下行枝病変をプラークの性状に応じて、脂質に富むプラーク(lipid rich)群11例、中等度の脂質群15例、少量の脂質群(lipid poor)11例の3群に分類した。脂質体積分率は平均で32.7±6.0%であった。心外膜脂肪組織におけるVEGF発現を定量化したところ、VEGF-AおよびVEGF-Bはいずれもlipid rich群の方がlipid poor群より有意に高かった(P<0.05)。また外膜内の脈管の脈管の密度もlipid rich群(1.50±0.58%)の方がlipid poor群(0.88±0.23%)より有意に高かった(P<0.05)。以上より、脂質に富む冠動脈プラークは心外膜脂肪組織の炎症と関連することが示唆された。

  • ペーシングによる速伝導路と遅伝導路のマッピングが治療に有用であった通常型房室結節リエントリー性頻拍の1例

    堀 祥昌, 飛梅 威, 松本 和久, 松浦 朋美, 添木 武, 志村 拓哉, 高橋 智子, 谷 彰浩, 藤本 裕太, 大櫛 祐一郎, 數藤 久美子, 高橋 智紀, 上野 理絵, 門田 宗之, 川端 豊, 坂東 美佳, 山田 なお, 伊藤 浩敬, 伊勢 孝之, 楠瀬 賢也, 山口 浩司, 八木 秀介, 福田 大受, 山田 博胤, 若槻 哲三, 佐田 政隆

    四国医学雑誌   76 ( 1-2 )   127 - 128   2020.04( ISSN:0037-3699

  • ヒト生検検体を用いた腎臓周囲と皮下の脂肪組織におけるアディポネクチン発現量とその決定因子(Levels of Adiponectin Expression in Peri-Renal and Subcutaneous Adipose Tissue and Its Determinants in Human Biopsied Samples)

    Maimaituxun Gulinu, 福田 大受, 井崎 博文, 平田 陽一郎, 金山 博臣, 益崎 裕章, 佐田 政隆, 島袋 充生

    日本臨床分子医学会学術総会プログラム・抄録集   57回   75 - 75   2020.04

  • A Deep Learning Approach for Assessment of Regional Wall Motion Abnormality From Echocardiographic Images.

    Kenya Kusunose, Takashi Abe, Akihiro Haga, Daiju Fukuda, Hirotsugu Yamada, Masafumi Harada, Masataka Sata

    JACC. Cardiovascular imaging   13 ( 2 Pt 1 )   374 - 381   2020.02( ISSN:1936-878X

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    OBJECTIVES: This study investigated whether a deep convolutional neural network (DCNN) could provide improved detection of regional wall motion abnormalities (RWMAs) and differentiate among groups of coronary infarction territories from conventional 2-dimensional echocardiographic images compared with that of cardiologists, sonographers, and resident readers. BACKGROUND: An effective intervention for reduction of misreading of RWMAs is needed. The hypothesis was that a DCNN trained using echocardiographic images would provide improved detection of RWMAs in the clinical setting. METHODS: A total of 300 patients with a history of myocardial infarction were enrolled. From this cohort, 3 groups of 100 patients each had infarctions of the left anterior descending (LAD) artery, the left circumflex (LCX) branch, and the right coronary artery (RCA). A total of 100 age-matched control patients with normal wall motion were selected from a database. Each case contained cardiac ultrasonographs from short-axis views at end-diastolic, mid-systolic, and end-systolic phases. After the DCNN underwent 100 steps of training, diagnostic accuracies were calculated from the test set. Independently, 10 versions of the same model were trained, and ensemble predictions were performed using those versions. RESULTS: For detection of the presence of WMAs, the area under the receiver-operating characteristic curve (AUC) produced by the deep learning algorithm was similar to that produced by the cardiologists and sonographer readers (0.99 vs. 0.98, respectively; p = 0.15) and significantly higher than the AUC result of the resident readers (0.99 vs. 0.90, respectively; p = 0.002). For detection of territories of WMAs, the AUC by the deep learning algorithm was similar to the AUC by the cardiologist and sonographer readers (0.97 vs. 0.95, respectively; p = 0.61) and significantly higher than the AUC by resident readers (0.97 vs. 0.83, respectively; p = 0.003). From a validation group at an independent site (n = 40), the AUC by the deep learning algorithm was 0.90. CONCLUSIONS: The present results support the possibility of using DCNN for automated diagnosis of RWMAs in the field of echocardiography.

    DOI: 10.1016/j.jcmg.2019.02.024

    PubMed

  • Association of Local Epicardial Adipose Tissue Depots and Left Ventricular Diastolic Performance in Patients With Preserved Left Ventricular Ejection Fraction.

    Gulinu Maimaituxun, Hirotsugu Yamada, Daiju Fukuda, Shusuke Yagi, Kenya Kusunose, Yukina Hirata, Susumu Nishio, Takeshi Soeki, Hiroaki Masuzaki, Masataka Sata, Michio Shimabukuro

    Circulation journal : official journal of the Japanese Circulation Society   84 ( 2 )   203 - 216   2020.01( ISSN:1346-9843

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    BACKGROUND: Although full-volume quantification of epicardial adipose tissue (EAT) is a predictor of LV diastolic dysfunction (LVDD), how localized EAT depots are linked to LVDD remains unclear. We evaluated the effect of local EAT depots on LV diastolic function parameters in patients with preserved LV ejection fraction (LVEF).Methods and Results:From 423 consecutive patients who underwent cardiac CT angiography, we recruited 252 with sinus rhythm and normal LVEF. The EAT volume index (EATV/body surface area) and the localized EAT thickness around the right coronary artery (EATRCA), left anterior descending artery (EATLAD), left circumflex artery (EATLCX), right ventricle (EATRV), left ventricle (EATLV), right atrium (EATRA), and left atrium (EATLA) were measured using cardiac CT. In the LVDD group (n=71), the EATV index (75±30 vs. 64±28 mL/m2, P=0.010), EATLCX(10.7±3.8 vs. 9.4±3.4 mm, P=0.008), and EATLV(2.6±1.6 vs. 2.1±1.4 mm, P=0.024) were greater than in the non-LVDD group (n=181). In contrast, EATLCXand EATLVwere markedly associated with decreased lateral e' and increased lateral E/e'. Multiple regression analysis indicated that EATLCXand EATLVwere strongly associated with LV diastolic function parameters. CONCLUSIONS: Localized EAT depots are linked to altered mitral annular motion. Further study is warranted to clarify whether localized EAT depots are functionally linked to the clinical manifestations of LVDD.

    DOI: 10.1253/circj.CJ-19-0793

    PubMed

    CiNii Article

  • Measurement of the muon neutrino charged-current single π+ production on hydrocarbon using the T2K off-axis near detector ND280

    Abe K.

    Physical Review D   101 ( 1 )   2020.01( ISSN:24700010

     More details

  • 左室駆出率の保たれた患者における局所的心外膜脂肪組織集積と左室拡張能の関連(Association of Local Epicardial Adipose Tissue Depots and Left Ventricular Diastolic Performance in Patients With Preserved Left Ventricular Ejection Fraction)

    Maimaituxun Gulinu, Yamada Hirotsugu, Fukuda Daiju, Yagi Shusuke, Kusunose Kenya, Hirata Yukina, Nishio Susumu, Soeki Takeshi, Masuzaki Hiroaki, Sata Masataka, Shimabukuro Michio

    Circulation Journal   84 ( 2 )   203 - 216   2020.01( ISSN:1346-9843

     More details

    左室駆出率の保たれた患者における心エコー左室拡張機能パラメータと左室拡張機能障害(LVDD)診断に対する局所的心外膜脂肪組織(EAT)集積の影響を評価した。2012〜2015年に冠動脈疾患が疑われて心臓CTを実施した患者のうち、洞調律と正常な左室駆出率を示す患者252例(男性54%、平均66±13歳)を後ろ向きに解析した。心臓CTを実施し、EAT容積係数、局所的EAT厚として右冠動脈(EATRCA)、左前下行枝(EATLAD)、左回旋枝(EATLCX)、右室(EATRV)、左室(EATLV)、右房(EATRA)、左房(EATLA)周囲を測定した。心エコーを実施して、中隔および外側でE/e'を計算した。LVDDありが71例、LVDDなしが181例であった。EAT容積係数はLVDD群が75±30cm3/m2、非LVDD群が64±28cm3/m2、EATLCXは10.7±3.8mmと9.4±3.3mm、EATLVは2.6±1.6mmと2.1±1.4mmで、非LVDD群よりもLVDD群の方が有意に大きかった。EATLCXとEATLVは外側e'の減少と外側E/e'の増加に顕著に関連していた。重回帰分析ではEATLCXとEATLVは左室拡張機能パラメータと強く関連していた。

  • Thrombin inhibition by dabigatran attenuates endothelial dysfunction in diabetic mice.

    Arief Rahadian, Daiju Fukuda, Hotimah Masdan Salim, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takeshi Soeki, Michio Shimabukuro, Masataka Sata

    Vascular pharmacology   124   106632 - 106632   2020.01( ISSN:1537-1891

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Diabetic patients have coagulation abnormalities, in which thrombin plays a key role. Whereas accumulating evidence suggests that it also contributes to the development of vascular dysfunction through the activation of protease-activated receptors (PARs). Here we investigated whether the blockade of thrombin attenuates endothelial dysfunction in diabetic mice. Induction of diabetes by streptozotocin (STZ) increased the expression of PAR1, PAR3, and PAR4 in the aorta. STZ-induced diabetic mice showed impairment of endothelial function, while the administration of dabigatran etexilate, a direct thrombin inhibitor, significantly attenuated endothelial dysfunction in diabetic mice with no alteration of metabolic parameters including blood glucose level. Dabigatran did not affect endothelium-independent vasodilation. Dabigatran decreased the expression of inflammatory molecules (e.g., MCP-1 and ICAM-1) in the aorta of diabetic mice. Thrombin increased the expression of these inflammatory molecules and the phosphorylation of IκBα, and decreased the phosphorylation of eNOSSer1177 in human umbilical endothelial cells (HUVEC). Thrombin significantly impaired the endothelium-dependent vascular response of aortic rings obtained from wild-type mice. Inhibition of NF-κB attenuated thrombin-induced inflammatory molecule expression in HUVEC and ameliorated thrombin-induced endothelial dysfunction in aortic rings. Dabigatran attenuated the development of diabetes-induced endothelial dysfunction. Thrombin signaling may serve as a potential therapeutic target in diabetic condition.

    DOI: 10.1016/j.vph.2019.106632

    PubMed

  • Association Between Right Ventricular Contractile Function and Cardiac Events in Isolated Postcapillary and Combined Pre- and Postcapillary Pulmonary Hypertension.

    Kenya Kusunose, Nao Yamada, Hirotsugu Yamada, Susumu Nishio, Yoshihito Saijo, Yukina Hirata, Yuta Torii, Takayuki Ise, Koji Yamaguchi, Daiju Fukuda, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    Journal of cardiac failure   26 ( 1 )   43 - 51   2020.01( ISSN:1071-9164

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: Recent studies have shown that patients with combined pre- and postcapillary pulmonary hypertension (CpcPH) had worse outcomes than those with isolated postcapillary pulmonary hypertension (IpcPH). However, the prognostic factors including right ventricular (RV) function have not been well documented. The aim of this study was to assess the differentiation of PH phenotypes, using echocardiography, and the association between RV longitudinal strain and cardiac events. METHODS AND RESULTS: We prospectively recruited consecutive patients who had undergone right heart catheterization. The primary endpoint was cardiovascular death or readmission due to heart failure. We included 137 patients with Group 2 PH. A RV longitudinal strain of 17% was sensitive (85%) and specific (70%) to determine the CpcPH. During a median period of 31 months, 43 patients experienced the primary endpoint during follow-up. In a multivariate analysis, RV longitudinal strain was associated with the primary endpoint in both CpcPH and IpcPH (HR: 0.84, P = 0.003; HR: 0.86, P = 0.001). CONCLUSIONS: Lower RV longitudinal strain was independently associated with worse outcomes in CpcPH and IpcPH. RV longitudinal strain may play a prognostic role in PH phenotypes.

    DOI: 10.1016/j.cardfail.2019.08.021

    PubMed

  • Deleterious Effects of Epicardial Adipose Tissue Volume on Global Longitudinal Strain in Patients With Preserved Left Ventricular Ejection Fraction.

    Gulinu Maimaituxun, Kenya Kusunose, Hirotsugu Yamada, Daiju Fukuda, Shusuke Yagi, Yuta Torii, Nao Yamada, Takeshi Soeki, Hiroaki Masuzaki, Masataka Sata, Michio Shimabukuro

    Frontiers in cardiovascular medicine   7   607825 - 607825   2020

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Background: It is known that epicardial adipose tissue (EAT) volume is linked to cardiac dysfunction. However, it is unclear whether EAT volume (EATV) is closely linked to abnormal LV strain. We examined the relationship between EATV and global longitudinal strain (GLS), global circumferential strain (GCS), and global radial strain (GRS) in patients with preserved LV function. Methods: Notably, 180 consecutive subjects (68 ± 12 years; 53% men) underwent 320-slice multi-detector computed tomography coronary angiography and were segregated into coronary artery disease (CAD) (≥1 coronary artery branch stenosis ≥50%) and non-CAD groups. GLS, GCS, and GRS were evaluated by 2-dimensional speckle tracking in patients with preserved left ventricular (LV) ejection fraction (LVEF) ≥50%. Results: First, GLS, but not GRS and GCS, was lower in the high EATV group though the LVEF was comparable to the low EATV group. Frequency of GLS ≤18 was higher in the high EATV group. Second, multiple regression model showed that EATV, age, male sex, and CAD, were determinants of GLS. Third, the cutoff points of EATV were comparable (~116-117 mL) in both groups. The cutoff of EATV ≥116 showed a significant correlation with GLS ≤18 in overall subjects. Conclusions: Increasing EATV was independently associated with global longitudinal strain despite the preserved LVEF and lacking obstructive CAD. Our findings suggest an additional role of EAT on myocardial systolic function by impaired LV longitudinal strain.

    DOI: 10.3389/fcvm.2020.607825

    PubMed

  • Emerging roles of Toll-like receptor 9 in cardiometabolic disorders.

    Sachiko Nishimoto, Daiju Fukuda, Masataka Sata

    Inflammation and regeneration   40 ( 1 )   18 - 18   2020( ISSN:1880-9693

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Growing evidence suggests that damage-associated molecule patterns (DAMPs) and their receptors, pattern recognition receptors (PRRs), are associated with the progression of cardiometabolic disorders, including obesity-related insulin resistance and atherosclerosis. Cardiometabolic disorders share sterile chronic inflammation as a major cause; however, the exact mechanisms are still obscure. Toll-like receptor 9 (TLR9), one of the nucleic acid-sensing TLRs, recognizes DNA fragments derived from pathogens and contributes to self-defense by activation of the innate immune system. In addition, previous studies demonstrated that TLR9 recognizes DNA fragments released from host cells, accelerating sterile inflammation, which is associated with inflammatory diseases such as autoimmune diseases. In obese adipose tissue and atherosclerotic vascular tissue, various stresses release DNA fragments and/or nuclear proteins as DAMPs from degenerated adipocytes and vascular cells. Recent studies indicated that the activation of TLR9 in immune cells including macrophages and dendritic cells by recognition of these DAMPs promotes inflammation in these tissues, which causes cardiometabolic disorders. This review discusses recent advances in understanding the role of sterile inflammation associated with TLR9 and its endogenous ligands in cardiometabolic disorders. New insights into innate immunity may provide better understanding of cardiometabolic disorders and new therapeutic options for these major health threats in recent decades.

    DOI: 10.1186/s41232-020-00118-7

    PubMed

  • Effects of L-/N-Type Calcium Channel Blockers on Angiotensin II-Renin Feedback in Hypertensive Patients.

    Yutaka Kawabata, Takeshi Soeki, Hiroyuki Ito, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Takeshi Tobiume, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Mitsuhiro Kitani, Kazuhiro Kawano, Yoshio Taketani, Masataka Sata

    International journal of hypertension   2020   6653851 - 6653851   2020( ISSN:2090-0384

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Objectives: Cilnidipine, an L-/N-type calcium channel blocker (CCB), has unique organ-protective properties due to suppression of hyperactivity in the sympathetic nervous system and renin-angiotensin system (RAS). In this study, we hypothesized that cilnidipine might exert a renoprotective effect by suppressing the RAS. Methods: A total of 25 hypertensive patients receiving a RAS inhibitor were randomly assigned to a cilnidipine (n = 12) or amlodipine (n = 13) group. The effects of cilnidipine on proteinuria and angiotensin II-renin feedback were assessed. Results: After 6 months of treatment, both systolic and diastolic blood pressures were significantly reduced to a similar extent in both groups. The urine albumin-to-creatinine ratio was significantly lower in the cilnidipine group (p < 0.05) than in the amlodipine group. Amlodipine increased plasma angiotensin I and angiotensin II levels (p < 0.05), whereas cilnidipine did not. Interestingly, the cilnidipine group had a higher ratio of angiotensin-(1-7) (Ang-(1-7)) to angiotensin II in plasma than the amlodipine group (p < 0.05). Conclusions: The L-/N-type CCB cilnidipine, but not amlodipine, decreased urinary albumin excretion in hypertensive patients. Cilnidipine also increased the ratio of Ang-(1-7) to angiotensin II in plasma, which might be one factor underlying its beneficial effects.

    DOI: 10.1155/2020/6653851

    PubMed

  • Pulmonary Artery Hypertension-Specific Therapy Improves Exercise Tolerance and Outcomes in Exercise-Induced Pulmonary Hypertension.

    Kenya Kusunose, Hirotsugu Yamada, Susumu Nishio, Yukina Hirata, Yoshihito Saijo, Yuta Torii, Nao Yamada, Takayuki Ise, Koji Yamaguchi, Daiju Fukuda, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    JACC. Cardiovascular imaging   12 ( 12 )   2576 - 2579   2019.12( ISSN:1936-878X

     More details

    International / domestic magazine:International journal  

    DOI: 10.1016/j.jcmg.2019.07.002

    PubMed

  • 房室ブロックの予防に順行性速伝導路と順行性遅伝導路のマッピングが有用であった順行性速伝導路の下方偏位を伴う遅速型房室結節リエントリー性頻拍の1例

    井口 裕貴, 飛梅 威, 松本 和久, 坂東 左知子, 松浦 朋美, 添木 武, 志村 拓哉, 高橋 智子, 谷 彰浩, 藤本 裕, 大櫛 祐一郎, 數藤 久美子, 高橋 智紀, 上野 理絵, 門田 宗之, 川端 豊, 坂東 美佳, 山田 なお, 伊藤 浩敬, 伊勢 孝之, 楠瀬 賢也, 山口 浩司, 八木 秀介, 福田 大受, 山田 博胤, 若槻 哲三, 佐田 政隆

    四国医学雑誌   75 ( 5-6 )   259 - 259   2019.12( ISSN:0037-3699

  • 房室ブロックの進行に伴い明らかになり、恒久的ペースメーカー植込み術後のファーフィールドR波センシングへの関与が疑われた束枝心室間副伝導路の1例

    木田 貴弘, 飛梅 威, 松本 和久, 坂東 左知子, 松浦 朋美, 添木 武, 志村 拓哉, 高橋 智子, 谷 彰浩, 藤本 裕, 大櫛 祐一郎, 數藤 久美子, 高橋 智紀, 上野 理絵, 門田 宗之, 川端 豊, 坂東 美佳, 山田 なお, 伊藤 浩敬, 伊勢 孝之, 楠瀬 賢也, 山口 浩司, 八木 秀介, 福田 大受, 山田 博胤, 若槻 哲三, 佐田 政隆

    四国医学雑誌   75 ( 5-6 )   259 - 259   2019.12( ISSN:0037-3699

  • Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice.

    Kunduziayi Aini, Daiju Fukuda, Kimie Tanaka, Yasutomi Higashikuni, Yoichiro Hirata, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takeshi Soeki, Masataka Sata

    International heart journal   60 ( 6 )   1421 - 1429   2019.11( ISSN:1349-2365

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    Dipeptidyl peptidase-4 (DPP-4) inhibitors are novel antidiabetic agents with possible vascular protection effects. Endothelial dysfunction is an initiation step in atherogenesis. The purpose of this study was to investigate whether vildagliptin (Vilda) attenuates the development of endothelial dysfunction and atherosclerotic lesions in nondiabetic apolipoprotein E-deficient (ApoE-/-) mice. Eight-week-old nondiabetic ApoE-/- mice fed a Western-type diet received Vilda (50 mg/kg/day) for 20 weeks or 8 weeks. After 20 weeks of treatment, Vilda administration reduced atherogenesis in the aortic arch as determined by en face Sudan IV staining compared with the vehicle group (P < 0.05). Vilda also reduced lipid accumulation (P < 0.05) and vascular cell adhesion molecule-1 (VCAM-1) expression (P < 0.05) and tended to decrease macrophage infiltration (P = 0.05) into atherosclerotic plaques compared with vehicle. After 8 weeks of treatment, endothelium-dependent vascular reactivity was examined. Vilda administration significantly attenuated the impairment of endothelial function in nondiabetic ApoE-/- mice compared with the vehicle group (P < 0.05). Vilda treatment did not alter metabolic parameters, including blood glucose level, in both study protocols. To investigate the mechanism, aortic segments obtained from wild-type mice were incubated with exendin-4 (Ex-4), a glucagon-like peptide-1 (GLP-1) analog, in the presence or absence of lipopolysaccharide (LPS). Ex-4 attenuated the impairment of endothelium-dependent vasodilation induced by LPS (P < 0.01). Furthermore, Ex-4 promoted phosphorylation of eNOS at Ser1177 which was decreased by LPS in human umbilical endothelial cells (P < 0.05). Vilda inhibited the development of endothelial dysfunction and prevented atherogenesis in nondiabetic ApoE-/- mice. Our results suggested that GLP-1-dependent amelioration of endothelial dysfunction is associated with the atheroprotective effects of Vilda.

    DOI: 10.1536/ihj.19-117

    PubMed

    CiNii Article

  • Association of Echocardiography Before Major Elective Non-Cardiac Surgery With Improved Postoperative Outcomes - Possible Implications for Patient Care.

    Kenya Kusunose, Yuta Torii, Hirotsugu Yamada, Susumu Nishio, Yukina Hirata, Yoshihito Saijo, Takayuki Ise, Koji Yamaguchi, Daiju Fukuda, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    Circulation journal : official journal of the Japanese Circulation Society   83 ( 12 )   2512 - 2519   2019.11( ISSN:1346-9843

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    BACKGROUND: Whether preoperative echocardiography improves postoperative outcomes is not well established, so we examined the value of echocardiographic assessment on the onset of postoperative heart failure (HF), and determining which patients benefitted most from undergoing echocardiography prior to major elective non-cardiac surgery.Methods and Results:We identified all patients aged 50 years and older who had major elective non-cardiac surgery, and excluded patients with previously identified severe cardiovascular disease. The primary endpoint was the onset of HF during hospitalization. A total of 806 patients were included in the analysis. During hospitalization, 49 patients (6%) reached the primary endpoint. Within the matched cohort, preoperative echocardiography was associated with a statistically significant decrease in postoperative HF (hazard ratio: 0.46, P=0.01). In subgroup analyses, age, sex, body surface area, hypertension, diabetes mellitus, prior HF, surgical type, chronic kidney disease, pulmonary disease, and malignancy influenced the association of echocardiography with postoperative HF. CONCLUSIONS: The use of echocardiography in elderly patients with certain risk factors was associated with improved postoperative outcomes. The basis for this finding remains to be determined; particularly whether echocardiography is simply a marker of a population with better outcomes or whether it leads to better management that improves outcomes.

    DOI: 10.1253/circj.CJ-19-0663

    PubMed

    CiNii Article

  • DPP-4阻害薬であるビルダグリプチンは非糖尿病性のApoE欠損マウスにおける血管内皮機能障害とアテローム性動脈硬化を緩和する(Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice)

    Aini Kunduziayi, Fukuda Daiju, Tanaka Kimie, Higashikuni Yasutomi, Hirata Yoichiro, Yagi Shusuke, Kusunose Kenya, Yamada Hirotsugu, Soeki Takeshi, Sata Masataka

    International Heart Journal   60 ( 6 )   1421 - 1429   2019.11( ISSN:1349-2365

     More details

    ApoE欠損マウスを用いて、DPP-4阻害薬であるビルダグリプチンが血管内皮機能とアテローム性動脈硬化に及ぼす影響を検討した。ApoE欠損マウスに西洋型食餌を8週齢から28週齢まで与え、ビルダグリプチン(50mg/kg)を0.5%カルボキシメチルセルロース(CMC)水溶液に懸濁して投与した。対照群には同量のCMC水溶液を投与した。大動脈のen face sudan IV染色を実施し、ビルダグリプチン投与群でアテローム性動脈硬化の進展が有意に抑制された。またビルダグリプチン投与群ではプラーク中における脂質蓄積とVCAM-1の発現が対照群より有意に低く、マクロファージの浸潤も少なかった。非糖尿病マウスの血管内皮機能に対するビルダグリプチンの効果を検討するため、ApoE欠損マウスと野生型マウスに西洋型食餌を与えた。8週間後にApoE欠損マウスで血管内皮機能障害を認めたが、8週間のビルダグリプチン投与により血管内皮機能障害は対照群に比べて有意に改善した。ビルダグリプチン投与により血糖値を含む代謝パラメータに有意な群間差はみられなかった。

  • 待機的非心臓手術前の心エコーと術後転帰改善の関連 患者診療への潜在的な影響(Association of Echocardiography Before Major Elective Non-Cardiac Surgery With Improved Postoperative Outcomes: Possible Implications for Patient Care)

    Kusunose Kenya, Torii Yuta, Yamada Hirotsugu, Nishio Susumu, Hirata Yukina, Saijo Yoshihito, Ise Takayuki, Yamaguchi Koji, Fukuda Daiju, Yagi Shusuke, Soeki Takeshi, Wakatsuki Tetsuzo, Sata Masataka

    Circulation Journal   83 ( 12 )   2512 - 2519   2019.11( ISSN:1346-9843

     More details

    心エコー評価と術後心不全の発生率との関係性を評価し、待機的非心臓手術に先行した心エコー検査によって便益が得られる患者を明らかにした。2013年1月31日〜2015年10月31日に緊急非心臓手術を実施した50歳以上の患者を後ろ向きに調べた。入院中の心不全の発症を評価した。傾向スコアマッチング後、心エコーを実施した403例(男性41%、平均70±9歳)と心エコー非実施の403例(男性42%、平均70±9歳)を評価した。入院中に49例が心不全を発症した。術前心エコーは術後心不全の減少と有意に関連した。サブグループ解析では、年齢、性別、体表面積、高血圧、糖尿病、先行する心不全、手術型、慢性腎疾患、肺疾患、悪性腫瘍が心エコーと術後心不全の関連に影響を及ぼしていることが示された。危険因子のある高齢患者における心エコーの使用は術後転帰の改善と関連した。

  • 深層学習を用いた左室駆出率の推定 心エコー図法による検討

    山口 夏美, 楠瀬 賢也, 芳賀 昭弘, 森田 沙瑛, 平田 有紀奈, 鳥居 裕太, 西尾 進, 山田 なお, 阿部 美保, 福田 大受, 山田 博胤, 佐田 政隆

    日本心臓病学会学術集会抄録   67回   優秀3 - 5   2019.09

  • Recent Advance in Atherosclerosis Research

    Tanaka Kimie, Hirata Yoichiro, Fukuda Daiju, Sata Masataka

    Nihon Naika Gakkai Zasshi   108 ( 8 )   1607 - 1616   2019.08( ISSN:00215384

  • Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice.

    Phuong Tran Pham, Daiju Fukuda, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takeshi Soeki, Michio Shimabukuro, Masataka Sata

    Scientific reports   9 ( 1 )   11206 - 11206   2019.08

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Activated factor X (FXa) plays a central role in the coagulation cascade, while it also mediates vascular function through activation of protease-activated receptors (PARs). Here, we examined whether inhibition of FXa by rivaroxaban, a direct FXa inhibitor, attenuates endothelial dysfunction in streptozotocin (STZ)-induced diabetic mice. Induction of diabetes increased the expression of a major FXa receptor, PAR2, in the aorta (P < 0.05). Administration of rivaroxaban (10 mg/kg/day) to diabetic wild-type (WT) mice for 3 weeks attenuated endothelial dysfunction as determined by acetylcholine-dependent vasodilation compared with the control (P < 0.001), without alteration of blood glucose level. Rivaroxaban promoted eNOSSer1177 phosphorylation in the aorta (P < 0.001). Induction of diabetes to PAR2-deficient (PAR2-/-) mice did not affect endothelial function and eNOSSer1177 phosphorylation in the aorta compared with non-diabetic PAR2-/- mice. FXa or a PAR2 agonist significantly impaired endothelial function in aortic rings obtained from WT mice, but not in those from PAR2-/- mice. FXa promoted JNK phosphorylation (P < 0.01) and reduced eNOSSer1177 phosphorylation (P < 0.05) in human coronary artery endothelial cells (HCAEC). FXa-induced endothelial dysfunction in aortic rings (P < 0.001) and eNOSSer1177 phosphorylation (P < 0.05) in HCAEC were partially ameliorated by a JNK inhibitor. Rivaroxaban ameliorated diabetes-induced endothelial dysfunction. Our results suggest that FXa or PAR2 is a potential therapeutic target.

    DOI: 10.1038/s41598-019-47474-0

    PubMed

  • 免疫グロブリンA血管炎の成人発症例 1症例報告(Adult onset of Immunoglobulin A vasculitis: A case report)

    Yagi Shusuke, Endo Itsuro, Murakami Taichi, Hida Tetsuya, Yamamoto Yousuke, Soga Tomohiro, Ise Takayuki, Kusunose Kenya, Yamaguchi Koji, Fukuda Daiju, Yamada Hirotsugu, Soeki Takeshi, Wakatsuki Tetsuzo, Kawahito Shinji, Sata Masataka

    The Journal of Medical Investigation   66 ( 3-4 )   344 - 346   2019.08( ISSN:1343-1420

     More details

    症例は20歳男性で、気管支喘息の病歴が存在していた。嘔気、咽頭痛、下肢の皮疹が続くため来院した。受診時の診察では下肢に隆起性の紫斑を認め、また咽頭はわずかに発赤している様子が観察された。患者からは急性腹症の履歴は聴取されなかった。心拍数は98拍/分、体温は37.8℃で血液検査では白血球数上昇、フィブリノゲン高値、および抗ストレプトリジン-O抗体価陽性が示されたが血清免疫グロブリン(Ig)A濃度は基準範囲内であった。尿検査では蛋白尿(1+)と判定された。皮膚生検を施行し蛍光免疫染色の直接法にて血管中膜にIgA沈着を認めた。これらの所見からガイドラインに準拠してpossibleなIgA血管炎と診断した。アセトアミノフェン500mg/日で加療したところ2週間以内に紫斑を含む症状は完全消退し、最後の受診から1ヵ月後の時点でも患者は体調が快調であると報告していた。

  • 多数の骨に骨溶解病変を呈した原発性骨リンパ腫(Osteolytic primary bone lymphoma in the multiple bones)

    Yagi Shusuke, Zheng Robert, Nishiyama Seiichi, Kawabata Yutaka, Ise Takayuki, Sugiura Kosuke, Yoshinari Haruhiko, Nishisho Toshihiko, Bando Yoshimi, Kagawa Kumiko, Fukuda Daiju, Soga Tomohiro, Saijo Yoshihito, Kusunose Kenya, Yamaguchi Koji, Yamada Hirotsugu, Soeki Takeshi, Wakatsuki Tetsuzo, Kawahito Shinji, Akaike Masashi, Sata Masataka

    The Journal of Medical Investigation   66 ( 3-4 )   347 - 350   2019.08( ISSN:1343-1420

     More details

    症例は89歳女性で、転倒後に生じた右臀部の疼痛を主訴に当院を受診した。患者には無症候性の重症大動脈弁狭窄が存在していた。CTでは右大腿骨幹の完全骨折に加え、その受傷部、頭蓋骨、両側肩甲骨、および腰椎に骨溶解性腫瘍が多発していることが判明した。経カテーテル大動脈弁留置術、次いで骨折に対する手術を施行して成功した。血清学的検査ではEpstein-Barrウイルス(EBV)の核抗原に対するIgG、およびEBVカプシド抗原に対するIgGが陽性であったが、EBVのDNAに対するPCR検査は施行しなかった。右側頭軟部組織の生検ではCD20とB-cell lymphoma 2(BCL-2)が陽性の大型細胞がび漫性に増殖している所見が観察され、Ki-67標識指数は80%と増殖能が高いことも示された。骨髄生検は行わなかった。こうした多発病変は骨に限局していたことから高齢者EBウイルス陽性び漫性大細胞型B細胞リンパ腫による原発性骨リンパ腫(臨床ステージIV、予後リスク高)と診断した。治療法には最善の支持療法が選択され、その後は骨病変の進行が示されるとともに患者の全身状態は悪化して入院9週後に死亡した。

  • SGLT2阻害薬canagliflozinは糖尿病発症性ApoE-/-マウスにおいて内皮機能障害とアテローム性動脈硬化症を軽減する(SGLT2 inhibitor, Canagliflozin, Ameliorate Endothelial Dysfunction and Atherosclerosis in Diabetic ApoE-/- Mice)

    Arief Rahadian, 福田 大受, Hotima Salim, 八木 秀介, 楠瀬 賢也, 山田 博胤, 添木 武, 佐田 政隆

    日本性機能学会雑誌   34 ( 2 )   190 - 190   2019.08( ISSN:1345-8361

  • 非糖尿病アポリポタンパク質E欠損マウスにおいてDPP-4阻害薬vildagliptinは内皮機能障害を予防する(Vildagliptin, a DPP-4 Inhibitor, prevents endothelial dysfunction in non-diabetic apolipoprotein E-deficient mice)

    アイニ・クンドゥズアイ, 福田 大受, 八木 秀介, 楠瀬 賢也, 山田 博胤, 添木 武, 佐田 政隆

    日本性機能学会雑誌   34 ( 2 )   189 - 189   2019.08( ISSN:1345-8361

  • 野生型マウスにおいてFXaの直接阻害薬であるrivaroxabanは糖尿病誘発性内皮機能障害を抑制する(Rivaroxaban, a direct inhibitor of FXa, attenuated diabetes-induced endothelial dysfunction in wild-type mice)

    Pham Tran Phuong, 福田 大受, 八木 秀介, 楠瀬 賢也, 山田 博胤, 添木 武, 島袋 充生, 佐田 政隆

    日本性機能学会雑誌   34 ( 2 )   191 - 191   2019.08( ISSN:1345-8361

  • アポリポタンパク質E欠損マウスにおいてS1P2拮抗薬は内皮機能障害を抑制しアテローム動脈硬化を阻害する(S1P2 antagonist attenuates endothelial dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient Mice)

    ガンバートル・ビャンバスレン, 福田 大受, 八木 秀介, 添木 武, 佐田 政隆

    日本性機能学会雑誌   34 ( 2 )   192 - 192   2019.08( ISSN:1345-8361

  • 医学と医療の最前線 動脈硬化研究の最近の進歩 Reviewed

    田中 君枝, 平田 陽一郎, 福田 大受, 佐田 政隆

    日本内科学会雑誌   108 ( 8 )   1607 - 1616   2019.08( ISSN:0021-5384

  • 冠動脈疾患に対する心外膜脂肪組織肥厚度の性別特異的影響(Gender specific impact of epicardial adipose tissue thickness on coronary artery disease)

    マイマイチュクン・グリヌ, 福田 大受, 八木 秀介, 平田 有紀奈, 岩瀬 俊, 松浦 朋美, 伊勢 孝之, 楠瀬 賢也, 山口 浩司, 山田 博胤, 添木 武, 若槻 哲三, 佐田 政隆, 島袋 充生

    日本抗加齢医学会総会プログラム・抄録集   19回   254 - 254   2019.06

  • Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis.

    Daiju Fukuda, Sachiko Nishimoto, Kunduziayi Aini, Atsushi Tanaka, Tsuyoshi Nishiguchi, Joo-Ri Kim-Kaneyama, Xiao-Feng Lei, Kiyoshi Masuda, Takuya Naruto, Kimie Tanaka, Yasutomi Higashikuni, Yoichiro Hirata, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takeshi Soeki, Issei Imoto, Takashi Akasaka, Michio Shimabukuro, Masataka Sata

    Journal of the American Heart Association   8 ( 7 )   e010860   2019.04

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Background Toll-like receptor ( TLR ) 9 recognizes bacterial DNA , activating innate immunity, whereas it also provokes inflammation in response to fragmented DNA released from mammalian cells. We investigated whether TLR 9 contributes to the development of vascular inflammation and atherogenesis using apolipoprotein E-deficient ( Apoe -/-) mice. Methods and Results Tlr9-deficient Apoe -/- ( Tlr9 -/- Apoe -/-) mice and Apoe -/- mice on a Western-type diet received subcutaneous angiotensin II infusion (1000 ng/kg per minute) for 28 days. Angiotensin II increased the plasma level of double-stranded DNA, an endogenous ligand of TLR 9, in these mice. Genetic deletion or pharmacologic blockade of TLR 9 in angiotensin II-infused Apoe -/- mice attenuated atherogenesis in the aortic arch ( P<0.05), reduced the accumulation of lipid and macrophages in atherosclerotic plaques, and decreased RNA expression of inflammatory molecules in the aorta with no alteration of metabolic parameters. On the other hand, restoration of TLR 9 in bone marrow in Tlr9 -/- Apoe -/- mice promoted atherogenesis in the aortic arch ( P<0.05). A TLR 9 agonist markedly promoted proinflammatory activation of Apoe -/- macrophages, partially through p38 mitogen-activated protein kinase signaling. In addition, genomic DNA extracted from macrophages promoted inflammatory molecule expression more effectively in Apoe -/- macrophages than in Tlr9 -/- Apoe -/- macrophages. Furthermore, in humans, circulating double-stranded DNA in the coronary artery positively correlated with inflammatory features of coronary plaques determined by optical coherence tomography in patients with acute myocardial infarction ( P<0.05). Conclusions TLR 9 plays a pivotal role in the development of vascular inflammation and atherogenesis through proinflammatory activation of macrophages. TLR 9 may serve as a potential therapeutic target for atherosclerosis.

    DOI: 10.1161/JAHA.118.010860

    PubMed

  • Left atrial functional response after a marathon in healthy amateur volunteers.

    Yukina Hirata, Kenya Kusunose, Hirotsugu Yamada, Sae Morita, Yuta Torii, Susumu Nishio, Robert Zheng, Yoshihito Saijo, Daiju Fukuda, Shusuke Yagi, Takeshi Soeki, Masataka Sata

    The international journal of cardiovascular imaging   35 ( 4 )   633 - 643   2019.04( ISSN:1569-5794

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Middle-aged marathon runners have an increased risk of developing atrial fibrillation (AF). A previous study described that repetitive marathon running was associated with left atrial (LA) dysfunction. However, whether this change is common in marathon runners and which runners are at risk of LA dysfunction remain unknown. The purpose of this study was to determine which factors could predict LA dysfunction. We prospectively examined 12 healthy amateur volunteers (9 males, 31 ± 8 years old) who participated in a full marathon. All echocardiographic measurements and speckle-tracking echocardiography were performed before and after the marathon. The endpoint was defined as reduced LA reservoir strain 1 day after the marathon (non-responder group). Seven participants were in the non-responder group. Age (35 ± 9 vs. 26 ± 2 years, p = 0.020), augmentation index (76 ± 12 vs. 55 ± 8, p = 0.002), and diastolic blood pressures (83 ± 11 vs. 70 ± 7 mmHg, p = 0.021) in the non-responder group were significantly higher compared with the responder group. In multivariate linear regression analysis, only the augmentation index was an independent predictor of reduced LA reservoir function after the marathon (β = - 0.646, p = 0.023). The augmentation index was a predictive marker for reduction in LA reservoir function after a marathon in healthy amateur volunteers.

    DOI: 10.1007/s10554-018-1502-2

    PubMed

  • 早期に診断し得た心臓原発悪性腫瘍の一例

    中村 昌史, 川端 豊, 伊勢 孝之, 藤本 裕太, 原田 貴文, 松本 和久, 西條 良仁, 上野 理絵, 山田 なお, 伊藤 浩敬, 轟 貴史, 楠瀬 賢也, 飛梅 威, 山口 浩司, 福田 大受, 八木 秀介, 山田 博胤, 添木 武, 若槻 哲三, 佐田 政隆

    四国医学雑誌   75 ( 1-2 )   91 - 91   2019.04( ISSN:0037-3699

  • Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome.

    Shusuke Yagi, Daisuke Kondo, Takayuki Ise, Daiju Fukuda, Koji Yamaguchi, Tetsuzo Wakatsuki, Yutaka Kawabata, Hiroyuki Ito, Yoshihito Saijo, Hiromitsu Seno, Kumiko Sutou, Rie Ueno, Takafumi Todoroki, Kenya Kusunose, Tomomi Matsuura, Takeshi Tobiume, Hirotsugu Yamada, Takeshi Soeki, Michio Shimabukuro, Ken-Ichi Aihara, Masashi Akaike, Masataka Sata

    Journal of atherosclerosis and thrombosis   26 ( 3 )   272 - 281   2019.03( ISSN:1340-3478

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    AIM: It is speculated that statin therapy modulates the synthesis of polyunsaturated fatty acids (PUFA), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). However, the data available on the effects of statin therapy on the serum levels of PUFA and the subsequent impact on in-stent restenosis (ISR) in patients with acute coronary syndrome (ACS) are limited. METHODS: A total of 120 ACS patients who received emergent coronary stent implantation, follow-up coronary angiography to evaluate ISR, and new statin therapy were enrolled. We measured the serum levels of the PUFA and lipids at the onset of ACS and at the follow-up coronary angiography. RESULTS: The follow-up coronary angiography revealed 38 ISR cases. New statin therapy significantly reduced the serum levels of DHA and low-density lipoprotein cholesterol (LDL-C), while it did not affect EPA level. Single regression analysis revealed that a decreased serum level of LDL-C was associated with decreased DHA level. The multiple logistic regression analysis revealed that the decreased DHA level after statin therapy and low serum level of EPA on admission were determinants of prevalence of ISR. CONCLUSION: Statin therapy decreased the serum level of DHA with a parallel reduction in LDL-C level in patients with ACS. Decreased DHA level after statin therapy and low EPA level on admission are risk factors for ISR, indicating that in patients with ACS, decreased serum levels of DHA may be a residual target for the prevention of ISR.

    DOI: 10.5551/jat.44735

    PubMed

    CiNii Article

  • 急性冠症候群患者におけるスタチン療法後のドコサヘキサエン酸値減少および低エイコサペンタエン酸値とステント内再狭窄との関連(Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome)

    Yagi Shusuke, Kondo Daisuke, Ise Takayuki, Fukuda Daiju, Yamaguchi Koji, Wakatsuki Tetsuzo, Kawabata Yutaka, Ito Hiroyuki, Saijo Yoshihito, Seno Hiromitsu, Sutou Kumiko, Ueno Rie, Todoroki Takafumi, Kusunose Kenya, Matsuura Tomomi, Tobiume Takeshi, Yamada Hirotsugu, Soeki Takeshi, Shimabukuro Michio, Aihara Ken-ichi, Akaike Masashi, Sata Masataka

    Journal of Atherosclerosis and Thrombosis   26 ( 3 )   272 - 281   2019.03( ISSN:1340-3478

     More details

    急性冠症候群(ACS)患者における血清多価不飽和脂肪酸(PUFA)値とステント内再狭窄(ISR)に及ぼすスタチン療法の影響を調査した。2009年1月〜2017年7月に当施設で新規病変に対してステント留置による緊急経皮的冠動脈インターベンション(PCI)を実施したACS患者のデータを後ろ向きに調査した。ACS患者120例(男性74%、平均67±13歳)に緊急冠動脈ステント留置を実施し、緊急PCI後3ヵ月以降に経過観察で冠動脈造影によってISRを評価し、スタチン療法を実施した。ACS発症時と経過観察冠動脈造影時にPUFAと脂質の血清値を測定した。38例でISRが明らかになった。新規スタチン療法によって血清LDLコレステロール(C)値とドコサヘキサエン酸(DHA)が有意に減少したが、エイコサペンタエン酸(EPA)は変化しなかった。単一回帰分析では血清LDL-C値の減少がDHA値の減少と関連した。多重ロジスティック回帰分析ではスタチン療法後のDHA値の減少と入院時のEPAの低血清値がISR有病率の決定因子であった。

  • 冠動脈プラークと脈管の血管の微小管腔構造は冠動脈の炎症に影響を与える 未固定遺体による研究(Microluminal Structures of Coronary Plaque and Vasa Vasorums Affect Coronary Inflammation: A Fresh Cadaveric Study)

    伊藤 浩敬, 若槻 哲三, 山口 浩司, 福田 大受, 川端 豊, 轟 貴史, 松浦 朋美, 伊勢 孝之, 楠瀬 賢也, 飛梅 威, 八木 秀介, 山田 博胤, 添木 武, 佐田 政隆

    日本循環器学会学術集会抄録集   83回   PJ106 - 5   2019.03

  • 冠動脈プラーク内微小管腔構造は心外膜の脂肪組織の質と量に関連する 新鮮遺体を用いた研究(Coronary Intraplaque Microluminal Structure are Associated with the Quality and Quantity of Epicardial Adipose Tissue: A Fresh Cadaveric Study)

    川端 豊, 若槻 哲三, 山口 浩司, 伊藤 浩敬, 福田 大受, 轟 貴史, 松浦 朋美, 伊勢 孝之, 楠瀬 賢也, 飛梅 威, 八木 秀介, 山田 博胤, 添木 武, 佐田 政隆

    日本循環器学会学術集会抄録集   83回   PJ057 - 2   2019.03

  • 対角枝の急性心筋梗塞によるラムダ様J波(Lambda-like J wave due to acute myocardial infarction of the diagonal branch)

    Yagi Shusuke, Ueno Rie, Sutou Kumiko, Wakatsuki Tetsuzo, Yamaguchi Koji, Saijo Yoshihito, Hara Tomoya, Ise Takayuki, Kusunose Kenya, Bando Mika, Matsuura Tomomi, Tobiume Takeshi, Yamada Hirotsugu, Fukuda Daiju, Soeki Takeshi, Akaike Masashi, Sata Masataka

    The Journal of Medical Investigation   66 ( 1-2 )   185 - 187   2019.02( ISSN:1343-1420

     More details

    症例は80歳女性で、網膜中心静脈閉塞症手術のための術前心電図検査の最中に、安静時胸痛が突然出現した。高血圧の既往はあったが、高脂血症はなく、慢性心房細動のため25年間にわたり抗凝固療法を受けていた。心エコーではI、aVL、V2-6リードにJ波を伴うST上昇およびIIIとaVFリードにST低下を認めた。5分後、前胸波はcoved型からST上昇Saddleback型に変化した。心電図の所見により近位左前下行枝(LAD)の閉塞による広汎性前側急性心筋梗塞(AMI)が示唆されたが、心エコーでは壁運動異常は示されなかった。緊急冠動脈血管造影ではLADにおける狭窄または閉塞は認めなかったが、対角枝の先端の閉塞が示された。血管形成の翌日にI、aVL、V2-5リードに陰性T波を認めた。抗凝固療法の2週間後に実施した冠血管造影では対角枝の再灌流を認め、対角枝の先端は心房細動による血栓にて閉塞していたと考えられた。造影MRIの画像は前外側左心室壁に小さな梗塞を示した。AMI発症の3週間後に合併症なく退院した。

  • 血管内皮機能改善作用を有する新たな機能性脂質の同定

    阪上 浩, 堤 理恵, 宮原 裕子, 丹波 洋介, 板東 正浩, 瀬部 真由, 山崎 幸, 升本 早枝子, 黒田 雅士, 竹尾 仁良, 福田 大受, 佐田 政隆

    日本病態栄養学会誌   22 ( Suppl. )   S - 20   2019.01( ISSN:1345-8167

  • Adult onset of Immunoglobulin A vasculitis - A case report.

    Shusuke Yagi, Itsuro Endo, Taichi Murakami, Tetsuya Hida, Yousuke Yamamoto, Tomohiro Soga, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Shinji Kawahito, Masataka Sata

    The journal of medical investigation : JMI   66 ( 3.4 )   344 - 346   2019( ISSN:1343-1420

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    Immunoglobulin A vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, primarily occurs during childhood between the ages of 3 and 15 years and is the most common form of systemic vasculitis in children ; its occurrence in adults has been rarely reported. Such low incidence could be attributable to either under-diagnosis or misdiagnosis. Thus, not only pediatricians but also physicians should be able to diagnose IgAV accurately to manage the patients appropriately and avoid its associated complications. In addition, treatment of adult onset IgAV with renal involvement has not been fully established yet. We describe here a case of adult onset IgAV complicated by proteinuria and pharyngitis, which was cured by no specific treatment. J. Med. Invest. 66 : 344-346, August, 2019.

    DOI: 10.2152/jmi.66.344

    PubMed

    CiNii Article

  • Osteolytic primary bone lymphoma in the multiple bones.

    Shusuke Yagi, Robert Zheng, Seiichi Nishiyama, Yutaka Kawabata, Takayuki Ise, Kosuke Sugiura, Haruhiko Yoshinari, Toshihiko Nishisho, Yoshimi Bando, Kumiko Kagawa, Daiju Fukuda, Tomohiro Soga, Yoshihito Saijo, Kenya Kusunose, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Shinji Kawahito, Masashi Akaike, Masataka Sata

    The journal of medical investigation : JMI   66 ( 3.4 )   347 - 350   2019( ISSN:1343-1420

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    Primary non-Hodgkin bone lymphoma (PBL) can involve solitary or multiple destructive bone lesions such as those of the femur or pelvis humerus, and some cases have osteolytic lesions. PBL is a rare disease in adults. Thus, PBL is rarely considered a differential diagnosis of the osteolytic tumor. In addition, PBL can be underdiagnosed because patients do not experience symptoms or show objective abnormalities in the early stage. Here, we reported an elderly patient with PBL in multiple bones, including the cranial and femoral bones that were fractured due to falling. J. Med. Invest. 66 : 347-350, August, 2019.

    DOI: 10.2152/jmi.66.347

    PubMed

    CiNii Article

  • Levels of Adiponectin Expression in Peri-Renal and Subcutaneous Adipose Tissue and Its Determinants in Human Biopsied Samples.

    Gulinu Maimaituxun, Daiju Fukuda, Hirofumi Izaki, Yoichiro Hirata, Hiro-Omi Kanayama, Hiroaki Masuzaki, Masataka Sata, Michio Shimabukuro

    Frontiers in endocrinology   10   897 - 897   2019

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Background: The interactions of adipose tissue with the kidney are hypothesized to affect kidney function. Also, excessive peri-renal fat may increase the risk of cardiometabolic risk. However, the role(s) of peri-renal fat adipocytokine has never been evaluated. Objectives: To elucidate levels of adiponectin expression in peri-renal and subcutaneous adipose tissue and its determinants in human biopsied samples. Methods: A pair of subcutaneous and perirenal fat tissue samples were collected from 80 patients (men: 54; women: 26) who underwent urological operations. Subcutaneous adipose tissue (SAT) area, visceral adipose tissue (VAT) area and peri-renal adipose tissue (RAT) volume were quantified on abdominal computed tomography. Cytokine/adipocytokine expression was evaluated by real-time semi-quantitative polymerase chain reaction (qPCR). Probability was considered significant if P < 0.05. Results: Current study evaluated determinants of plasma adiponectin levels and expression levels of adiponectin in SAT and RAT in human samples. We found that: first, plasma adiponectin levels were correlated with VAT area but not with BMI, waist circumference, SAT area, and RAT volume; second, expression levels of adiponectin in SAT were correlated with BMI, waist circumference, and SAT area but not with VAT area and RAT volume; and third, expression levels of adiponectin in RAT were correlated with all adiposity indices including BMI, waist circumference, SAT area, VAT area, and RAT volume. Conclusion: This study evaluated levels of adiponectin expression in RAT and SAT and its determinants in patients who underwent urological operation. Levels of adiponectin mRNA in RAT were negatively correlated with remote fat mass in SAT and VAT and also with local fat mass in RAT, while level of adiponectin in SAT was not correlated with RAT volume. Further studies are warranted to evaluate roles of peri-renal fat mass accumulation and its pathophysiological machineries.

    DOI: 10.3389/fendo.2019.00897

    PubMed

  • Lambda-like J wave due to acute myocardial infarction of the diagonal branch.

    Shusuke Yagi, Rie Ueno, Kumiko Sutou, Tetsuzo Wakatsuki, Koji Yamaguchi, Yoshihito Saijo, Tomoya Hara, Takayuki Ise, Kenya Kusunose, Mika Bando, Tomomi Matsuura, Takeshi Tobiume, Hirotsugu Yamada, Daiju Fukuda, Takeshi Soeki, Masashi Akaike, Masataka Sata

    The journal of medical investigation : JMI   66 ( 1.2 )   185 - 187   2019( ISSN:1343-1420

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    The culprit lesion of acute myocardial infarction could be predicted by electrocardiogram findings. However, we experienced some cases with coronary angiographic finding in the area of ST-T elevation that was different from that predicted. The lambda-like J wave could be caused by ischemia although the mechanism has not been fully elucidated. We report a case of acute myocardial infarction that showed discrepancy between ST-T elevation with lambda-like ischemic J wave in a broad area and coronary angiographical finding of diagonal branch occlusion. J. Med. Invest. 66 : 185-187, February, 2019.

    DOI: 10.2152/jmi.66.185

    PubMed

    CiNii Article

  • Combined Analysis of Neutrino and Antineutrino Oscillations at T2K.

    Abe K, Amey J, Andreopoulos C, Antonova M, Aoki S, Ariga A, Autiero D, Ban S, Barbi M, Barker GJ, Barr G, Barry C, Bartet-Friburg P, Batkiewicz M, Berardi V, Berkman S, Bhadra S, Bienstock S, Blondel A, Bolognesi S, Bordoni S, Boyd SB, Brailsford D, Bravar A, Bronner C, Buizza Avanzini M, Calland RG, Campbell T, Cao S, Cartwright SL, Catanesi MG, Cervera A, Checchia C, Cherdack D, Chikuma N, Christodoulou G, Clifton A, Coleman J, Collazuol G, Coplowe D, Cudd A, Dabrowska A, De Rosa G, Dealtry T, Denner PF, Dennis SR, Densham C, Dewhurst D, Di Lodovico F, Di Luise S, Dolan S, Drapier O, Duffy KE, Dumarchez J, Dziewiecki M, Emery-Schrenk S, Ereditato A, Feusels T, Finch AJ, Fiorentini GA, Friend M, Fujii Y, Fukuda D, Fukuda Y, Galymov V, Garcia A, Giganti C, Gizzarelli F, Golan T, Gonin M, Hadley DR, Haegel L, Haigh MD, Hansen D, Harada J, Hartz M, Hasegawa T, Hastings NC, Hayashino T, Hayato Y, Helmer RL, Hillairet A, Hiraki T, Hiramoto A, Hirota S, Hogan M, Holeczek J, Hosomi F, Huang K, Ichikawa AK, Ikeda M, Imber J, Insler J, Intonti RA, Ishida T, Ishii T, Iwai E, Iwamoto K, Izmaylov A, Jamieson B, Jiang M, Johnson S, Jonsson P, Jung CK, Kabirnezhad M, Kaboth AC, Kajita T, Kakuno H, Kameda J, Karlen D, Katori T, Kearns E, Khabibullin M, Khotjantsev A, Kim H, Kim J, King S, Kisiel J, Knight A, Knox A, Kobayashi T, Koch L, Koga T, Konaka A, Kondo K, Kormos LL, Korzenev A, Koshio Y, Kowalik K, Kropp W, Kudenko Y, Kurjata R, Kutter T, Lagoda J, Lamont I, Lamoureux M, Larkin E, Lasorak P, Laveder M, Lawe M, Licciardi M, Lindner T, Liptak ZJ, Litchfield RP, Li X, Longhin A, Lopez JP, Lou T, Ludovici L, Lu X, Magaletti L, Mahn K, Malek M, Manly S, Marino AD, Martin JF, Martins P, Martynenko S, Maruyama T, Matveev V, Mavrokoridis K, Ma WY, Mazzucato E, McCarthy M, McCauley N, McFarland KS, McGrew C, Mefodiev A, Metelko C, Mezzetto M, Mijakowski P, Minamino A, Mineev O, Mine S, Missert A, Miura M, Moriyama S, Mueller TA, Myslik J, Nakadaira T, Nakahata M, Nakamura KG, Nakamura K, Nakamura KD, Nakanishi Y, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, Novella P, Nowak J, O'Keeffe HM, Okumura K, Okusawa T, Oryszczak W, Oser SM, Ovsyannikova T, Owen RA, Oyama Y, Palladino V, Palomino JL, Paolone V, Patel ND, Paudyal P, Pavin M, Payne D, Perkin JD, Petrov Y, Pickard L, Pickering L, Pinzon Guerra ES, Pistillo C, Popov B, Posiadala-Zezula M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radermacher T, Radicioni E, Ratoff PN, Ravonel M, Rayner MA, Redij A, Reinherz-Aronis E, Riccio C, Rodrigues PA, Rondio E, Rossi B, Roth S, Rubbia A, Rychter A, Sakashita K, Sánchez F, Scantamburlo E, Scholberg K, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaikhiev A, Shaker F, Shaw D, Shiozawa M, Shirahige T, Short S, Smy M, Sobczyk JT, Sobel H, Sorel M, Southwell L, Steinmann J, Stewart T, Stowell P, Suda Y, Suvorov S, Suzuki A, Suzuki SY, Suzuki Y, Tacik R, Tada M, Takeda A, Takeuchi Y, Tanaka HK, Tanaka HA, Terhorst D, Terri R, Thakore T, Thompson LF, Tobayama S, Toki W, Tomura T, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Vagins M, Vallari Z, Vasseur G, Vladisavljevic T, Wachala T, Walter CW, Wark D, Wascko MO, Weber A, Wendell R, Wilkes RJ, Wilking MJ, Wilkinson C, Wilson JR, Wilson RJ, Wret C, Yamada Y, Yamamoto K, Yamamoto M, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yoshida K, Yuan T, Yu M, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman ED, Zito M, Żmuda J, T2K Collaboration

    Physical review letters   118 ( 15 )   151801   2017.04( ISSN:0031-9007

  • PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation.

    Iwata H, Goettsch C, Sharma A, Ricchiuto P, Goh WW, Halu A, Yamada I, Yoshida H, Hara T, Wei M, Inoue N, Fukuda D, Mojcher A, Mattson PC, Barabási AL, Boothby M, Aikawa E, Singh SA, Aikawa M

    Nature communications   7   12849   2016.10

     More details

  • Delta-Like Ligand 4-Notch Signaling in Macrophage Activation.

    Nakano T, Fukuda D, Koga J, Aikawa M

    Arteriosclerosis, thrombosis, and vascular biology   36 ( 10 )   2038 - 47   2016.10( ISSN:1079-5642

  • Depot- and gender-specific expression of NLRP3 inflammasome and toll-like receptors in adipose tissue of cancer patients.

    Shimabukuro M, Sato H, Izaki H, Fukuda D, Uematsu E, Hirata Y, Yagi S, Soeki T, Sakaue H, Kanayama HO, Masuzaki H, Sata M

    BioFactors (Oxford, England)   42 ( 4 )   397 - 406   2016.07( ISSN:0951-6433

     More details

  • Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.

    Hara T, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Nishimoto S, Yagi S, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Sata M

    Atherosclerosis   242 ( 2 )   639 - 46   2015.10( ISSN:0021-9150

  • Histopathological heterogeneity of in-stent restenosis in four coronary endarterectomy specimens.

    Takashima A, Shimabukuro M, Tabata M, Fukuda D, Uematsu E, Ishibashi-Ueda H, Takanashi S, Sata M

    Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology   24 ( 3 )   194 - 7   2015.05( ISSN:1054-8807

  • Plasma microRNA-100 is associated with coronary plaque vulnerability.

    Soeki T, Yamaguchi K, Niki T, Uematsu E, Bando S, Matsuura T, Ise T, Kusunose K, Hotchi J, Tobiume T, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M

    Circulation journal : official journal of the Japanese Circulation Society   79 ( 2 )   413 - 8   2015( ISSN:1346-9843

  • Effects of docosahexaenoic Acid on the endothelial function in patients with coronary artery disease.

    Yagi S, Aihara K, Fukuda D, Takashima A, Hara T, Hotchi J, Ise T, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M

    Journal of atherosclerosis and thrombosis   22 ( 5 )   447 - 54   2015( ISSN:1340-3478

     More details

  • Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension.

    Yagi S, Takashima A, Mitsugi M, Wada T, Hotchi J, Aihara K, Hara T, Ishida M, Fukuda D, Ise T, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M

    Therapeutics and clinical risk management   11   83 - 8   2015( ISSN:1176-6336

     More details

  • Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease.

    Yagi S, Hara T, Ueno R, Aihara K, Fukuda D, Takashima A, Hotchi J, Ise T, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M

    Nutrition journal   13 ( 1 )   112   2014.12

  • Pentraxin 3 is a local inflammatory marker in atrial fibrillation.

    Soeki T, Bando S, Uematsu E, Matsuura T, Niki T, Ise T, Kusunose K, Hotchi J, Ueda Y, Tomita N, Yamaguchi K, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M

    Heart and vessels   29 ( 5 )   653 - 8   2014.09( ISSN:0910-8327

  • Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice.

    Matsumoto S, Shimabukuro M, Fukuda D, Soeki T, Yamakawa K, Masuzaki H, Sata M

    Cardiovascular diabetology   13   30   2014.01

     More details

  • MicroRNA-378 regulates adiponectin expression in adipose tissue: a new plausible mechanism.

    Ishida M, Shimabukuro M, Yagi S, Nishimoto S, Kozuka C, Fukuda D, Soeki T, Masuzaki H, Tsutsui M, Sata M

    PloS one   9 ( 11 )   e111537   2014

  • HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9.

    Hirata Y, Kurobe H, Higashida M, Fukuda D, Shimabukuro M, Tanaka K, Higashikuni Y, Kitagawa T, Sata M

    Atherosclerosis   231 ( 2 )   227 - 33   2013.12( ISSN:0021-9150

  • Ghrelin protects the heart against ischemia-induced arrhythmias by preserving connexin-43 protein.

    Soeki T, Niki T, Uematsu E, Bando S, Matsuura T, Kusunose K, Ise T, Ueda Y, Tomita N, Yamaguchi K, Koshiba K, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Akaike M, Shimabukuro M, Kishimoto I, Kangawa K, Sata M

    Heart and vessels   28 ( 6 )   795 - 801   2013.11( ISSN:0910-8327

  • Expanded roles of the renin-angiotensin system.

    Fukuda D, Sata M

    Hypertension research : official journal of the Japanese Society of Hypertension   36 ( 7 )   586 - 7   2013.07( ISSN:0916-9636

     More details

  • Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis.

    Shimabukuro M, Hirata Y, Tabata M, Dagvasumberel M, Sato H, Kurobe H, Fukuda D, Soeki T, Kitagawa T, Takanashi S, Sata M

    Arteriosclerosis, thrombosis, and vascular biology   33 ( 5 )   1077 - 84   2013.05( ISSN:1079-5642

  • Pharmacology of Aldosterone and the Effects of Mineralocorticoid Receptor Blockade on Cardiovascular Systems.

    Yagi S, Akaike M, Aihara K, Fukuda D, Ishida M, Ise T, Niki T, Sumitomo-Ueda Y, Yamaguchi K, Iwase T, Taketani Y, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Sata M

    Acta Cardiologica Sinica   29 ( 3 )   201 - 7   2013.05( ISSN:1011-6842

     More details

  • Beneficial effect of a synthetic prostacyclin agonist, ONO-1301, in rat autoimmune myocarditis model.

    Hirata Y, Kurobe H, Uematsu E, Yagi S, Soeki T, Yamada H, Fukuda D, Shimabukuro M, Nakayama M, Matsumoto K, Sakai Y, Kitagawa T, Sata M

    European journal of pharmacology   699 ( 1-3 )   81 - 7   2013.01( ISSN:0014-2999

  • Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury.

    Hirata Y, Kurobe H, Nishio C, Tanaka K, Fukuda D, Uematsu E, Nishimoto S, Soeki T, Harada N, Sakaue H, Kitagawa T, Shimabukuro M, Nakaya Y, Sata M

    European journal of pharmacology   699 ( 1-3 )   106 - 11   2013.01( ISSN:0014-2999

  • Ectopic fat deposition and global cardiometabolic risk: new paradigm in cardiovascular medicine.

    Shimabukuro M, Kozuka C, Taira S, Yabiku K, Dagvasumberel M, Ishida M, Matsumoto S, Yagi S, Fukuda D, Yamakawa K, Higa M, Soeki T, Yoshida H, Masuzaki H, Sata M

    The journal of medical investigation : JMI   60 ( 1-2 )   1 - 14   2013( ISSN:1343-1420

     More details

  • Expanding role of delta-like 4 mediated notch signaling in cardiovascular and metabolic diseases.

    Fukuda D, Aikawa M

    Circulation journal : official journal of the Japanese Circulation Society   77 ( 10 )   2462 - 8   2013( ISSN:1346-9843

  • Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice.

    Shiota A, Shimabukuro M, Fukuda D, Soeki T, Sato H, Uematsu E, Hirata Y, Kurobe H, Maeda N, Sakaue H, Masuzaki H, Shimomura I, Sata M

    Cardiovascular diabetology   11   139   2012.11

  • Activation of AMPK-Sirt1 pathway by telmisartan in white adipose tissue: A possible link to anti-metabolic effects.

    Shiota A, Shimabukuro M, Fukuda D, Soeki T, Sato H, Uematsu E, Hirata Y, Kurobe H, Sakaue H, Nakaya Y, Masuzaki H, Sata M

    European journal of pharmacology   692 ( 1-3 )   84 - 90   2012.10( ISSN:0014-2999

  • Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: a 3-dimensional cardiac computed tomography imaging study in Japanese subjects.

    Dagvasumberel M, Shimabukuro M, Nishiuchi T, Ueno J, Takao S, Fukuda D, Hirata Y, Kurobe H, Soeki T, Iwase T, Kusunose K, Niki T, Yamaguchi K, Taketani Y, Yagi S, Tomita N, Yamada H, Wakatsuki T, Harada M, Kitagawa T, Sata M

    Cardiovascular diabetology   11   106   2012.09

  • Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders.

    Fukuda D, Aikawa E, Swirski FK, Novobrantseva TI, Kotelianski V, Gorgun CZ, Chudnovskiy A, Yamazaki H, Croce K, Weissleder R, Aster JC, Hotamisligil GS, Yagita H, Aikawa M

    Proceedings of the National Academy of Sciences of the United States of America   109 ( 27 )   E1868 - 77   2012.07( ISSN:0027-8424

     More details

  • [Endothelial dysfunction].

    Shimabukuro M, Fukuda D, Sata M

    Nihon rinsho. Japanese journal of clinical medicine   70 Suppl 5   236 - 42   2012.07( ISSN:0047-1852

     More details

  • Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation.

    Tang EH, Shvartz E, Shimizu K, Rocha VZ, Zheng C, Fukuda D, Shi GP, Sukhova G, Libby P

    Arteriosclerosis, thrombosis, and vascular biology   31 ( 2 )   261 - 9   2011.02( ISSN:1079-5642

  • [Critical role of renin-angiotensin system in the pathogenesis of atherosclerosis].

    Hirata Y, Fukuda D, Sata M

    Nihon rinsho. Japanese journal of clinical medicine   69 ( 1 )   55 - 9   2011.01( ISSN:0047-1852

     More details

  • Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis.

    Sata M, Fukuda D

    The journal of medical investigation : JMI   57 ( 1-2 )   12 - 25   2010.02( ISSN:1343-1420

     More details

  • Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease.

    Aikawa E, Aikawa M, Libby P, Figueiredo JL, Rusanescu G, Iwamoto Y, Fukuda D, Kohler RH, Shi GP, Jaffer FA, Weissleder R

    Circulation   119 ( 13 )   1785 - 94   2009.04( ISSN:0009-7322

  • [The role of renin-angiotensin system in the pathogenesis of atherosclerosis].

    Hirata Y, Fukuda D, Sata M

    Nihon rinsho. Japanese journal of clinical medicine   67 ( 4 )   707 - 13   2009.04( ISSN:0047-1852

     More details

  • Relation between aortic stiffness and coronary flow reserve in patients with coronary artery disease.

    Fukuda D, Yoshiyama M, Shimada K, Yamashita H, Ehara S, Nakamura Y, Kamimori K, Tanaka A, Kawarabayashi T, Yoshikawa J

    Heart (British Cardiac Society)   92 ( 6 )   759 - 62   2006.06( ISSN:1355-6037

     More details

  • Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.

    Fukuda D, Shimada K, Tanaka A, Kusuyama T, Yamashita H, Ehara S, Nakamura Y, Kawarabayashi T, Iida H, Yoshiyama M, Yoshikawa J

    The American journal of cardiology   97 ( 2 )   175 - 80   2006.01( ISSN:0002-9149

  • Long-term beneficial effect of infarct-related artery patency in acute anterior myocardial infarction in patients with poor myocardial viability in the region-at-risk.

    Fukuda D, Yoshiyama M, Shimada K, Kawarabayashi T, Tanaka A, Ehara S, Nakamura Y, Akioka K, Takeuchi K, Yoshikawa J

    Circulation journal : official journal of the Japanese Circulation Society   68 ( 12 )   1110 - 6   2004.12( ISSN:1346-9843

     More details

  • The impact of IVUS guided bare metal stent implantation for non-small vessel.

    Kataoka T, Shimada K, Fukuda D, Nishioka H, Oda S, Ehara S, Hirose M, Kamimori K, Kobayashi Y, Yoshiyama M, Takeuchi K, Yoshikawa J

    Osaka city medical journal   50 ( 2 )   79 - 86   2004.12( ISSN:0030-6096

     More details

  • Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study.

    Ehara S, Kobayashi Y, Yoshiyama M, Shimada K, Shimada Y, Fukuda D, Nakamura Y, Yamashita H, Yamagishi H, Takeuchi K, Naruko T, Haze K, Becker AE, Yoshikawa J, Ueda M

    Circulation   110 ( 22 )   3424 - 9   2004.11( ISSN:0009-7322

  • Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery disease.

    Shimada K, Kawarabayashi T, Tanaka A, Fukuda D, Nakamura Y, Yoshiyama M, Takeuchi K, Sawaki T, Hosoda K, Yoshikawa J

    Diabetes research and clinical practice   65 ( 3 )   227 - 34   2004.09( ISSN:0168-8227

  • Implications of plasma concentrations of adiponectin in patients with coronary artery disease.

    Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, Kataoka T, Kamimori K, Shimodozono S, Kobayashi Y, Yoshiyama M, Takeuchi K, Yoshikawa J

    Heart (British Cardiac Society)   90 ( 5 )   528 - 33   2004.05( ISSN:1355-6037

     More details

  • Circulating monocytes and in-stent neointima after coronary stent implantation.

    Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M, Yoshikawa J

    Journal of the American College of Cardiology   43 ( 1 )   18 - 23   2004.01( ISSN:0735-1097

  • Predicting angiographic distal embolization following percutaneous coronary intervention in patients with acute myocardial infarction.

    Fukuda D, Tanaka A, Shimada K, Nishida Y, Kawarabayashi T, Yoshikawa J

    The American journal of cardiology   91 ( 4 )   403 - 7   2003.02( ISSN:0002-9149

  • Assessment of myocardial viability using coronary zero flow pressure after successful angioplasty in patients with acute anterior myocardial infarction.

    Shimada K, Sakanoue Y, Kobayashi Y, Ehara S, Hirose M, Nakamura Y, Fukuda D, Yamagishi H, Yoshiyama M, Takeuchi K, Yoshikawa J

    Heart (British Cardiac Society)   89 ( 1 )   71 - 6   2003.01( ISSN:1355-6037

     More details

  • Lesion characteristics of acute myocardial infarction: an investigation with intravascular ultrasound.

    Fukuda D, Kawarabayashi T, Tanaka A, Nishibori Y, Taguchi H, Nishida Y, Shimada K, Yoshikawa J

    Heart (British Cardiac Society)   85 ( 4 )   402 - 6   2001.04( ISSN:1355-6037

     More details

▼display all

Books and Other Publications

MISC

  • 3830 lead extraction from two patients with left bundle branch area pacing

    Hayashi Y.

    Journal of Arrhythmia   39 ( 4 )   623 - 626   2023.08( ISSN:18804276

     More details

  • 移植後17ヵ月のWATCHMANの内視鏡評価(Endoscopic assessment of WATCHMAN 17 months after implantation)

    Yamazaki Takanori, Yoshiyama Tomotaka, Ito Asahiro, Izumiya Yasuhiro, Fukuda Daiju

    Cardiovascular Intervention and Therapeutics   38 ( 2 )   258 - 259   2023.04( ISSN:1868-4300

  • 心血管代謝障害におけるプロテアーゼ活性化受容体の新たな役割(Emerging roles of protease-activated receptors in cardiometabolic disorders)

    Hara Tomoya, Sata Masataka, Fukuda Daiju

    Journal of Cardiology   81 ( 3-4 )   337 - 346   2023.04( ISSN:0914-5087

  • 治療の実際 動脈硬化合併心房細動患者の治療

    林 央, 福田 大受

    臨牀と研究   100 ( 2 )   251 - 255   2023.02( ISSN:0021-4965

  • LSIM-CTで計測したCTEPD患者の血流低下域比はmPAPと相関する

    山口智大, 泉家康宏, 林央, 林浩也, 柴田敦, 山崎貴紀, 江原省一, 福田大受

    日本肺高血圧・肺循環学会学術集会抄録集(Web)   8th   2023

     More details

  • 高血圧診療におけるARNIへの期待~ARBからARNIへ~

    山崎貴紀, 工藤新三, 泉家康宏, 福田大受

    日本心臓病学会学術集会(Web)   71st   2023

     More details

  • 血管内視鏡により静脈内血栓と鑑別した静脈内腫瘍浸潤の一例

    林浩也, 若狭志保, 山崎貴紀, 泉家康宏, 福田大受

    静脈学(Web)   34 ( 2 )   2023( ISSN:2186-5523

     More details

  • 心血管代謝疾患におけるDNAセンサーの役割

    福田 大受

    大阪市医学会雑誌   71   9 - 16   2022.12( ISSN:0386-4103

     More details

    慢性炎症はインスリン抵抗性,動脈硬化症などの心血管代謝疾患の病態基盤となる.しかしながら,無菌性慢性炎症の基盤メカニズムの全体像は未解明である.糖尿病や脂質異常症,高血圧などの様々な生活習慣に関連したリスク因子は,代謝臓器や血管組織において,細胞や組織のダメージを誘発し,種々のパターン認識受容体に対する様々な内因性リガンドを放出させる.近年,ダメージを受けた細胞から放出されるDNA断片などの核酸は,組織内に蓄積し,内因性リガンドとして役割を果たすことが明らかになってきた.生体内には,核酸断片を認識する受容体(DNAセンサー)が存在している.DNAセンサーは,本来,病原体由来のDNA断片を認識し,強力な免疫反応を誘導することで,生体防御システムとして作用する.しかし,最近の研究によって,DNAセンサーは,自己細胞由来のミトコンドリアDNAなどの核酸断片をも認識することにより,無菌性炎症を惹起し,種々の炎症性疾患の病態に関与することが明らかになってきた.本稿では,複数あるDNAセンサーのうち,エンドソームに局在するToll様受容体9と細胞質内に存在するcyclic GMP-AMP synthase-stimulator of interferon genesが,心血管代謝疾患の病態に与える影響を概説する.(著者抄録)

  • 320列CT冠動脈血管造影を用いた冠動脈病変と胸部大動脈プラークの包括的診断法の開発とその臨床的意義の探索

    大塚 憲一郎, 笠行 典章, 福田 大受

    福田記念医療技術振興財団情報   ( 35 )   115 - 121   2022.12

     More details

    冠動脈CT血管造影(CCTA)-Wide Volume Scan(WVS)により冠動脈疾患と胸部大動脈プラークを同時に評価し、心血管予後との関連について検討した。2017年4月~2019年11月の期間にCCTA-WVS検査により冠動脈疾患の評価と大動脈弓を含む胸部大動脈の評価を行った胸痛患者455名(男性234名、女性221名、平均65±13歳)を対象とした。CCTA-WVS所見は冠動脈石灰化スコア0、0~100、101~400、>400がそれぞれ42.9%、26.8%、20.6%、11.2%であった。平均2.8±0.9年の追跡期間中、445例中34例(7.6%)に主要有害事象(MACE)を認めた。吹田CVDリスクスコアで調整したCox比例ハザードモデルでは、冠動脈石灰化スコア>400と胸部大動脈プラークスコア(T3)が心血管イベント発症の独立した予測因子であった。CCTA-WVSを用いた胸部大動脈プラークスコアと冠動脈疾患の包括的評価が心血管イベントリスクの層別化に貢献できると考えられた。

  • 選択的鉱質コルチコイド受容体拮抗薬エサキセレノンは血管機能とアテローム性動脈硬化を減弱させる(A selective mineralocorticoid receptor antagonist, esaxerenone, attenuates vascular function and atherosclerosis)

    Munkhjargal Uugantsetseg, 福田 大受, 佐田 政隆

    日本老年医学会雑誌   59 ( 4 )   595 - 595   2022.10( ISSN:0300-9173

  • 高脂肪食による肥満マウスにて、選択的鉱質コルチコイド受容体拮抗薬エサキセレノンはインシュリン感受性を改善する(A selective mineralocorticoid receptor blocker, esaxerenone, improves insulin sensitivity in diet induced obese mice)

    Bavuu Oyunbileg, 福田 大受, 佐田 政隆

    日本老年医学会雑誌   59 ( 4 )   595 - 595   2022.10( ISSN:0300-9173

  • 24時間自由行動下血圧測定での血圧変動性と心房細動カテーテルアブレーション後の再発に関する検討

    伊藤 文花, 伊藤 朝広, キム・アンドリュー・ティー, 小川 真奈, 北田 諒子, 石川 世良, 岩田 真一, 泉家 康宏, 福田 大受

    日本心臓病学会学術集会抄録   70回   O - 2   2022.09

  • 夜間血圧、夜間心拍と心血管疾患患者の予後予測に関する検討

    キム・アンドリュー・ティー, 伊藤 朝広, 伊藤 文花, 小川 真奈, 北田 諒子, 石川 世良, 岩田 真一, 泉家 康宏, 福田 大受

    日本心臓病学会学術集会抄録   70回   O - 4   2022.09

  • 【アルドステロンをめぐる臨床課題】血管リモデリングとアルドステロン

    八木 秀介, Uugantsetseg Munkhjargal , 門田 宗之, Bavuu Oyun Bileg , Munkhtsetseg Tserensonom , 原 知也, 數藤 久美子, 伊勢 孝之, 福田 大受, 佐田 政隆

    糖尿病・内分泌代謝科   55 ( 2 )   164 - 169   2022.08( ISSN:2435-1946

  • 【アルドステロンをめぐる臨床課題】血管リモデリングとアルドステロン

    八木 秀介, Uugantsetseg Munkhjargal, 門田 宗之, Bavuu Oyun Bileg, Munkhtsetseg Tserensonom, 原 知也, 數藤 久美子, 伊勢 孝之, 福田 大受, 佐田 政隆

    糖尿病・内分泌代謝科   55 ( 2 )   164 - 169   2022.08( ISSN:2435-1946

  • マクロファージ特異的DNaseII欠損が動脈硬化に与える影響

    數藤 久美子, 佐田 政隆, 福田 大受

    日本動脈硬化学会総会プログラム・抄録集   54回   207 - 207   2022.07( ISSN:1347-7099

  • Emerging Roles of the Innate Immune System Regulated by DNA Sensors in the Development of Vascular and Metabolic Diseases(和訳中)

    Fukuda Daiju, Pham Phuong Tran, Sata Masataka

    Journal of Atherosclerosis and Thrombosis   29 ( 3 )   297 - 307   2022.03( ISSN:1340-3478

  • 両心不全で搬送された超高齢慢性血栓塞栓性肺高血圧症の一例

    山口智大, 泉家康宏, 林央, 林浩也, 柴田敦, 山崎貴紀, 福田大受

    脈管学(Web)   62 ( supplement )   2022( ISSN:1880-8840

     More details

  • 両上肢深部静脈血栓症をきっかけに肺癌が疑われるも早期診断に至らなかった一例

    林浩也, 林央, 山崎貴紀, 泉家康宏, 福田大受

    日本腫瘍循環器学会学術集会抄録集(Web)   5th   2022

     More details

  • Stimulator of interferon genesは血管の炎症と動脈硬化を促進する

    福田 大受, Phuong Tran Pham, 佐田 政隆

    日本動脈硬化学会総会プログラム・抄録集   53回   191 - 191   2021.10( ISSN:1347-7099

  • 【糖尿病専門医に必要な心不全の知識update】SGLT2阻害薬と心不全

    八木 秀介, 福田 大受, 平田 有紀奈, Byambasuren Ganbaatar, Arief Rahadian, 伊勢 孝之, 楠瀬 賢也, 山田 博胤, 山口 浩司, 松浦 朋美, 飛梅 威, 曽我 朋宏, 添木 武, 若槻 哲三, 川人 伸次, 佐田 政隆

    糖尿病・内分泌代謝科   52 ( 3 )   257 - 264   2021.03( ISSN:2435-1946

  • 冠動脈アテローム硬化症の病態形成における心外膜下脂肪組織の役割 最近の知見のアップデート(Roles of Epicardial Adipose Tissue in the Pathogenesis of Coronary Atherosclerosis: An Update on Recent Findings)

    Tanaka Kimie, Fukuda Daiju, Sata Masataka

    Circulation Journal   85 ( 1 )   2 - 8   2020.12( ISSN:1346-9843

  • 動脈硬化抑制に向けた直接経口抗凝固薬の可能性

    田中 君枝, 福田 大受, 佐田 政隆

    脈管学   60 ( 10 )   171 - 179   2020.10( ISSN:0387-1126

     More details

    冠動脈の動脈硬化プラークが破綻すると血栓が形成され,急激な管腔閉塞により心筋梗塞や不安定狭心症の原因となる。血栓形成には,血小板と血液凝固系の両方が関与する。血液凝固因子は,血管構成細胞のプロテアーゼ活性型受容体の活性化を介して血管の炎症にも関与する。最近の臨床試験で直接経口抗凝固薬は,抗血小板薬との併用により動脈硬化疾患の二次予防に有効であった。この効果には抗炎症作用も寄与している可能性がある。(著者抄録)

  • Erratum: The evaluation of aortic stenosis, how the new guidelines are implemented across Europe: a survey by EACVI (European Heart Journal - Cardiovascular Imaging (2020) 21 (357-362) DOI: 10.1093/ehjci/jeaa009)

    Kusunose K.

    European Heart Journal Cardiovascular Imaging   21 ( 7 )   2020.07( ISSN:20472404

     More details

  • 心血管代謝疾患における最近発見されたToll様受容体9の役割(Emerging roles of Toll-like receptor 9 in cardiometabolic disorders)

    Nishimoto Sachiko, Fukuda Daiju, Sata Masataka

    Inflammation and Regeneration   40   1 of 13 - 13 of 13   2020.07( ISSN:1880-9693

  • 血管の炎症と動脈硬化における核酸受容体の役割

    福田 大受, 佐田 政隆

    Anti-aging Science   11 ( 1 )   59 - 59   2019.12( ISSN:1884-3891 ( ISBN:9784779223440

  • Assessment of Left Ventricular Ejection Fraction From Echocardiographic Images Using Deep Learning Algorithm

    Kenya Kusunose, Akihiro Haga, Takashi Abe, Daiju Fukuda, Hirotsugu Yamada, Masataka Sata

    CIRCULATION   140   2019.11( ISSN:0009-7322 ( eISSN:1524-4539

     More details

    Publishing type:Research paper, summary (international conference)  

    0

  • 医学と医療の最前線 動脈硬化研究の最近の進歩

    田中 君枝, 平田 陽一郎, 福田 大受, 佐田 政隆

    日本内科学会雑誌   108 ( 8 )   1607 - 1616   2019.08( ISSN:0021-5384

  • 糖尿病と動脈硬化 血液凝固因子と動脈硬化 新規経口抗凝固薬の血管保護効果について

    福田 大受, 佐田 政隆

    糖尿病合併症   33 ( 1 )   85 - 87   2019.06

  • 糖尿病と動脈硬化 血液凝固因子と動脈硬化 新規経口抗凝固薬の血管保護効果について

    福田 大受, 佐田 政隆

    糖尿病合併症   33 ( 1 )   85 - 87   2019.06

▼display all

Presentations

▼display all

Outline of education staff

  • 循環器内科学